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SUMMARY 
The aim of these studies was to utilise the thy-1-YFP-H transgenic mouse strain to 
investigate the effects of exogenous agents and the use of nerve conduits on peripheral 
nerve repair, while developing analysis methods to quantify nerve regeneration in this strain. 
Using a thy-1-YFP-H mouse common fibular nerve repair model, two potential nerve 
regeneration enhancing agents [mannose-6-phosphate and EC23] and four conduit designs 
were assessed. 
The outcomes of the experiments were measured by analysing whole mount images of the 
repaired nerves and comparing: axon numbers across the repairs, the proportion of unique 
axons reaching set distances within the repairs, and the disruption of axons as they entered 
the repairs. Of the two potential nerve regeneration enhancing agents [administered by pre-
soaking the graft tissue and injections into the surrounding tissue] mannose-6-phosphate 
was shown to significantly reduce the disruption of axons entering the graft, which tied in 
with results of previous studies on mannose-6-phosphate. EC23 did not appear to have any 
significant effect upon nerve regeneration, displaying similar results to vehicle treated grafts. 
Within the conduit studies, both micro-stereolithography produced hollow conduit designs 
proved successful at enabling regeneration across a short nerve defect - with quantitative 
results similar to graft repairs - however, axon organisation within those repairs was greatly 
reduced. The other two conduit designs [aligned fibre filled and hollow nylon-12] were less 
successful, with limited regeneration occurring across the nerve defect. 
Through the results of these studies the usefulness of the thy-1-YFP-H transgenic mouse 
strain in assessing nerve regeneration has been further established. The ability to trace the 
fate of individual axons through repairs reveals much information that was previously not 
possible or very difficult to obtain. In addition, the ability to obtain results in only 2-3 weeks 
makes this model ideal for obtaining useful data quickly for pilot studies.   
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remaining definitions. 
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†, †† and ††† denote significant differences in level compared to uninjured controls, p<0.05, 
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Figure 6.10: Percentages of start axons represented at subsequent 0.5mm intervals; * and 
*** denote significant difference compared to graft repairs, p<0.05 and p<0.001 respectively; 
† and ††† denote significant difference compared to uninjured controls, p<0.05 and p<0.001 
respectively. 
Figure 6.11: Percentage increase in axon length across the initial 1.5mm of repair; * denotes 
significant difference compared to uninjured controls, p<0.05. 
Figure 6.12: Effects of conduit compression on nerve regeneration. Left: Narrow internal 
diameter of conduit [blue] constricts regenerating nerve, impeding regeneration of outer 
axons [red] while inner axons [green] are cushioned by connective tissue. Right: Wider 
internal diameter allows nerve to regenerate unimpeded. 
Figure 6.13: Representation of the impact of conduit wall size on sectioned nerve ending 
positioning. 
Figure 7.1: Close-up view of YFP nerve with suspected blood vessels obscuring fluorescent 
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Figure 7.2: Example of fluorescence leaching into non-axonal tissues in 6-month post-
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1.0 INTRODUCTION 
The body of work presented within this thesis utilises a transgenic mouse strain - 
thy-1-YFP-H - to develop a range of analysis methods for assessing nerve regeneration in a 
peripheral nerve repair model. These methods were used to assess the regeneration of 
injured peripheral nerves following a variety of interventions carried out using the 
thy-1-YFP-H peripheral nerve repair model.    
Prior to discussing results of the studies carried out I will provide a general overview of the 
current state of knowledge on peripheral nerve injuries and their repair. 
1.1 CAUSES AND IMPACT OF NERVE INJURIES 
Injuries to the peripheral nerves are commonplace throughout the world, with a reported 
300,000 cases annually in Europe alone (Ciardelli and Chiono, 2006). These range from 
minor compression injuries and simple transections, through to injuries associated with 
severe lacerations or avulsion fractures.  
Of the vast number of potential causes of peripheral nerve injury [PNI] motor vehicle 
accidents account for a large percentage among the general population [43.9%]; more than 
three-quarters of non-iatrogenic civilian PNIs can be accounted for when combining the 
number of injuries caused by motor vehicle accidents with those caused by falls and 
laceration/penetration injuries [77.8%] (Kouyoumdjian, 2006). One particular injury 
associated with motor vehicle accidents is to the brachial plexus, which consists of a series 
of major nerve trunks originating from the C5 to T1 spinal nerves that come together near 
the shoulder joint (Orebaugh and Williams, 2009). It is estimated that around 1.2% of 
multiple-trauma patients suffer an injury to the brachial plexus and of those patients the 
causative factor is stated as motor vehicle accident in 21-29% of cases and motorcycle 
accident in 22-27% (Midha, 1997, Dubuisson and Kline, 2002).  
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Bone fractures and dislocations are another important cause of PNIs, with the median and 
radial nerves in the arms appearing particularly susceptible. Galbraith and McCulloch (1979) 
reported an incidence of 1.4% [over a seven year period] of nerve injuries associated with 
fractures and dislocations of the elbow. A more recent study by Senes et al. (2009) reported 
that 42.9% of PNIs resulting from upper limb trauma were as a result of bone fractures - 
84.4% of those involved either median or ulnar nerves.       
Both upper and lower extremities appear to suffer a higher level of nerve injuries than the 
torso, perhaps in part as a result of the higher range of flexibility and movement required by 
the limbs. In a military setting it has been estimated that 30% of combat injuries to the 
extremities include PNIs (Roganovic and Petkovic, 2004). Schulz et al. (2012) reported that, 
over a recent three year period, 5.8% of neurological surgical procedures carried out at an 
Afghanistan field hospital were for PNIs. In the past, this high incidence of PNIs sustained by 
military personnel in wars has proven to be an important factor in driving forward the 
understanding of PNIs and methods to repair them (Seddon, 1943).   
The surgical setting is another area where a significant number of nerve injuries occur. In a 
study by Kretschmer et al. (2001) it was reported that, over a nine-year period at one nerve 
centre, 4.5% of all operations to repair PNIs were iatrogenic in origin, with the largest 
proportion as a result of orthopaedic surgeries. Location plays an important role in iatrogenic 
injuries for certain nerves: for example, those in the mandibular branch of the trigeminal 
nerve are at relatively high risk of becoming damaged during extraction of the lower third 
molars due to their close proximity to the roots of those teeth (Holland and Robinson, 1998, 
Fried et al., 2001). In addition, procedures involving general anaesthesia can result in 
indirect nerve injuries, often in the upper extremities and possibly as a result of a patient's 
position during the procedure (Kroll et al., 1990, Cheney et al., 1999, Welch et al., 2009).    
Aside from the impact upon the patient there is the potential for litigation against the surgeon 
and medical institution, a previous study reported that from 2500 medical liability cases, 217 
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[8.7%] were for iatrogenic PNIs (Mullervahl, 1984). Two closed claims analyses by Kroll et 
al. (1990) and Cheney et al. (1999) which looked at anaesthesia related nerve injuries 
reported 15% - 16% of claims in the American Society of Anesthesiologists Closed Claims 
Project Database were for nerve injuries related to anesthesia. The median compensation 
payments related to these claims were $18,000 (Kroll et al., 1990) and $35,600 (Cheney et 
al., 1999), though in both studies the median payments for nerve injury claims were 
significantly lower than non-nerve injury claims.      
Although the impact of peripheral nerve injuries will naturally vary between cases - based on 
severity, permanence and location - most injuries will have a major effect on the quality of 
life of a patient. Declines in both physical and psychological quality of life, along with 
increased indications of clinical depression, have been shown in studies assessing the 
impact of upper extremity nerve injuries (Bailey et al., 2009). Moreover, the level of post-
traumatic stress following traumatic injuries to the arms and hands, which often result in 
PNIs, has been quoted as being equivalent to that experienced by survivors of a high 
mortality shipwreck (Ruijs et al., 2005). Damage to nerves supplying the mouth and lips can 
be extremely traumatic, as symptoms often include problems with speech and taste 
(Hillerup, 2007). 
The poor prognosis for recovery of function in many nerve injuries is likely an important 
factor in the increase of depression and decrease in quality of life perceived by patients. 
Despite many important breakthroughs and discoveries, and the ability of peripheral nerves 
to regenerate following injury, full functional recovery following surgical intervention is still 
unpredictable and never complete (Robinson et al., 2000). The morphology of individual 
nerves and the complex anatomy of peripheral nerves as a whole is a key factor in this 
failure of complete regeneration. 
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1.2 THE INTACT PERIPHERAL NERVE 
The peripheral nervous system [PNS] is a complex network of nerves consisting of 12-pairs 
of cranial nerves and 31-pairs of spinal nerves, each made up of many thousands of 
individual nerve cells connecting a wide variety of end organs with the central nervous 
system [CNS] (Fernandez et al., 1996, Zochodne, 2008).  
Information flows to and from the CNS via individual sensory and motor nerve cell axons. 
These axons can be either myelinated or unmyelinated: myelinated axons are individually 
enveloped by the myelin sheath from a series of Schwann cells running along the length of 
the axon. Each individual Schwann cell myelinates a separate section of the axon - these 
myelinated sections are termed internodes as they separate areas of bare axon called nodes 
of Ranvier (Vizoso and Young, 1948, Lascelle and Thomas, 1966). The length of these 
internodes is an important factor in nerve function, with faster conductance achieved in 
axons with longer internodes (Wu et al., 2012). The length of the internodes of nerves 
increase linearly in relation to the diameter of the nerve, with larger diameter nerves 
possessing internodes of longer length (Boycott, 1903, Vizoso and Young, 1948, Cragg and 
Thomas, 1964, Lascelle and Thomas, 1966). Once an axon is myelinated the number of 
internodes it has remains constant, with the only change being the increase in length of the 
internodes to accommodate a juvenile animal's transition to adult (Vizoso and Young, 1948, 
Vizoso, 1950).     
Unmyelinated axons are not, as the name suggests, completely devoid of Schwann cell 
myelination - the axons are grouped together within myelin from a single Schwann cell at 
each internode, forming a Remak bundle (Geuna et al., 2009, Kaplan et al., 2009). A large 
proportion of axons in the mammalian PNS are unmyelinated, with myelination generally 
occurring in larger diameter [1.5µm and above] axons (Matthews, 1968). In the dorsal and 
ventral spinal roots the percentages of unmyelinated axons are 75% and 30% respectively 
(Geuna et al., 2009). 
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Within a peripheral nerve the neuronal axons are bound together by connective tissue 
sheaths. The endoneurium surrounds the axons of individual nerve cells, the perineurium 
surrounds bundles of endoneurial tubes [known as fascicles], and the epineurium is the 
outer layer of nerve tissue responsible for much of the protection required by the nerve [fig. 
1.1](Geuna et al., 2009). 
The endoneurium consists mainly of type I and III collagen along with endoneurial fluid, 
blood vessels and a variety of cells [mainly Schwann and endothelial cells]. It functions to 
protect the fascicles from blunt trauma and each fascicle within a nerve is surrounded by the 
perineurium (Zochodne, 2008, Geuna et al., 2009)[fig. 1.1]. 
The perineurium is a dense, strong sheath that is made up of layers of collagen and 
epithelium-like cells, with these layers arranged in an alternating pattern. Towards the outer 
edge of the perineurium the alternating collagen/cell layers give way to fibrous tissue which 
merges with the epineurium (Geuna et al., 2009)[fig. 1.1].     
The epineurium [which is also known as the epineural sheath] is the outer layer of a nerve 
and contains blood and lymph vessels and cells, such as resident macrophages, fibroblasts, 
and mast cells. It is mostly made up of type I collagen with some elastic fibres and it's 
structure, along with its limited connection to other local tissues, allows the nerve to slide into 
different positions and extend [to a limited extent] during movement (Zochodne, 
2008)[fig. 1.1].  
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Figure 1.1: Diagram showing the general structure of a peripheral nerve trunk (Weber and 
Dellon, 2004) Used with permission from Lippincott Williams and Wilkinson, 
http://www.lww.com/Product/9780781728744.  
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1.3. CLASSIFICATION OF PERIPHERAL NERVE INJURIES 
1.3.1 Seddon's Classification. 
The first published attempt at classifying nerve injuries was made by H. J. Seddon and 
published in 1943. At that time the terms used in situations where nerve damaged had 
occurred tended to describe 'how' the injury had occurred [e.g. compression, contusion etc.] 
rather than describing the actual injury suffered by the nerve (Seddon, 1943). Seddon 
defined three types, or grades, of nerve injury; neurotmesis, axonotmesis and neurapraxia - 
the terms used were suggested by Professor Henry Cohen (Seddon, 1943). 
Neurapraxia is the mildest nerve injury type in Seddon's classification and, unlike 
axonotmesis and neurotmesis, no Wallerian degeneration occurs following the injury. It is 
often caused by blunt trauma or compression and is essentially a temporary block in axonal 
conductance. Recovery from the associated, often incomplete impairment is rapid and 
complete (Seddon, 1943). 
In Seddon's classification the next level of nerve injury is termed axonotmesis; this type of 
injury occurs when individual axons become disrupted to the extent that Wallerian 
degeneration takes place. With axonotmesis the supporting structures remain relatively 
intact which allows the damaged nerve to recover, spontaneously, to a good level of 
functionality (Seddon, 1943). 
The term used for the most severe level of nerve injury in Seddon's classification is 
neurotmesis; this type of injury involves the complete transection of all essential structures in 
the nerve and has the poorest prognosis for recovery. The main difficulty for the 
regenerating nerve fibres is that the supporting structures, that in the case of axonotmesis 
would serve to guide them to where they should be, have also been damaged (Seddon, 
1943). The retraction of the nerve stumps following neurotmesis is another major factor in 
the ability of the nerve to regenerate successfully, as without surgical repair the nerve fibres 
would need to bridge a potentially significant gap.         
8 
 
1.3.2 Sunderland's Classification. 
Expanding the concepts proposed by Seddon in 1943, S. Sunderland proposed a method of 
classification which involved five degrees of nerve injury [fig. 1.2]. Sunderland's classification 
is comparable with Seddon's, with a 1st degree injury equivalent to neurapraxia, 2nd, 3rd & 4th 
degree injuries roughly equivalent to varying severities of axonotmesis and 5th degree 
injuries roughly equivalent to neurotmesis (Sunderland, 1951). 
In 1st degree nerve injuries [fig. 1.2a], as in neuropraxia, a blunt trauma or compression of 
the nerve results in a conduction block; this block can result in paralysis due to loss of nerve 
motor function, and also sensory impairment. Both motor and proprioceptor function [the 
ability to know the position of one's limbs/body] are affected more than the sensations of 
touch and pain, with the latter sensations regained earlier during recovery (Sunderland, 
1978). Unlike the more severe degrees of injury, where axon conductance is lost distal to the 
lesion, in 1st degree injuries distal nerve fibres are still excitable – although not across the 
lesion area (Fowler et al., 1972, Sunderland, 1978). Recovery from 1st degree injury is 
spontaneous; sensory function is first to return followed by motor function. Recovery of 
motor function in this type of nerve injury, unlike nerve injuries where the axon is transected, 
does not have a sequential recovery order related to the distance that the innervated muscle 
is from the lesion and muscles will either recover function simultaneously or in a random 
order over the course of a few days (Sunderland, 1978). In experimental studies 
relationships between the length of time of compression and recovery [longer compression 
time resulting in longer recovery time] and also between the length of compressed nerve and 
recovery [a longer section of nerve compressed resulting in longer recovery] have been 
established (Fowler et al., 1972, Rudge et al., 1974, Sunderland, 1978), although clinical 
observations often differ. Occasionally the instigation of recovery is delayed until exploratory 
surgery and neurolysis is performed, in those cases that are not simply coincidental this is 
due to continued pressure from fibrous tissue in the local area that is relieved during the 
surgical procedure (Sunderland, 1978).  
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In 2nd degree nerve injury [fig. 1.2b] the continuity of the axon is compromised, either by the 
distal portion becoming detached or axonal mechanisms becoming disrupted to the extent 
that the distal portion fails to survive (Sunderland, 1978). Other than the damage to the 
axon, the nerve is relatively damage free; with the endoneurium surrounding each axon 
remaining continuous. Wallerian degeneration occurs due to the loss of axon continuity and 
the axon, along with its myelin sheath, is broken down - this results in the target organ 
becoming denervated (Sunderland, 1978). As the nerve must regenerate axons in order to 
reinnervate its target, the recovery time is longer than in 1st degree injury and muscles 
supplied by the nerve demonstrate signs of atrophy. Overall recovery of the nerve is good 
due to affected axons being constrained to their original endoneurial tube, which guides 
them along their original pathway to their target synapse - in some exceptional cases some 
minor traces of nerve defect remain due to the loss of axons (Sunderland, 1978). There are 
influencing factors that determine the length of time between the injury occurring and full 
recovery of function, such as the level of injury [how far the axons need to re-grow], rate of 
axon growth and how long the affected tissues are denervated. Reinnervation occurs in a 
systematic fashion, with the target organs closest to the lesion recovering prior to ones 
further away (Sunderland, 1978).           
In 3rd degree injury [fig. 1.2c] there is intra-fascicular damage which results, in addition to the 
axon severance seen in 2nd degree injury, in the loss of endoneurial continuity within 
fascicles. The loss of endoneurial continuity is an important factor in the additional recovery 
time and poorer functional recovery of 3rd degree injury when compared to 2nd degree injury 
(Sunderland, 1978). As axons are no longer constrained to their original endoneurial tube 
there is a significant chance that they may enter the wrong endoneurial tube distal to the 
lesion or fail to reach a distal endoneurial tube at all. An additional obstacle for axons to 
overcome is the fibrosis that forms within the fascicle due to the intra-fascicle damage 
suffered [haemorrhage, oedema, ischemia]. This fibrosis causes the rate of regeneration of 
axons to slow and can also block and divert axons away from their intended path 
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(Sunderland, 1978). As the regenerating axons may enter the wrong distal endoneurial tubes 
or become delayed by fibrosis, the subsequent re-innervation usually occurs in a much less 
systematic manner than in 2nd degree injuries and in addition is much less complete due to 
an increase in neurone death in addition to axon misguidance (Sunderland, 1978).  
Differences in the level of impact of 3rd degree injuries can occur as a result of the affected 
fascicles composition; with injuries to fascicles containing axons wholly responsible for motor 
function resulting in localised paralysis but mixed axon fascicle injuries often resulting in 
more wide spread parethisis and sensory impairment (Sunderland, 1978). 
 With 4th degree nerve injury [fig. 1.2d] the continuity of the perineurium is affected in 
addition to the epineurium, resulting in axons being able to enter the intra-fascicular space 
with the potential to form painful neuromas. An increase in fibrosis formation, neuronal cell 
death and difficulty in axons reaching the correct epineurial tube result in very poor, if any, 
true functional recovery without surgical intervention (Sunderland, 1978). 
Corresponding to Seddon's neurotmesis, 5th degree nerve injury [fig. 1.2e] involves the 
complete disruption of the nerve, to the extent that the portion of nerve distal to the lesion 
site is no longer physically connected to the portion proximal of the lesion. This exacerbates 
the problems observed in 4th degree nerve injury as, in addition to navigating across the gap 
formed when the nerve is transected, there is also considerable scar tissue formation in the 
area surrounding the lesion site (Sunderland, 1978) and potential for infection in cases 
where the injury is caused by an external object piercing the skin. The severity of this degree 
of injury often leads to significant neurone death and, with many of the axons of remaining 
neurons unable to navigate successfully to the distal stump, functional recovery is negligible. 
Additional features of 5th degree nerve injury that add to the difficulty of regeneration are that 
the distal end often shrinks in diameter following transection leading to a difference in the 
cross-sectional area between nerve ends, and the pattern of fascicles is affected during the 
injury event - especially if, rather than a straight forward clean cut, some of the nerve tissue 
is destroyed or removed (Sunderland, 1978).   
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 Figure 1.2: Simple diagrammatical representation of nerve injuries in Sunderland’s 
classification  system. A) 1st degree injury - transient conductance block. B) 2nd degree injury 
- severance of axon. C) 3rd degree injury - severance of axon and endoneurial sheath. D) 4th 
degree injury - severance of axon, endoneurial sheath and perineurium. E) 5th degree injury - 
complete severance of nerve.  
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1.4. EVENTS IN THE PERIPHERAL NERVE FOLLOWING INJURY 
In nerve injuries where the continuation of axons is interrupted, Wallerian degeneration is 
instigated within hours, along with numerous other changes around both the injury site and 
the cell bodies of neurons affected. Within the first few hours of transection the axons reseal 
their ends in order to prevent the continued loss of axoplasm and Schwann cells change 
from their seemingly dormant state to a more active state and undergo hypertrophy of the 
cytoplasm (Lubinska, 1982, Zochodne, 2008) 
In the first twenty-four hours following injury a number of important events take place: 
calcium dependant axonal degeneration, down regulation of myelin synthesis and retraction 
of cytoplasm from the myelin sheath by Schwann cells, and the loss of nerve action 
potentials (Brueck, 1997). The calcium dependant degeneration of axons occurs due to an 
influx of calcium into the nerve environment which modulates the activity of local enzymes 
involved in the degeneration of enzymes. Calpain is one enzyme whose activation appears 
critical in triggering axon degeneration (Schlaepfer and Hasler, 1979, George et al., 1995), 
and is necessary in order to clear the distal section of the nerve for the regenerating axons 
to travel through. This degeneration has been shown to be a pre-requisite of sensory nerve 
regeneration (Bisby and Chen, 1990), although some experiments involving motor neurons 
did not display the same inhibitory effects (Lunn et al., 1989). In a study by Sørensen et al. 
(2001) axonal outgrowth only occurred in sections of nerve that had been cleared of myelin 
and axonal sprouts did not enter areas containing intact myelin debris. Some early studies 
identified this apparent passive degeneration process as the solitary mechanism of direct 
axonal degeneration with the cessation of the supply of proteins from the cell body also an 
indirect factor (Schlaepfer and Hasler, 1979). The discovery of the role of various cytokines, 
chemokines, growth factors and adhesion molecules, along with studies on C57BL/Wlds-
mutant mice [which have axons resistant to Wallerian degeneration] demonstrated the multi-
mechanistic and active process nature of Wallerian degeneration following injury (Coleman 
and Perry, 2002, Martini et al., 2008).   
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The breakdown and clearance of myelin is another key event in Wallerian degeneration with 
Schwann cells playing a key role in the process. Shortly after injury Schwann cells proliferate 
rapidly and change to a more active phenotype that, instead of maintaining myelination of 
the axon, is geared towards the breakdown and phagocytosis of myelin (Clemence et al., 
1989). How Schwann cells become activated is not fully understood, however, the binding of 
endogenous molecules [such as mRNA] derived from damaged nerves to toll-like receptors 
[TLRs] expressed on the surface of Schwann cells is implicated (Karanth et al., 2006, Lee et 
al., 2006). Once activated Schwann cells begin expressing monocyte chemotactic protein-1 
[MCP-1], which in turn is linked to the expression of members of the phospholipase A2 
[PLA2] family of enzymes (Martini et al., 2008). Two forms of PLA2 have been identified as 
being present in the very early stages following nerve injury; group IIA sPLA2 [a secreted 
form] and group IVA cPLA2 [a cytosolic form] and their expression correlates with the rate of 
Wallerian degeneration (De et al., 2003). PLA2s hydrolyse membrane phospholipids and 
when hydrolysed phosphotidylcholine - found in high quantities in myelin membranes - 
becomes lysophosphotidylcholine [LPC]: a potent myelinolytic agent [fig. 3] (Hall and 
Gregson, 1971, Martini et al., 2008) which can initiate signs of demyelination in 30 minutes 
when injected into peripheral nerves (Hall and Gregson, 1971). 
Although local Schwann cells are capable of a certain amount of myelin degradation and 
clearance, perhaps enough to clear myelin from small myelinated fibres (Stoll et al., 1989), 
the presence of macrophages recruited to the area by Schwann cell signalling enables 
further degradation and clearance along with the triggering of rapid Schwann cell 
proliferation (Clemence et al., 1989, Kubota et al., 1998, Liu et al., 2000). 
Despite the ability of Schwann cells to degrade myelin and also proliferate to some extent [in 
part through assistance of the local macrophage population] (Fernandezvalle et al., 1995) 
and actively participate in Wallerian degeneration (Shen et al., 2000), it is recruited 
hematogenous macrophages that enable the rapid degredation and clearance of myelin 
(Beuche and Friede, 1984). Beuche and Friede (1984) demonstrated the importance of 
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hematogenous macrophages in Wallerian degeneration in an experiment where sections of 
pre-degenerated peripheral nerves of mice were implanted within the peritoneal cavity within 
diffusion chambers with pore sizes that either excluded macrophages or did not exclude 
macrophages. The results of the experiment showed that when macrophages were 
excluded, limited myelin degradation occurred over a long course of time but the nerves 
where macrophages were not excluded underwent a breakdown of myelin much closer to 
normal Wallerian degeneration. Numerous molecules are linked with hematogenous 
macrophage recruitment following nerve injury, though the exact recruitment process is 
complex, it relies of many different systems and is not fully understood (Martini et al., 2008). 
Monocyte chemoattractant protein-1 [MCP-1] and macrophages inflammatory protein-1α 
[MIP-1α] are known to be important in macrophage recruitment as their inhibition by function 
blocking antibodies has been shown to reduce macrophage numbers in an injured nerve by 
78% (Perrin et al., 2005). Also linked to macrophage recruitment into nerve tissue are 
tumour necrosis factor-α (TNF-α), interleukin-1α [IL-1α] and interleukin-1β [IL-1β], which are 
expressed by Schwann cells and whose deficiency is notable in delayed Wallerian 
degeneration in certain mutant strains of mice (Shamash et al., 2002).  
Once recruited to the site of nerve injury hematogenous macrophages contribute to the 
expression of PLA2 and resultant LPC production, which is capable of activating the 
complement element of the immune system (Hack et al., 1997). The activation of 
complement results in the opsonization of myelin with C3 protein, which enables myelin to 
be phagocytosed at an increased rate due to the increased efficiency of phagocytosis of 
cells and cellular material following opsonization (Kemp and Turner, 1986). As a matter of 
fact, macrophage phagocytosis of myelin is highly dependent on myelin becoming opsonized 
as blocking complement receptor 3, which is one of two phagocytosis mediating receptors 
found on macrophages, halts myelin phagocytosis but blocking of the other, non-
complement dependant, Fc receptor does not (Brueck, 1997). 
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Around 10-20 days after the initiation of Wallerian degeneration the local Schwann cells and 
endoneurial tubes form guidance tubes known as bands of Büngner which provide both 
physical and neurotrophic guidance for regenerating axons and increase the potential for re-
innervation of target organs/tissues (Sunderland, 1978). 
The central ends of damaged axons usually begin sprouting from the first node of Ranvier 
proximal to the site of injury, though some may begin sprouting from the second node of 
Ranvier (Friede and Bischhausen, 1980). Although it is primarily the injured axons that 
sprout, collateral sprouting from nearby uninjured axons can also take place (Zochodne, 
2008). 
The leading edge of the regenerating axon is formed into a structure called the growth cone, 
which has a key role in the navigation and continued growth of the axon. The growth cone 
structure is often compared to a hand - a central 'palm' area contains the terminal ends of 
microtubules and axoplasm from which the web-like lamellipodia emerge and actin filaments 
from the lamellipodia help to form the finger-like extensions called filopodia (Zochodne, 
2008). 
The area of the growth cone consisting of lamellipodia and filopodia is motile and 
responsible for exploration of the local area, responding to various signals that guide the 
regenerating axon towards its target; the filamentous actin [f-actin] that makes up this portion 
of the growth cone is in a state of constant retrograde flow [movement towards the central 
region of the growth cone, powered by myosin connected to a non-moving sub-membranous 
matrix] which is counteracted by what is called f-actin treadmilling [where f-actin subunits are 
moved towards the edge of the filopodia] and it is the balance between these two 
movements that allow filopodia to extend, retract or remain stationary (Mitchison and 
Kirschner, 1988, Lowery and Van Vactor, 2009). The rate of retrograde flow is continuous so 
in order for filopodia to extend or retract the rate of f-actin subunit transportation to the end of 
the filopodia needs to increase or decrease respectively - this is dependent on the 
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availability of f-actin subunits and also the accessibility of the distal f-actin end (Mitchison 
and Kirschner, 1988). Forward movement of the growth cone [rather than just filopodia 
extension] occurs when filopodia bind to adhesion molecules that fix the f-actin in position; 
now the myosin will effectively 'pull' the growth cone forwards, resulting in the extension of 
the axon behind it - this mechanism is often likened to placing a car in gear (Mitchison and 
Kirschner, 1988). 
Axon regeneration following 2nd degree nerve injury, where the axons remain confined to 
their original endoneurial tubes, is considered a simpler process than axon regeneration 
following a more severe injury where the endoneurial tubes are breached. However, the 
actual method of axon regeneration remains the same in either case - figures 1.3 & 1.4 show 
the differences in regeneration between these injuries. 
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Figure 1.3: Axon regeneration following a crush injury resulting in a 2nd degree nerve injury. 
A) Uninjured nerve. B) Crush injury to the nerve. C) Axon sprouting and regenerating along 
original endoneurial tube. D) Successful regeneration. (Holland and Robinson, 1998). 
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Figure 1.4: Axon regeneration following transection injury. A) Uninjured nerve. B) Transection 
injury to the nerve with retraction of severed nerve endings. C) Axon sprouting and attempting 
to find endoneurial tube. D) Potential outcomes for the regenerating axon - finds original 
endoneurial tube and regenerates to original target; enters incorrect endoneurial tube and fails 
to find original target; fails to enter any endoneurial tube and forms a neuroma. (Holland and 
Robinson, 1998). 
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1.5. A BRIEF HISTORY OF SURGICAL PERIPHERAL NERVE REPAIR 
The surgical repair of injured peripheral nerves by direct suturing has long been used in 
order to improve the recovery of sensory and/or motor functionality. Gabriele Ferrara, a 
Milanese surgeon in the late 16th century, is often regarded as being the first to provide an 
accurate description of peripheral nerve suturing and is attributed with being the "father" of  
peripheral nerve reconstruction (Artico et al., 1996). Despite this there were actually many 
previous descriptions of the potential for peripheral nerve regeneration and repair throughout 
the previous centuries from the likes of Galen in the second century and Paul von Aegina in 
the seventh century (Battiston et al., 2009).  
In the mid to late 17th century two early pioneers of microscopy, Robert Hooke and Antonio 
van Leeuwenhoek, ignited scientific interest in the microscopical world with accounts of their 
discovery's using their simple self made microscopes; van Leeuwenhoek giving accounts of, 
amongst many other things, nerve fibres (Gest, 2004, Wade, 2004). Van Leeuwenhoek 
noted that optic nerves happened to be made up of "many filamentous particles", rather than 
being hollow as claimed by anatomists of the period (Wade, 2004). 
In the 19th century, thanks to significant developments in microscope construction (Wade, 
2004), research into the nervous system began to gather pace and key discoveries about 
nerve injury and regeneration were made. In 1850 Augustus Waller published what would 
become a decisive paper in the development of understanding nerve injuries; in this paper 
Waller described events following nerve transection which included axon and myelin 
degeneration distal to the injury (Waller, 1850)  - an event which would later be termed 
"Wallerian degeneration". Later in the 19th century the first descriptions of end-to-side nerve 
repair, autograft and allograft repair, and tubular nerve defect bridging were published 
(Battiston et al., 2009) 
Early in the 20th century there was a great deal of interest and cooperation between clinical 
and basic scientists in the field of peripheral nerve repair and regeneration. However, as the 
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century progressed interest and cooperation began to fade due to doubts over the potential 
for improving nerve regeneration and differences in direction of clinical and basic research - 
with clinical research moving towards optimization of repair techniques and basic research 
moving towards molecular and chemical study (Battiston et al., 2009). In recent years the 
interest in peripheral nerve regeneration has undergone a resurgence with an increase in 
research related to understanding and improving peripheral nerve regeneration which, 
hopefully, will lead to new breakthroughs that can reduce the personal impact of peripheral 
nerve injury. 
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1.6. CURRENT CLINICAL REPAIR TECHNIQUES 
Direct surgical intervention is usually limited to the more severe nerve injuries; mainly 5th 
degree nerve injuries in Sunderland's classification. Any surgery performed on a patient 
exhibiting symptoms of less severe nerve injuries [such as 1st or 2nd degree injuries] is 
usually to reduce pressure on the nerve from surrounding tissues or reduce internal pressure 
within the nerve (Sunderland, 1978, Matz et al., 1989). 
1.6.1 Directly Sutured Repairs. 
The choice of repair technique used is highly dependent on the extent of damage to the 
nerve but in a simple transection with no significant loss of nerve tissue the preferred repair 
method is end-to-end repair. The simplest form of end-to-end repair is epineural repair 
[fig. 1.5], which is used when the nerve injury is a clean full or partial transection where 
fascicles can be easily aligned correctly. This technique usually involves suturing the nerve 
ends together with sutures passing through the epineurium, although fibrin glue can be used 
as an alternative method with the benefit of less foreign material present and reduced 
potential for scar tissue formation (Ornelas et al., 2006a, b). 
When minor trimming of the nerve ends is required grouped fascicle repair can be used. In 
this technique the epineurium is retracted allowing access to the fascicles and then groups 
of fascicles from the central end are approximated to their corresponding distal partners by 
passing sutures through the inter-fascicular epineural space (Siemionow and Brzezicki, 
2009). A third end-to-end repair technique is fascicular repair; which uses sutures through 
the perineurium to align individual fascicles more precisely [fig. 1.6], however, due to its 
technical demands and high number of sutures required it is not a commonly used technique 
(Siemionow and Brzezicki, 2009). Although both grouped fascicular and fascicular repairs 
align the fascicles more precisely than epineural repair, which theoretically should lead to 
less misdirected axons, experimental studies have indicated little advantage when functional 
recovery is evaluated (Lundborg et al., 1997) and there is additional risk of fibrosis formation 
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in the nerve due to the significant increase in the amount of sutures required (Siemionow 
and Brzezicki, 2009). 
 
Figure 1.5: Epineural repair of transected peripheral nerve (Siemionow and Brzezicki, 2009). 
Used with permission from Elsevier Inc. 
 
Figure 1.6: Individual fascicular repair of transected peripheral nerve (Siemionow and 
Brzezicki, 2009). Used with permission from Elsevier Inc. 
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An additional method of end-to-end repair is epineural sleeve repair. In this method the 
epineural sheath of the distal end of the nerve is turned back to expose approximately 2mm 
of nerve tissue, which is then removed. Two sutures are then passed through opposing 
sides of the now excess epineural sheath and it is pulled over the central nerve end and 
secured in position with two additional sutures [fig. 1.7](Lubiatowski et al., 2008). This 
method has been shown to improve the speed of functional recovery in studies when 
compared to the more established end-to-end techniques; with reasons such as the 
epineural sleeve providing a sealed neuro-permissive environment and the transfer of 
tension away from the lesion site both being postulated (Lubiatowski et al., 2008, Siemionow 
and Brzezicki, 2009). 
 
Figure 1.7: Epineural sleeve repair of transected peripheral nerve (Siemionow and Brzezicki, 
2009). Used with permission from Elsevier Inc. 
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Often nerve injuries result in the loss of tissue to the extent that the nerve ends cannot be 
brought together without undue tension, in certain cases the nerve can be repositioned to 
reduce the gap between nerve ends to allow conventional end-to-end repair (Roganovic and 
Petkovic, 2004), if this is not possible the gap can be bridged using a nerve graft. The 
reason that undue tension following a repair is avoided is that the blood flow within the nerve 
is inversely proportionate to the tension in the nerve, with the result that an excessive 
increase of tension will cause ischemia around the repair site and inhibit the regeneration 
process (Siemionow and Brzezicki, 2009). Although nerve grafts allow repair with little or no 
tension they do include a second repair site for the regenerating axons to transverse which 
can cause further axon loss due to the increased potential for scar tissue and misdirection 
(Bratton et al., 1979, Hudson et al., 1979). A number of studies have compared results of 
direct repair under moderate tension with graft repairs and have reported similar outcomes in 
both repair techniques (Bratton et al., 1979, Hudson et al., 1979, Wong and Scott, 1991). 
Thus, direct repair with some tension is preferred, providing the negative impact of the 
tension is lower than the negative impact that the additional repair site in a graft would be 
(Siemionow and Brzezicki, 2009). 
1.6.2 Nerve Graft Repairs. 
Nerve autografts are currently the 'gold-standard' repair technique for bridging nerve gaps 
that would place excessive tension upon the repair site and they involve the harvesting of a 
sensory donor nerve of the correct size from the patient. The choice of donor nerve is 
influenced by factors such as the size of the nerve gap and the morbidity at the donor site, 
sensory nerves are used as the loss of sensation has less impact on a patient than a loss of 
mobility although the use of motor nerve grafts in a number of studies has revealed 
significantly better nerve regeneration in motor and mixed nerve repairs - potentially due to 
the larger diameter endoneurial tubes found in motor nerve grafts (Nichols et al., 2004, 
Moradzadeh et al., 2008). The sural nerve is the most commonly used for nerve autografts 
(Ray and Mackinnon, 2010) but other suitable nerves include: the medial cutaneous nerve of 
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the arm, medial and lateral cutaneous nerves of the forearm, superficial branch of the radial 
nerve and intercostal nerves; ideally the donor nerve will be in a convenient position for 
harvesting, located near to the proposed repair site and will result in the least amount of 
morbidity possible (Norkus et al., 2005). Although nerve autografts provide a method of 
successfully bridging larger nerve gaps than direct repair can there are more disadvantages 
than just donor site morbidity; there is an increased infection risk due to a second incision 
site being made, it is considered inferior to a tension-free direct repair and, probably most 
importantly, there is only a limited amount of nerve available to harvest (Ray and Mackinnon, 
2010). 
In cases where nerve autografts are not suitable, either because the length of nerve gap is 
too great or a large number of nerves require repair, then nerve allografts can be used as an 
alternative. Harvesting of donor nerves from cadavers can supply nerve grafts long enough 
to bridge almost any gap and as the graft can be taken from the relevant nerve required 
there is greater compatibility between the graft and regenerating nerve (Siemionow and 
Brzezicki, 2009). The major drawback of nerve allografts is the need for immunosuppression 
of the patient to avoid rejection of the graft, although, unlike in organ transplant where 
immunosuppression is required for the life of the patient, immunosuppression is only 
required for a limited time [varying between six and twenty-four months] following a nerve 
allograft due to the migration of host Schwann cells into the graft replacing those of the 
donor (Mackinnon et al., 2001, Ray and Mackinnon, 2010). As with organ transplantation, 
the donor and recipient need to be matched by MHC [major histocompatibility complex] in 
order to minimise the possibility of graft rejection, additionally matching by ABO blood type 
has shown improvements in functional recovery (Mackinnon et al., 2001).  
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1.6.3 Nerve Guide Conduit Repairs. 
An alternative to bridging gaps with nerve grafts is to use artificially constructed biological or 
synthetic conduits, which can avoid the disadvantages associated with nerve autografts. The 
repairing of a nerve using a conduit is similar in concept to using a graft - provide a scaffold 
guiding axons across the gap between nerve ends - but uses alternative laboratory 
constructed materials [whether biological or synthetic in nature]. Clinical use of conduits is 
not as commonplace as nerve grafting currently, though there are a number of authorised 
products available [see table 1]. Currently all approved artificial conduits for use in nerve 
repair are simple hollow tubes which are effective for bridging relatively short nerve gaps 
(Ichihara et al., 2008).  
A number of animal studies have demonstrated the potential for artificial conduits to improve 
nerve regeneration over small gaps (Meek et al., 1996, Den Dunnen et al., 1998, Meek et 
al., 2001) and there is evidence that larger gaps [e.g. 80mm] can also be bridged with 
certain types of conduit (Matsumoto et al., 2000). More detailed discussion on the use of 
conduits can be found in chapters 5 and 6. 
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Table 1: Clinically approved nerve repair conduits. PGA: polyglycolic acid. PDLLA/CL: 
poly-DL-lactide-co-ε-caprolactone. 
Product Name Material Company 
NeuraGen® Nerve Guide Collagen (type 1) Integra 
Neuromatrix™ Conduit Collagen (type 1) Collagen Matrix inc 
Neuroflex™ Conduit Collagen (type 1) Collagen Matrix inc 
Neurotube® PGA Synovis 
Neurolac® PDLLA/CL Polyganics 
AxoGuard® Nerve Connector Porcine small intestinal submucosa  AxoGen Inc. 
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1.7. FACTORS AFFECTING NERVE REGENERATION 
It is clear from both Seddon's and Sunderland's classifications that the degree of nerve injury 
suffered is a critically important factor in determining the level of functional recovery that an 
injured nerve may achieve. Although the degree of nerve injury may have the most influence 
over the level of functional recovery it is not, by any means, the only factor that affects 
successful nerve regeneration. Many other factors are linked, some more strongly than 
others, to the ability of a nerve to successfully regenerate; such as the nerve injured, the 
position of the injury, the type of nerve injured [motor/sensory/mixed], the age of the patient, 
the delay between injury and surgical repair, the type of surgery and even the sex of the 
patient.  
1.7.1 EFFECTS OF AGE ON NERVE REGENERATION 
Many studies have shown age to be an important factor in the outcome of peripheral nerve 
injury (Gutmann et al., 1942, Navarro and Kennedy, 1988, Vaughan, 1992, Ruijs et al., 
2005), with the reduced rate and extent of axonal regeneration along with impaired terminal 
and collateral sprouting of regenerated and intact axons observed in older nerves highlighted 
as limiting factors (Kovacic et al., 2009). The review by Kovacic et al. (2009) found that the 
literature suggested that, rather than a limited ability of aged neurons to regenerate or 
respond to trophic factors, changes in the peripheral neural pathways and target tissues 
were responsible for the reduced regeneration in older nerves; a further study by the same 
group demonstrated that older neurons still had the intrinsic ability to regenerate (Kovacic et 
al., 2010).  
One important age related factor appears to be a delay in the Wallerian degeneration 
response, Vaughan (1992) found that in older rats [fifteen months old] injured nerves were 
undergoing Wallerian degeneration with little axonal sprouting ten days post injury whilst in 
younger rats [3 months old] at the same time point injured nerves were showing signs of 
axonal regeneration. The cause of the delay in Wallerian degeneration is thought to be 
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related to the reduced proliferation and activity of Schwann cells in older nerves following 
injury. As Schwann cells play an important role in Wallerian degeneration [see section 2.2] a 
reduction in their number or activity will affect the speed and efficiency of this necessary step 
in nerve regeneration (Verdu et al., 2000, Kovacic et al., 2009). The reduction in proliferation 
of Schwann cells can be linked to a reduction in mitogenic factors secreted by the 
macrophages that migrate to the site of injury (Komiyama and Suzuki, 1991). There is a 
suggestion that better functional recovery in the PNS of children is related to the ability of the 
immature CNS to adapt to changes in signalling from the PNS (Dahlin, 2008). Essentially 
this means that when axons are misguided following peripheral nerve injury, a child's CNS is 
better able to adjust to the new signalling pattern it receives from the PNS than an adult's; 
which can lessen the functional difficulties experienced.    
1.7.2 EFFECTS OF SEX ON NERVE REGENERATION 
Differences in nerve regeneration between males and females have also been noted in 
studies on peripheral nerves (Kujawa et al., 1991, Kovacic et al., 2003, Kovacic et al., 2004). 
In a study on the effects of testosterone, the male sex hormone, Kujawa et al. (1991) found 
that the application of exogenous testosterone improved regeneration rates in both male and 
female hamsters but that the regeneration rates of untreated female hamsters were higher 
(4.6mm/day) than untreated males [3.7mm/day]. Another difference noted was that the delay 
between injury and axonal sprouting was shorter in male hamsters [1.7 days] than in female 
hamsters [2.5 days], so over a short time period nerve regeneration in males would appear 
to be better but once sprouting begins in the females then the early advantage of the shorter 
delay in males is soon overcome by the increased rate of regeneration in females (Kujawa et 
al., 1991). 
In the CNS patient sex is linked to differing recovery and impact of both stroke and traumatic 
brain injury: Alkayed et al. (1998) demonstrated that female rats had a more favourable 
outcome than male rats following stroke and they related this to the presence of estrogen in 
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female rats. They surmised that the reason human males and post-menopausal females 
have a higher risk of unfavourable outcome following stroke than age-matched pre-
menopausal women is that endogenous estrogen acts in a neuroprotective manner. A study 
by Groswasser et al. (1998) identified that female patients were more likely to have a better 
predicted outcome following traumatic brain injury than males and noted the suggestion that 
progesterone acting in a neuroprotective manner may explain the difference. It is likely that 
this neuroprotective role of female sex hormones could also provide a benefit to injured 
nerves in the PNS.     
A study by Jung-Testas et al. (1993) found that estrogen can stimulate proliferation of 
Schwann cells in the presence of cAMP which, given the important role played by Schwann 
cells in regeneration, would certainly have a positive effect on regeneration following injury. 
Their study also demonstrated that the effect of estrogen on Schwann cells was specific as 
no effect was observed with the use of progesterone instead (Jung-Testas et al., 1993). 
Estrogen has also been linked to neuroprotective effects in a number of studies (Behl and 
Manthey, 2000, Garcia-Segura et al., 2001) and also enhanced neurite outgrowth (Ferreira 
and Caceres, 1991).        
Progesterone, a gonadal steroid hormone found in higher concentrations in females than 
males (Schumacher et al., 2007), is believed to have at least two effects on nerves that may 
contribute to improved peripheral nerve regeneration. Firstly, progesterone has been shown 
to reduce the loss of neurons following injury which would result in a higher quantity of 
intrinsic neurons being available to regenerate axons (Yu, 1989). Secondly, it has been 
demonstrated that Schwann cells have progesterone receptors (JungTestas et al., 1996) 
and that progesterone can promote Schwann cell myelin formation (Jungtestas et al., 1994), 
which is a vital step in regeneration of nerves. 
The above examples indicate that the presence of certain steroid hormones found in 
naturally higher concentrations in females are responsible for the differences observed in 
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nerve regeneration between males and females, however, other studies have suggested that 
other intrinsic differences may have a part to play. One study by Kovacic et al. (2003) 
suggested that a gender-dependant difference in the level of retrograde transport of nerve 
growth factor [NGF] could be responsible for the higher sprouting capacity of female rat 
sensory axons that they observed. A later study by Kovacic et al. (2004) found that the 
reduction of female gonadal steroid hormones, via ovariectomy, did not have a significant 
effect upon the regeneration of female rat sensory nerves and indicates that these hormones 
alone are not the only factor in the difference between male and female nerve regeneration 
rates. Their hypothesised other factor was that, in female rats, more effective cell support in 
the distal portion of the nerve could improve regeneration rates (Kovacic et al., 2004) 
1.7.3 EFFECTS OF NERVE TYPE ON REGENERATION 
The addition [or neutralisation] of various beneficial [or detrimental] agents, as demonstrated 
in the studies mentioned, mean that although nothing can be done about the age or sex of a 
patient, something can potentially be done to counteract any detrimental effects of these 
factors upon nerve regeneration. Other factors that affect nerve regeneration, such as nerve 
type and position of injury, are more difficult to negate. 
Differences in regeneration between motor and sensory nerves have been reported in many 
studies; some concluding better regeneration in sensory axons (Riley et al., 1988, Madorsky 
et al., 1998) and others in motor axons (Shawe, 1955, Kerns et al., 1991). Additionally 
regeneration of sudomotor axons [responsible for innervating sweat glands] and nociceptor 
axons [responsible for pain response] has been shown to be quicker than motor and other 
sensory axons (Navarro et al., 1994). 
Studies assessing the potential for preferential motor reinnervation in mixed nerves have 
shown that motor axons can reach distal motor endoneurial tubes and reinnervate muscle at 
a rate higher than would be expected by chance alone (Brushart, 1988, Madison et al., 
1999). Sensory axons however do not demonstrate this ability, with many more sensory 
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axons detected entering distal motor endoneurial tubes that motor axons entering distal 
sensory endoneurial tubes (Brushart, 1988). This would indicate that mixed nerves with high 
proportions of motor axons could regenerate better than mixed nerves with high proportions 
of sensory nerves due to both the effects of the preferential motor reinnervation and the 
lower number of misdirected sensory axons blocking distal motor endoneurial tubes. The 
mechanism for preferential motor reinnervation is believed to be a specific interaction 
between the regenerating axons and Schwann cells; possibly neurotropism [guidance by 
diffusible factors], specific recognition [axons select endoneurial tubes based upon surface 
proteins], or neurotrophism [axons only receive survival signals in appropriate endoneurial 
tubes] (Brushart, 1988). The location of the injury plays an important role in the speed and 
functionality of recovery as, due to the limited speed that regenerating axons advance 
distally, the greater distance regeneration is required to cover the longer it will be before 
regenerating axons reinnervate their original targets. Additionally, the diameter of distal 
endoneurial tubes is reduced over time, which can further reduce the speed of the 
regenerating axon's advance (Sunderland, 1991).  
1.7.4 EFFECTS OF SCARRING ON REGENERATION 
Scarring is a normal part of wound healing in mammals (Shah et al., 1992), however, the 
presence of scarring at the site of a nerve injury can be detrimental to the regeneration 
process (Sunderland, 1978, Atkins et al., 2006b). In a previous study by Atkins et al. (2006b) 
it was demonstrated that, in transgenic mice with an increased propensity for scar formation 
[IL-4/IL10 null], peripheral nerve regeneration was reduced compared to normal mice. On 
the other hand, in the same study, mice with a reduced propensity for scarring [M6PR/IGF2 
null], regeneration was improved compared to normal mice (Atkins et al., 2006b).  
Other studies have looked at the potential of treating nerve injuries with therapeutics that 
reduce the formation of scarring at the injury site. The main areas investigated so far have 
involved manipulating local levels of inflammation (Atkins et al., 2007, Ngeow et al., 2011a) 
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or transforming growth factor-β [TGF-β], which is linked to wound healing (Atkins et al., 
2006a, Ngeow et al., 2011b). 
1.7.4.1 The Role of TGF-β in Scarring and nerve regeneration. 
TGF-β [transforming growth factor-β] is a cytokine associated with the repair of damaged 
tissue; it is considered have the widest range of activities of any cytokine involved in the 
tissue repair due to the range of effects that it induces and also the wide variety of cell types 
that either produce or respond to it (Roberts and Sporn, 1996).  
The form of TGF-β secreted from cells is unable to bind to its signalling receptors as it is 
secreted in its latent form which can be one of two forms: the small latent complex which 
consists of TGF-β bound to the latency-associated protein [LAP] or the large latent complex 
which has an additional protein, the latent TGF-β binding protein [LTBP] - the LTBP is 
believed to promote binding of TGF-β to extracellular matrix and have a role in increasing 
the efficiency of secretion of TGF-β (Roberts and Sporn, 1996). In order for TGF-β to 
become activated it is widely reported that the LAP must bind to the cation independent 
mannose-6-phosphate/insulin-like growth factor receptor [CI-M6PR], this releases the TGF-β 
from the LAP and allows binding to TGF-β receptors [fig 1.8] (Dennis and Rifkin, 1991, 
Roberts and Sporn, 1996, Okane and Ferguson, 1997).  Despite the level of importance 
placed on the CI-M6PR in TGF-β activation it is not the sole route of TGF-β activation. A 
study by Wong et al. (2011) found that although inhibiting the CI-M6PR inhibited activation of 
TGF-β in normal conditions, activation was less reliant on the CI-M6PR in hypoxic 
conditions. In addition, a number of mechanisms for activating TGF-β - acidification, 
alkalinization, detergents, urea and temperature - have been identified in vitro, though only 
acidification is thought to be utilized in vivo (Harpel et al., 1993).  
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Figure 1.8: Diagram showing the role of M6P in preventing latent TGF-β activation. M6P in the 
local environment competes with latent TGF-β for access to M6P receptors, occupying the 
available receptors and preventing latent TGF-β activation.  
In mammals there have been three iso-forms of TGF-β isolated, simply named TGF-β1, -β2 
and β3; TGF-β1 is the most abundant as it is found in all tissues, whereas TGF-β2 and -β3 
are less abundant (Roberts and Sporn, 1996). TGF-β is known to have a number of 
important roles in nerve regeneration; TGF-β1 has been shown to alter the phenotype of 
schwann cells from their relative inactive state during normal nerve function to the 
proliferative non-myelinating state favourable during nerve regeneration (Einheber et al., 
1995) and a study by Gordon et al. (2003) demonstrated the potential for exogenous TGF-β 
to maintain chronically denervated Schwann cells in a state that would encourage axonal 
regeneration for a longer period of time. TGF-β is also well known as a stimulator of 
chemotaxis of numerous cell types, including monocytes [which become macrophages upon 
entering tissue] which have an important role in Wallerian degeneration (Wahl et al., 1987, 
Roberts and Sporn, 1996). In addition, the survival of neurons post-injury is improved by the 
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presence of TGF-β1 and -β2 - though TGF-β1 is by far the more potent (Chalazonitis et al., 
1992), which obviously increases the potential for nerve function recovery. 
The ratio between the different iso-types of TGF-β found in adult wounds has provoked a 
great deal of interest due to the differences between adult and embryonic wound repair and 
the altered ratio of TGF-β iso-types found in embryonic wounds. Adult wounds contain a 
high level of TGF-β1 and -β2 with very little TGF-β3 present and when healed contain scar 
tissue, however, early embryonic wounds - which repair without scarring (Whitby and 
Ferguson, 1991a, b) - contain very low levels of TGF-β1 and -β2 with high levels of TGF-β3 
(Ferguson and O'Kane, 2004).  
1.7.4.2 Antibodies to TFG-β as an Anti-Scarring Agent. 
Studies on scar reduction using antibodies to TGF-β1 and -β2 have shown that neutralising 
these iso-forms can provide a significant reduction in scar formation in dermal wounds (Shah 
et al., 1994, 1995). In a study to test the effectiveness of exogenous application of TGF-β1 
and -β2 antibodies on intra-neural scar reduction and, in addition, the impact of this scar 
reduction on nerve regeneration, Atkins et al. (2006a) found that scar formation at the injury 
site was reduced but nerve regeneration was not improved. It was hypothesised that the 
neutralisation of TGF-β1 and -β2 may have impacted upon the beneficial actions of TGF-β1 
and -β2 related to nerve regeneration [see section 3.1 for further discussion]. An alternative 
approach to scar reduction has been the addition of exogenous TGF-β3; Shah et al. (1995) 
found that the addition of exogenous TGF-β3 significantly reduced levels of dermal scarring 
while neutralising all iso-forms of TGF-β negated the reduction in scarring shown by 
neutralising just TGF-β1 and -β2. On the basis of the results obtained by reducing TGF-β1 
and -β2 levels and/or increasing TGF-β3 levels novel pharmaceutical agents have been 
developed and have shown comparable results to the earlier in vivo studies in early phase 
clinical trials conducted in skin (Ferguson and O'Kane, 2004). However, in a study by Atkins 
et al. (2007) the application of exogenous TGF-β3 did not appear to reduce intra-neural 
collagen formation or improve nerve regeneration.  
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1.7.4.3 Interleukin-10 as an Anti-Scarring Agent. 
Interleukin-10 [IL-10] is a cytokine known to have a number of regulatory functions, including 
neutralising other cytokines, and is considered to be anti-inflammatory (Yamamoto et al., 
2001). A number of studies have noted a connection between IL-10 and reduced levels of 
collagen; Yamamoto et al.(2001) found than IL-10 down regulated collagen I mRNA by over 
30% and Liechty et al. (2000) demonstrated that skin grafts taken from normal C57BL/6 fetal 
mice heal without scarring or inflammation but scarring does occur when using skin grafts 
taken from IL-10 knockout fetal mice. 
Atkins et al. (2007) were able to demonstrate that a low dose of IL-10 [125ng] injected 
beneath the epineurium and also into surrounding soft tissues reduced collagen formation 
and also improved nerve regeneration. A higher dose of IL-10 [500ng], however, did not 
reduce collagen formation or improve nerve regeneration (Atkins et al., 2007).  
1.7.4.4 Mannose-6-Phosphate as an Anti-Scarring Agent. 
An alternative approach to neutralising TGF-β with antibodies is to prevent or limit the 
activation of latent TGF-β, via the application of substances that interfere with the binding of 
latent TGF-β to receptors required to release the active form of TGF-β. 
Mannose-6-phosphate [M6P] is a molecule that in previous studies has been linked to a 
reduction in the formation of scar tissue in dermal wounds. Studies by McCallion & Ferguson 
(1996) demonstrated that M6P does indeed reduce scar formation and they postulated a 
number of theories for this: 
 Inhibition of activation of latent TGF-β [fig. 1.8]. 
 Reduction in the cellular sequestration of platelet-released latent TGF-β by cells at 
the wound site. 
 Inhibition of formation of the large latent TGF-β complex by prevention of latent TGF-
β-binding protein polymerisation to the LAP [latency associated peptide] at the M6P 
receptor. 
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 Induction of changes in the number or state of activation of inflammatory cells 
recruited to the wound site. 
Additionally, recent studies (Ngeow, 2010, Ngeow et al., 2011a) have suggested that M6P 
has a beneficial effect upon early peripheral nerve regeneration in mice when injected at the 
site of sciatic nerve repair at a concentration of 600mM. Further discussion on M6P can be 
found in chapter 3 of this thesis.  
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1.8. METHODS OF ANALYSING IN VIVO PERIPHERAL NERVE 
REGENERATION 
When researching ways to improve nerve regeneration it is vital to have some method of 
analysing whether the intervention used is better than the controls. The most common 
methods of doing this are behavioural observations, electrophysiology and direct visual 
observation of the nerve. 
1.8.1 Behavioural Observations. 
Behavioural observations are non-invasive techniques that assess the functional recovery of 
injured nerves and can be used to assess the progress of functional recovery over many 
time points. The nature of techniques can vary from simple observation using images and 
video of the experimental animals (Wang et al., 2005), to more complex systems that 
measure multiple parameters in an automated way - such as the CatWalk gait analysis 
system assessed by Deumens (2007) and Bozkurt (2008). 
Analysis of functional recovery following sciatic injury in rodents can be analysed using gait 
analysis, of which the CatWalk [Noldus Information Technology, The Netherlands] is an 
advanced version. Walking track gait analysis can be used to measure toe spread, which 
decreases following sciatic injury and can be used to estimate functional loss (Menovsky and 
Beek, 2001) and is considered to be the most important measure of function of the sciatic 
nerve due to the reliance of toe spread on peroneal and tibial branches of the sciatic nerve 
(Bain et al., 1989). Additionally paw pressure, stride length and measurements of the 
duration a paw remains in position can also be measured to improve the overall picture of 
functionality gained by gait analysis. 
1.8.2 Electrophysiological Assessment.  
Much of the research into improving peripheral nerve regeneration is concerned with 
whether a treatment/technique will improve regeneration compared to standard nerve 
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suturing or autograft. Using behavioural observational techniques to find a difference 
between two injured nerves is far more difficult than finding differences between an injured 
and an uninjured nerve as often the difference in regeneration is quite small, so other 
techniques are needed in order to find any potential differences. 
Electrophysiology is a technique that uses electrodes placed on the nerve to stimulate the 
nerve and make recordings of the compound action potentials [CAPs] proximal and distal to 
the injury site [fig. 1.9]. CAPs can be assessed for both motor and sensory axons separately 
through changing the position of the recording and stimulating electrodes - e.g. recording 
motor CAPs from the motor end plates (Archibald et al., 1995). Using the proximal and distal 
compound action potentials a ratio can be calculated which will give an indication of the 
number of functional axons crossing the injury site (Ashur et al., 1987). Conduction 
velocities, which indicate maturation of axons [reaching their target tissues or becoming 
myelinated], can also be calculated (Olivier et al., 1997) 
 
Figure 1.9: Basic setup of an electrophysiological reading; R= recording electrode, S1= 
proximal stimulation electrode, S2= distal stimulation electrode - the difference in reading 
between S1 and S2 provides a ratio which can be used to calculate the percentage of axons 
crossing the injury site (adapted from Atkins et al., 2006a) 
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1.8.3 Direct Observation. 
Although electrophysiology can provide a more in depth analysis of peripheral nerve 
regeneration than behavioural observations such as gait analysis alone, it still does not 
explain what is happening at single axon levels and why, in a nerve with poor regeneration, 
axons are not crossing the injury site. In addition, when electrophysiology and walking track 
analyses are used in combination within a study, the results can contradict each other (Taha 
et al., 2004).  
Various methods of directly observing experimental nerves with the use of a microscope can 
be used to visualise and measure many parameters, such as; axon numbers before and 
after the injury site, axon thickness, axon length and axon sprouting. Fibre counts of axons 
both central and distal to an injury site can be made following histological preparation of 
nerves; this typically consists of embedding the nerve tissue within a resin, wax or other 
suitable material and then sectioning the embedded tissue and finally staining the sections 
with a suitable stain prior to microscopical analysis. For example, myelinated axons are often 
stained using the general stain toluidine blue in order to enable nerve fibre counts to be 
made (Atkins et al., 2006a, Waitayawinyu et al., 2007). 
Immunohistochemistry techniques - where antibodies to specific components of the nervous 
system are applied to the tissue - are used when increased information or differentiation 
between tissue types is desired. Antibodies to growth-associated protein-43 can be used to 
reveal axons with active growth cones, while antibodies to S-100 and peripheral myelin 
protein-22 can be used to reveal the location of Schwann cells and their myelin sheaths 
(Atsumi et al., 1999, D'Urso et al., 1999, Shin et al., 2003, Nie et al., 2014).    
The main drawback of direct observation methods is that the nerves can only be assessed at 
a single time point as the nerve must be harvested and prepared in order to visualise it 
under the microscope. When using a standard animal model for nerve regeneration studies 
the harvested nerve will need to be cut into thin sections and have a specific stain applied as 
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its axons will not otherwise be visible under the microscope. However, genetically modified 
animals in which the axons inherently fluoresce have now been created which greatly reduce 
the level of preparation required to image nerves and can allow observations to be made of 
regeneration over multiple time points from the same nerve (Pan et al., 2003, Unezaki et al., 
2009, Yan et al., 2011).  
In the mid-1990’s the jellyfish green fluorescent protein [GFP] was discovered to be an 
excellent marker of gene-expression that could be used to selectively stain specific 
components of living cells (Chalfie et al., 1994). Later work led to the generation of 
transgenic mice expressing GFP and additional mice expressing yellow [YFP], cyan [CFP] 
and red [RFP] fluorescent proteins [collectively termed XFP], incorporating regulatory 
elements from the thy-1 gene (Feng et al., 2000). Feng et al. (2000) demonstrated that the 
four variants of fluorescent protein satisfactorily label neurons in vivo, that they have no 
detrimental effect upon synaptic structure and that a unique, heritable pattern of expression 
occurs for offspring of a transgenic founder. 
GFP was originally isolated from the Pacific Northwest jellyfish [Aequoria victoria] 
(Shimomura et al., 1962) and later work produced mutated varieties with different emission 
wavelengths, providing the ability to have living tissues double labelled (Ellenberg et al., 
1999). The different emission wavelengths are produced by single amino acid substitutions 
at certain points, for example substituting tryptophan in place of tyrosine in the 66th position 
creates CFP (Heim et al., 1994) and substituting tyrosine in place of threonine at the 203rd 
position creates YFP (Ormo et al., 1996).   
1.8.4 Generation of Transgenic Mice Expressing Spectral Variants of GFP. 
To generate the transgenic mice mentioned above, Feng et al. (2000) used a modified thy-1 
vector in which exon 3 and the introns alongside had been deleted using Xho1 restriction 
enzymes to allow the insertion of a transgene into the deleted region [fig. 1.10] (Caroni, 
1997) - this deletion had the additional benefit of preventing expression of the modified thy-1 
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gene in non-neuronal tissues, which the removed sequence is responsible for (Vidal et al., 
1990). The modified thy-1 vector containing the relevant fluorescent protein transgene was 
then injected into a fertilized mouse oocyte using standard methods (Hogan et al., 1994) and 
animals positive for the transgene were used to found strains (Feng et al., 2000).   
 
Figure 1.10: Modification of thy-1 gene - Top: thy-1 gene prior to removal of exon 3 by Xho1 
restriction enzymes. Bottom: thy-1 gene with chosen transgene [i.e. YFP] in place. Adapted 
from Caroni (1997). 
Also known as cluster differentiation 90 [CD90], thy-1 is a cell-adhesion molecule expressed 
on numerous cell types (Nakamura et al., 2006, Haack-Sorensen et al., 2008, Guillot-Delost 
et al., 2012) and has an important role in wound healing and inflammation through triggering 
the synthesis and release of cytokines and enzymes (Saalbach et al., 2008). For example, 
when neutrophils bind to thy-1 it triggers an increase in secretion and activation of MMP-9 [a 
matrix metalloproteinase important for leukocyte migration through the extra-cellular matrix 
(Opdenakker et al., 2001a, 2001b)] and secretion of the chemoattractant, CXCL8 - 
enhancing neutrophil migration to sites of inflammation (Saalbach et al., 2008).  
Each XFP transgenic founder mouse generated by Feng et al. (2000) possessed a different, 
unique pattern of fluorescent protein expression [table 2]; which persisted consistently in the 
descendants of the founder mice, even when XFP mice were crossed with other strains. 
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Feng et al. (2000) stated that differences in transgene expression between founder mice 
were due to differences in the chromosomal integration of the transgene and/or the copy 
number of the transgene. The variation between strains came in two quantifiable types: 
firstly, the proportions of neurons located in specific tissues, and secondly, the intensity of 
the XFP labelling. The two types of variation were not correlated; labelling could be intense 
but limited to few neurones, or dim but labelling the all neurones of a specific type - 
homozygosity or heterozygosity also had no effect on the pattern of labelling, though 
labelling was stronger in homozygotes (Feng et al., 2000).    
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Table 2: Patterns of transgene expression in thy-1-XFP lines. All = expression in >80% of 
neurons; many = expression in 10-80%; few = expression in <10%. Numbers under 'cortex' = 
laminae in which somata of labelled neurons were present. RGC = retinal ganglion cells; INL = 
inner nuclear layer of the retina [A = amacrine cells, B = bipolar cells, M = Muller cells]; SCG = 
superior cervical ganglion; DRG = dorsal root ganglion; Mossy = mossy fibres in internal 
granulae layer of the cerebellum; Purk = cerebellar Purkinje cells; Molec = interneurons of the 
cerebellar molecular layer. Taken from Feng et al. (2000) and used with permission from 
Elsevier Inc. 
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1.8.5 Use of thy-1-XFP Mouse Strains in Neuroscience Research. 
The thy-1-YFP-H mouse model generated by Feng et al. (2000) has proven to be the most 
popular among the various XFP fluorescing strains they generated in terms of the number of 
published studies that have utilised it. Other strains generated by Feng et al. (2000) have 
been found to be particularly useful for certain types of research. 
1.8.5.1 Studies Using thy-1-CFP Mice. 
The thy-1-CFP-23 strain - which express cyan rather than yellow fluorescent protein - has 
been used in a number of studies investigating optical nerve injuries (Bernstein et al., 2007, 
Leung et al., 2008a, Leung et al., 2008b, Wang et al., 2010, Chindasub et al., 2013). Feng et 
al. (2000) reported that more than 80% of retinal ganglion cells were labelled in the strain 
and this was backed up by Bernstein et al. (2007). Of particular note is the blue-light 
confocal scanning laser ophthalmoscope technique developed by Leung et al. (2008b) which 
allows non-invasive in vivo imaging to determine the integrity of retinal ganglion cells. 
1.8.5.2 Studies Using thy-1-RFP Mice. 
The use of thy-1-RFP strains - which express red fluorescent protein - is more limited to 
date, with a single study by Favero et al. (2009) the only published study making use of them 
at the time of writing. In that study, Favero et al. (2009) investigated the role of post-synaptic 
action potentials using over-expression of Kir2.1 and Kir2.2 potassium channels to 
hyperpolarise membranes and prevent those action potentials. The exact strain of thy-1-RFP 
mice that Favero et al. (2009) used is not made clear in the article and the mice are only 
used to determine the localisation of the Kir over-expression. 
1.8.5.3 Studies Using thy-1-GFP Mice. 
Studies which have used the thy-1-GFP-M strain (Trachtenberg et al., 2002, Holtmaat et al., 
2006, Keck et al., 2008, Mostany et al., 2010, Singh et al., 2013) generated by Feng et al. 
(2000) have mostly concentrated on observing certain effects on neurones in the brain. 
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Trachtenberg et al. (2002) utilised the thy-1-GFP-M strain to study plasticity of individual 
pyramidal neurones in the cortex, with repeated imaging through a transparent skull cover 
taking place over a number of weeks. Also using a similar imaging technique were studies 
by Holtmaat et al. (2006) and Mostany et al. (2010), who investigated the effects of novel 
experiences, and the effects of stroke respectively. The relative popularity of this particular 
strain in studies of this type may be related to the fact that thy-1-GFP-M mice only have 
relatively few GFP labelled neurons in the cortex (Feng et al., 2000) - this prevents a 
potential issue where individual fluorescent neurons are difficult to separate for analysis 
(Lichtman and Sanes, 2003). 
1.8.5.4 Studies Using thy-1-YFP Mice. 
Of all the different colour variants Feng et al. (2000) used to generate strains of thy-1-XFP 
expressing mice, YFP [thy-1-YFP-H and thy-1-YFP-16 strains] has proven the most popular 
in studies to date. In two studies the thy-1-YFP-16 strain was used to observe retinal 
ganglion cell survival and changes in axon and dendrite arborisation (Leung et al., 2011, Li 
et al., 2011). These studies were derived from the previously discussed Leung et al. (2008b) 
study, which had used thy-1-CFP-23 mice. An advantage of the thy-1-YFP-16 mice used in 
these more recent studies appears to be that, with fewer positively stained retinal ganglion 
cells in the YFP model [reported in both studies as being <1% (Leung et al., 2011, Li et al., 
2011)], details such as axon and dendrite arborisation can be determined (Leung et al., 
2011). This assertion by Leung et al. (2011) and Li et al. (2011) contradicts the initial reports 
by Feng et al. (Feng et al., 2000), who indicated that >80% of retinal ganglion cells were 
labelled in the retina of the thy-1-YFP-16 strain; however, the labelling profiles reported by 
Feng et al. (2000) are not overly precise and no detailed evidence is provided.  
Conversely, the high levels of motor and sensory axon labelling in peripheral nerves has 
enabled non-invasive analysis of regeneration to be performed in some studies (Unezaki et 
al., 2009, Singh et al., 2012). A study by Unezaki et al. (2009) investigated the effects of 
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nerve growth factor and glial-cell derived neurotrophic factor on the regeneration of the 
sciatic nerve in thy-1-YFP-16 mice. Unezaki et al. (2009) used a silicone conduit [with an 
osmotic pump to administer a continuous dose of the desired factor] for sciatic nerve repairs, 
which they partially assessed through imaging the injured limb over the course of 8-weeks 
[fig. 1.11]. A similar method was used by Singh et al. (2012) in a study investigating the 
effects of electrical stimulation on nerve regeneration, in which they used images of the 
injury site and toe pads to determine the rate and extent of sciatic nerve regeneration 
through a silicone conduit. 
One strain of YFP mice, thy-1-YFP-H [YFP-H], generated by Feng et al. (2000) has been 
used successfully in a number of nerve regeneration studies by, among others, the Arthur 
W. English laboratory (English et al., 2005, Groves et al., 2005, Sabatier et al., 2008). In this 
strain the peripheral expression of YFP is limited to a subset of axons [table 2], but in those 
axons it is expressed along their entire length (Feng et al., 2000). An important consideration 
for using this strain in peripheral nerve studies is that the limited number of axons expressing 
YFP means that fluorescent axon density in the nerve is reduced, and as such individual 
axons are easier to discern. Groves et al. (2005) calculated that approximately 2.6% of all 
sensory axons are YFP labelled [based on 122.6 YFP labelled axons out of 4625 in the L4 
spinal nerve] and that sensory axons make up approximately 58% of all labelled axons. The 
nerve most often used for nerve regeneration studies in YFP-H mice is the common fibular 
[CF], a branch of the sciatic nerve, which has been found to contain an average of 36.03 
(±2.35) YFP labelled axons and is preferred to the tibular branch of the sciatic nerve as a 
higher proportion of fluorescent labelled nerves are located within the fibular branch of the 
sciatic nerve (Groves et al., 2005). 
Further discussion on the use of thy-1-YFP-H mouse strain - both in the studies presented 
here and previous work by others - generated by Feng et al. (2000) is presented in 
chapter 7.   
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Figure 1.11: Non-invasive imaging of sciatic nerve regeneration in thy-1-YFP-16 mice. D: regeneration through a nerve guide at 2-weeks post-
injury; E: at 4-weeks post-injury; H: view of reinnervation of foot at 8-weeks post injury (Unezaki et al., 2009). Used with permission from Elsevier 
In
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1.9 GENERAL AIMS AND OBJECTIVES 
With the commonly used, more established methods of analysing peripheral nerve 
regeneration it is either impossible or extremely difficult to observe the fate of individual 
axons as they cross the repair site. Using a YFP-H mouse nerve injury model enables a 
representative sample of axons to be traced across the entirety of the nerve repair and 
beyond. 
Despite the potential benefits of using YFP-H mice in peripheral nerve regeneration studies, 
there have been relatively few studies conducted with the strain [see section 7.1.2 for 
discussion of those studies]. Additionally, those studies that have used YFP-H mice do not 
appear to have fully utilised the potential of the strain - analysing only the number of axons 
regenerating into the repair and the length profiles of those axons (Groves et al., 2005). 
Therefore, the general aim of the work contained within this thesis was to utilise the YFP-H 
mouse to investigate nerve repair at the level of the individual axon, following a range of 
different treatments and repair methods. In order to achieve this, new analysis methods have 
been developed to enable a much greater level of information to be gained from using the 
YFP-H mouse strain. The treatments/repair methods used to achieve this aim were: 
 Graft repairs with/without a potential anti-scarring agent [M6P; chapter 3]. 
 Graft repairs with/without a potential regeneration enhancing/anti-scarring agent 
[EC23; chapter 4]. 
 Artificial nerve guide repair using a variety of nerve guide designs compared to graft 
repairs [chapter 5; chapter 6].   
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2.0 MATERIALS AND METHODS 
2.1 ANIMALS 
The experimental protocols were approved by the UK Home Office in accordance with the 
Animals (Scientific Procedures) Act 1986, as part of the project license numbers PPL 
40/3070 [for anti-scarring agents experiments] and 40/3342 [for artificial nerve guides 
experiments]. Following my completion of the requisite Home Office License modules [1-4] I 
was granted a personal license [number PIL 40/10013] to undertake the work described 
within this thesis.  
All experiments used thy-1-YFP-H transgenic mice [YFP-H], a strain possessing a subset of 
peripheral nerve cells expressing yellow fluorescent protein along the entire length of their 
axons [see section 1.8.4 for further details]. This strain was chosen in order to exploit the 
potential to trace the progress of individual regenerating axons through a repair. Four 
breeding pairs were purchased from JAX Mice in 2009 and all mice used in the experiments 
described here were descendants of those original breeding pairs. The YFP-H breeding 
pairs consisted of one heterozygous YFP-H mouse [possessing a single copy of the 
modified thy-1 gene] and one wild-type [WT] mouse [lacking the modified thy-1 gene and 
subsequently genetically identical to the C57BL-6J background strain used in the generation 
of the YFP-H strain] derived from previous YFP-H/WT matings. This mating arrangement is 
used in order to provide mixed litters containing approximately equal numbers of YFP-H and 
WT mice. In experiments that required nerve grafts, WT littermates of the experimental YFP-
H mouse were used to provide the graft material. The mice used were aged between 8- and 
20-weeks; typically mice aged between 8- and 16-weeks were used in the anti-scarring 
agents studies and mice aged between 12- and 20-weeks were used in the artificial nerve 
guide experiments. Mice were housed in soft wood chip lined plastic cages with a 12 hour 
light/dark cycle and an ambient temperature of between 19 and 21°C within a central animal 
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care facility [Biological Services Unit, University of Sheffield]. Mice were group housed where 
possible, depending on litter size and male-female ratio of the litter, prior to experiments 
being carried out. During the post-surgery recovery period mice were singly housed to 
minimize the incidence of suture removal. Standard rodent chow and water was provided for 
the mice ad libitum.     
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2.2 SURGICAL PROCEDURES 
2.2.1 ANAESTHESIA FOR RECOVERY EXPERIMENTS 
Animals involved in experiments requiring recovery from the surgical procedure were 
anaesthetised using an isoflurane [Isoflo, Abbot Laboratories, UK]  and oxygen mixture 
[BOC, UK]. Anesthesia was induced by placing the animal within an induction box connected 
to an anesthetic machine [Harvard Apparatus LTD, Kent, UK] providing 4L/min of 4% 
isoflurane in 100% oxygen. Once induction was complete the animal was transferred to a 
thermostatically controlled heated blanket covered with a sterile surgical drape to maintain 
body temperature [Harvard Apparatus LTD, Kent, UK], while anesthesia was maintained by 
the use of a nosepiece connected to the anesthesia machine's vaporizer and providing 1-
4L/min of 1.5-4% isoflurane in 100% oxygen, as required. 
Following the successful completion of surgery animals were transferred to an enclosed 
incubator containing a thick blanket and heated to 37.5°C and allowed time to fully recover 
from the affects of anesthesia.    
2.2.2 ANAESTHESIA FOR TISSUE HARVESTING 
Animals used to provide nerve graft tissue were anaesthetised either as specified in section 
2.2.1, or by inter-peritoneal injection [fluanisone, 0.8ml/kg; midazolam, 4mg/kg; ip] 
depending upon the specific study requirements. 
In animals where tissue was harvested for analysis, anesthesia was induced by inter-
peritoneal injection [fluanisone, 0.8ml/kg; midazolam, 4mg/kg; ip]. 
 Following successful tissue harvest, animals were culled by cervical dislocation while under 
deep anesthesia.  
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2.2.3 NERVE GRAFT REPAIRS 
The nerve grafts were obtained from WT littermates of the experimental YFP-H mouse under 
general anesthesia [as described in section 2.2.1] using the following procedure. The right 
rear leg of a WT mouse was shaved and disinfected with hibitane, an incision was made 
between mid-calf and mid-thigh level and the skin was freed by blunt dissection. The 
common fibular [CF] nerve was then exposed by separating the muscles behind the knee 
joint to allow access. The CF nerve was then freed from surrounding tissues and a section 
[5mm minimum length] extracted. Depending upon the specific study requirements, this 
section of nerve tissue was either transferred to a vial containing vehicle/therapeutic agent or 
into a prepared recipient YFP-H littermate.  
YFP-H mice were prepared to receive grafts under anesthesia [as described in section 
2.2.1]. The right CF nerve was exposed [as described above], carefully freed from the 
surrounding tissue and a 5mm silicone trough was inserted beneath the nerve prior to 
sectioning. The sectioned nerve endings were trimmed to create the required gap between 
central and distal ends, and graft tissue obtained from a WT littermate [as described above] 
was trimmed to fit the gap. The graft and nerve ends were aligned and the graft was secured 
in place with an application of fibrin glue; which was made up of fibrinogen [10mg/ml; Sigma 
Aldrich, UK] and thrombin [40IU/ml; Sigma Aldrich, UK] in a 1:1 ratio and allowed to set for 
five minutes. Once the repair was secured, the silicone trough was carefully removed and 
the wound closed using 6-O sutures [coated vicryl; Ethicon, UK]. A single dose of analgesic 
[0.01ml buprenorphine hydrochloride, 0.3mg/ml; Vetergesic®, Alstoe Animal Health, UK] 
was administered subcutaneously and the animals were allowed to recover for the length of 
time required by the specific experimental design.    
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2.2.4 NERVE GUIDE REPAIRS 
Under general anaesthesia [as described in section 2.2.1]  the right CF nerve of a YFP-H 
mouse was exposed and carefully freed from the surrounding tissue [as described in section 
2.2.3]. The nerve endings were trimmed to create the required gap between central and 
distal ends. The sectioned nerve ends were placed approximately 0.5mm within a conduit 
and secured in place with an application of fibrin glue [fig 2.1], the wound was closed and 
animals allowed to recover for a 3-week period.  
 
Figure 2.1: Nerve guide conduit repair. The CF nerve runs from right to left in this image and is 
sectioned midway between the branching of the sciatic [which starts a short distance from the 
right edge of this image] and the lateral edge of the knee joint [at the left edge of this image].  
2.2.5 HARVESTING NERVE TISSUE FOR ANALYSIS 
Following the appropriate recovery period, the repaired section of nerve tissue was 
harvested under general anesthesia [as described in section 2.2.2]. Following re-exposure 
and freeing of the CF nerve, the surrounding skin was sutured to an elevated brass ring to 
form a pool, which was then filled with 4% formaldehyde for 30 minutes to fix the nerve 
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tissue. The fixed nerve tissue was sectioned at a distance proximal [the branch point with the 
sciatic] and distal [where the CF nerve passed into the anterior region of the knee] to the 
repaired section, placed onto a microscope slide and coverslipped using Vectashield®.  
For harvests of conduit repaired nerve, the process was as described above with the 
additional step of carefully removing the conduit material following fixation. 
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2.3 IMAGE ACQUISITION AND ANALYSIS 
2.3.1 IMAGE ACQUISITION 
Images of nerves were acquired with fluorescent microscopy (Zeiss Axioplan 2 imaging 
microscope with Qimaging Retiga 1300R camera) using Image Pro-Plus software (version 5; 
Media Cybernetics, Bethesda, MD). Images were acquired with a x10 objective in stacks 
consisting of thirty 10µm thick sections - throughout the entire thickness of the nerve - from 
which composite images were obtained. To obtain images of the full length of the nerve, 
stacks were acquired from multiple adjoining microscope fields and the composite images 
were joined using Adobe Photoshop.  
Minimal image processing with Adobe Photoshop was applied to the joined images used for 
analysis, this consisted of adjusting brightness/contrast and image exposure in order to 
improve axon clarity. 
2.3.2 IMAGE ANALYSIS 
2.3.2.1 Sprouting Index. 
In previous studies of nerve regeneration using YFP-H mice, one outcome measure used 
was the quantification of axons proximal and distal to the repair to generate a ratio - termed 
sprouting index - of axon sprouting into the repair (Groves et al., 2005, Sabatier et al., 2008). 
The equivalent outcome measure used in the studies discussed within this thesis builds 
upon the previously used sprouting index method by increasing the distal data points from a 
single reference to a total of eight [for graft only studies] or nine [for studies using conduits] 
separate intervals encompassing the entirety of the graft repair and the initial portion of the 
distal nerve ending. By calculating sprouting index ratios at multiple points along the repair 
the entire sprouting profile could be determined, giving an increased level of information 
compared to the previously used single point method. 
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For analysis the nerve images were marked at approximate 0.5mm intervals originating from 
the point where abnormal axon morphology began to the point where axons had entered the 
distal nerve ending, with one additional interval marked at 0.5mm prior to the first interval 
[fig 2.2]. The point where axons entered the distal nerve ending varied between studies: in 
graft only studies, 3.5mm from the first interval was sufficient to cover the distal nerve 
ending; in conduit studies 4.0mm from the first interval was required due to the slightly larger 
gap required between nerve endings in those studies.    
The number of axons at each interval were counted and - in order to allow direct 
comparisons between different nerves - the number of axons at each interval were divided 
by the number of axons counted at the -0.5mm interval to give a sprouting index. Counts 
were made in triplicate and an average taken in order to minimise the effect of any 
miscounts [figs. 2.2 and 2.3]. 
2.3.2.2 Functional Axon Tracing. 
Axons were then traced [using pseudo-colour tracing methods in Adobe Photoshop] from the 
final interval back along the repair to the first interval or a branch point with a previously 
traced axon, with a minimum of 75% of the axons present traced. Tracing was subsequently 
performed at all preceding intervals in turn to allow the percentage of axons from the start 
interval represented at each interval to be calculated [figs. 2.2 and 2.3]. 
2.3.2.2 Axon Disruption. 
Finally, the direct path from the 0.0mm to 1.5mm intervals [the portion within repairs where 
axons typically appeared most disrupted] was accurately measured and the length of all 
traced axons between the two intervals was also measured. Axon lengths were compared to 
the direct path length to determine the average increase in axon length across the initial 
period of repair [fig. 2.4]. A greater average increase in traced axon length between the 
0.0mm and 1.5mm intervals was considered indicative of greater axon disruption between 
the central nerve end and graft.  
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Figure 2.2: Fully reverse traced pseudo-colour nerve image - initially, 75% of axons at the 
3.5mm interval were traced back to the 0.0mm interval, with further traces made at each 
preceding interval in turn to ensure 75% of axons present were traced.  
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Figure 2.3: Nerve image with sample tracing from 3.5mm interval only. Three of the six axons 
traced from the 3.5mm interval were duplicate sprouts - branch points are highlighted in the 
expanded sections [magenta circles].  
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Figure 2.4: Enlarged view of the initial intervals of the repair with full axon tracing [~75% of the 
total number] at each interval. Traced axons from the 1.5mm interval back to the 0.0mm 
interval were measured and compared to the direct distance between intervals [axons traced 
from intervals marked with X back to 0.0mm were ignored].  
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2.3.3 STATISTICAL ANALYSIS 
All statistical analysis of results was carried out using GraphPad Prism software [v.5.00, 
GraphPad Software Inc., California, USA].  
For sprouting index and axon tracing results a 2-way analysis of variance [ANOVA] with post 
tests consisting of a series of t-tests with a Bonferroni correction applied [hereafter referred 
to as Bonferroni post-tests] was used in order to detect overall differences between 
experimental groups and differences between experimental groups at individual intervals. 
For axon disruption results a 1-way ANOVA with Bonferroni post-tests was used in order to 
detect overall and individual interval differences between groups.  
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3.0 THE EFFECTS OF MANNOSE-6-
PHOSPHATE ON NERVE 
REGENERATION 
3.1 INTRODUCTION 
A proof of concept study by Atkins et al. (2006b) - which assessed regeneration in the sciatic 
nerve of mice with an increased or decreased propensity for forming scar tissue - revealed 
an inverse correlation between the level of intraneural scarring and the level of success of 
peripheral nerve regeneration. Following this, further studies have been undertaken in the 
attempt to discover a therapeutic agent that can reduce the formation of scar tissue following 
peripheral nerve injury. 
Atkins et al (2006a) conducted a study in which neutralising antibodies to TGF-β1 and -β2 
were shown to reduce scarring in regenerating nerve tissue [see sections 1.7.4.1 and 1.7.4.2 
for discussion on TGF-β and scarring] without improving overall nerve regeneration. It was 
suggested that, in the course of neutralising TGF-β1 and -β2, the positive roles that TGF-β is 
involved in during regeneration were impeded.  
One of these roles is to attract monocytes from the blood stream to the injury site, where 
they become macrophages and assist with the removal of myelin and axon debris (Wahl et 
al., 1987, Perry and Brown, 1992).  
Vargas et al. (2010) demonstrated the importance of myelin debris removal in a study using 
the JHD strain of mice. This strain is unable to produce antibodies [which would label 
degenerating myelin for targeting by macrophages] and as such 50% fewer macrophages 
were present at the injury site in JHD mice, with those present displaying a reduced 
phagocytic morphology. Vargas et al. (2010) found that myelin clearance was delayed in the 
JHD mice compared to wild-type mice and that the delay was in the second [macrophage 
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dependent] stage of clearance rather than the initial Schwann cell mediated [macrophage 
independent] stage of clearance. The result of this delay in clearance was a reduction in 
axon regeneration: in JHD mice crossed with YFP-H mice there were 50% fewer YFP 
labelled axons 16mm distal to the injury after 8-days and 9% fewer after 22-days compared 
to standard YFP-H mice. In addition, electrophysiological results indicated a 50% reduction 
in compound action potentials in the JHD mice compared to wild-types but no difference in 
the velocity of axon conduction; this indicates that although axons are inhibited from 
regenerating by the myelin debris, the process of re-myelination of regenerating axons is not 
affected.   
TGF-β1 is also known to regulate many functions of Schwann cells, including inhibiting 
myelination (Mews and Meyer, 1993, Einheber et al., 1995, Guenard et al., 1995) and 
promoting both Schwann cell proliferation and death (D'Antonio et al., 2006). TGF-β1 has 
been shown to increase Schwann cell expression of leukemia inhibitory factor [LIF] mRNA 
(Matsuoka et al., 1997) - a cytokine linked to neurone survival (Cheema et al., 1994). 
The phenotypic changes by Schwann cells following nerve injury [including downregulation 
of myelin production, expression of adhesion molecules, release of neurotrophic factors and 
proliferation] are understood to be a key stage in nerve regeneration and these changes are 
promoted by TGF-β1 (Einheber et al., 1995). The proliferation of Schwann cells following 
nerve injury would appear to be vital to successful nerve regeneration, as the application of 
anti-tumor necrosis factor-α [TNF-α] therapy following a sciatic crush injury has been shown 
to improve regeneration in rats (Kato et al., 2010). TNF-α is a cytokine linked to the transition 
of Schwann cells from their neural orientation to a more active immunological one following 
nerve injury (Schneiderschaulies et al., 1991) and has been shown to inhibit Schwann cell 
proliferation (Chandross et al., 1996) - though TNF-α has also been shown to adversely 
affect neurite outgrowth (Schneiderschaulies et al., 1991). 
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It is apparent that wholesale inhibition or removal of TGF-β1 and -β2 at the site of nerve 
injury to reduce intraneural scarring is inherently problematic due to the wide range of 
differing roles performed by the various TGF-β isoforms. However the mediation of TGF-β 
levels at the site of nerve injury still has potential, providing that it is performed in a more 
precise manner. 
As discussed in chapter 1 [section 1.7.4.4], mannose-6-phosphate is a molecule with the 
ability to reduce scarring in dermal tissue (McCallion and Ferguson, 1996). The scar 
reducing potential of M6P is strongly linked to its to its ability to bind to the cation-
independent M6P [CI-M6P] receptor, which latent TGF-β must bind to in order to cleave the 
LAP and become active (Dennis and Rifkin, 1991)[fig. 1.8]. M6P is found on the LAP as two 
of its three oligosaccharide side chains and binds with both high affinity and specificity to the 
CI-M6P receptor - it is this high affinity and specificity that allows non-LAP M6P to compete 
for receptor binding sites with latent TGF-β. The importance of the CI-M6P receptor to TGF-
β activation and subsequent scar formation can be observed in mice with a deficiency in CI-
M6P receptors, which demonstrate a reduced propensity for scarring and have also shown 
an improved ability to regenerate injured peripheral nerves (Atkins et al., 2006b). As a 
reduction in number of CI-M6P receptors is not a realistic clinical proposal, M6P could 
provide a simple method of achieving a similar result by preventing latent TGF-β from 
accessing the receptor without directly targeting TGF-β and affecting its suggested beneficial 
influence of nerve regeneration (Atkins et al., 2006a). 
Previously, Ngeow et al. (2011b, 2011a) assessed the compound action potentials of the 
sciatic nerve six weeks post-repair and found them to be significantly higher in M6P treated 
nerves than controls, in addition conduction velocities were significantly higher - indicating 
both a greater number of functional axons crossing the repair and that more myelinated 
axons were present in M6P treated repairs. Interestingly, the levels of intraneural scarring in 
M6P treated nerves were not considered to be significantly reduced compared to controls in 
both Ngeow studies (Ngeow et al., 2011a, Ngeow et al., 2011b). Over a longer time period 
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[12-weeks] the difference between M6P treated repairs and controls was no longer 
considered significant (Ngeow et al., 2011b); indicating that M6P may only give an early 
boost to regeneration. 
A number of suggestions were made by Ngeow et al. (2011a, 2011b) to account for the 
significantly improved regeneration in M6P treated repairs at 6-weeks post-injury compared 
to controls, and the subsequent equalisation of the difference between the two groups at 12-
weeks post-injury. Whether axons in M6P repairs had a faster rate of initial regeneration, 
collagen remodelling occurred sooner in M6P repairs, or the reduction in collagen at later 
time points allowed formerly blocked axons in control repairs to successfully regenerate at 
that point could not be ascertained using the methods of analysis performed in the Ngeow et 
al. (2011a, 2011b) studies [electrophysiology and walking gait analysis].  
3.1.1 AIM OF THIS STUDY 
The aim of the study reported in this chapter was to investigate the effects of the application 
of 600nM M6P to graft repairs in YFP-H mice. The ability to view the fate of individual 
regenerating axons in nerve injury models using YFP-H mice [see section 1.8] should enable 
confirmation of what causes the initial improvement in regeneration within M6P treated 
repairs. 
The hypothesis for this study was that the application of M6P would improve nerve 
regeneration, resulting in an axon sprouting profile closer to uninjured control nerves than 
injured controls, an increased proportion of unique axons regenerating through the repair 
and reduced disruption of axons entering the repair. The three groups in this study were:  
 Graft repairs treated with M6P.  
 Graft repairs treated with vehicle [PBS].  
 Uninjured nerves.   
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3.2 MATERIALS AND METHODS 
General materials and methods are detailed in chapter 2, more specific details for this 
chapter are detailed below.  
3.2.1 SURGICAL PROCEDURES 
In brief, common fibular nerve tissue was obtained from a wild-type littermate of the 
experimental YFP-H mouse and placed into a numbered vial containing a solution of 600nM 
M6P or PBS and left to soak for 30 minutes prior to being used to repair a 2.5mm defect 
created in the CF nerve of a YFP-H mouse. The vials were randomized by a colleague not 
involved in the analysis process. Following a two-week recovery period the repaired nerves 
were harvested and mounted onto slides. Uninjured nerves were harvested from YFP-H 
mice that had not been used in nerve repair experiments. 
An small additional group of YFP-H mice were used to ensure that fluorescence distal to the 
injury degraded sufficiently within the two-week recovery period - it had previously been 
indicated that a significant level of distal fluorescence could persist between 10- and 14-days 
post injury (Groves et al., 2005, Witzel et al., 2005). In these mice the CF nerve was 
transected and then the central end was tied-off with silk suture to prevent axon 
regeneration. Following the recovery period both central and distal nerve endings were 
harvested and mounted onto slides. 
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3.2.2 ANIMAL NUMBERS AND GROUPINGS 
In total 53 mice were used in the experiments described in this chapter, with equal numbers 
of WT and YFP-H mice used in the repair groups [WT mice used to provide graft tissue] and 
only YFP-H mice used in uninjured/non-repaired groups. All experiments were conducted 
under the UK Home Office project license number 40/3070. 
The experimental groups for this chapter were: M6P (n=10 YFP-H and 10 WT), PBS 
(n=10 YFP-H and 10 WT), uninjured (n=10) and injured with no repair (n=3).  
3.2.3 SAMPLE SIZE CALCULATIONS 
Groups sizes for M6P, PBS and uninjured were determined based upon previous M6P work 
by Ngeow et al. (2011b), as our analysis methods for YFP-H mice had not been fully 
developed at this stage and as such no data was available to make calculations from. 
3.2.4 STATISTICAL ANALYSIS 
Statistical analysis of the results was carried out as stated in section 2.3.3. All sprouting 
index and functional axon tracing results used 2-way ANOVA with Bonferroni post-tests; 
axon disruption results used a 1-way ANOVA with Bonferroni post-tests. Differences were 
considered to be significant when p<0.05. 
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3.3 RESULTS 
All animals recovered well following surgery, with no signs of infection or autotomy (self 
harm).  
3.3.1 DEGRADATION OF DISTAL FLUORESCENCE 
Fluorescence in the degenerating axons distal to the injury was almost completely degraded 
after the two-week recovery period [fig. 3.1]. All remaining fluorescence was limited to small 
flecks, indicating that analysis at the point where axons had re-entered the distal nerve 
ending would be unlikely to be adversely affected.  
 
Figure 3.1: Central [left] and distal [right] nerve endings two-weeks after transection with no 
repair. Scale bar = 1.0mm. 
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3.3.2 QUALITATIVE DIFFERENCES BETWEEN GROUPS 
Visually there was little difference between the two repair groups and no clear indicators that 
would allow the nerve images to be accurately separated into their respective groups 
[fig. 3.2].  
Nerve images for both repair groups displayed an area of disrupted axons around the initial 
join between the central nerve ending and the graft, with axons then becoming more 
organised once within the graft [fig. 3.2]. At the join between the graft and the distal nerve 
ending another, smaller area of disrupted axons was present and again, once the axons had 
crossed this area and entered the distal nerve ending, they became more organised 
[fig. 3.2]. 
The difference between nerve images from both repair groups and those in the uninjured 
group is much clearer, with axons within the uninjured nerves running near parallel through 
the imaged length and no noticeable disruption [fig. 3.3]  
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Figure 3.2: Typical images of vehicle (top) and M6P (bottom) treated nerve repairs with intervals marked. Scale bar = 1.0mm. 
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Figure 3.3: Typical uninjured nerve image with intervals marked. Scale bar = 1.0mm. 
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3.3.3 SPROUTING INDEX RESULTS 
There were no significant differences detected between repair groups at any interval, 
however, the M6P group did display slightly lower initial sprouting at the 0.5mm and 1.0mm 
intervals and this difference between treatment groups was maintained for the remaining 
intervals [table 3 and fig. 3.4].   
For both M6P and vehicle groups maximal sprouting was observed at the 0.5mm and 1.0mm 
intervals with sprouting in both groups significantly higher than the uninjured group. Minimal 
sprouting for both repair groups was observed at the 3.5mm [distal nerve stump] interval with 
sprouting in the M6P group significantly lower than the uninjured group [table 3 and fig. 3.4]. 
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Table 3: Sprouting index levels for M6P, vehicle and uninjured groups [%]. 
Repair 
Position 
Average 
Sprouting 
 (M6P) 
SEM  
(M6P) 
Average 
Sprouting 
(Vehicle) 
SEM 
(Vehicle) 
Average 
Sprouting 
(Uninjured) 
SEM 
(Uninjured) 
-0.5 100.0 0.0 100.0 0.0 100.0 0.0 
0 114.2 3.7 102.5 2.4 99.1 1.4 
0.5 160.2 16.3 178.1 12.8 96.2 1.1 
1 169.4 19.7 176.8 26.6 98.1 1.4 
1.5 119.5 14.4 123.5 16.1 96.8 1.8 
2 90.0 7.5 100.9 15.9 96.8 1.0 
2.5 76.2 6.5 90.5 2.7 97.7 1.9 
3 66.6 11.4 82.0 10.2 97.6 1.7 
3.5 52.5 8.7 77.6 14.4 98.5 1.3 
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Figure 3.4: Sprouting index levels at 0.5mm intervals along the graft; * and *** denote significant differences in value compared to uninjured 
controls, p<0.05 and p<0.001 respectively. Error bars denote SEM. Statistical test: 2-way ANOVA with Bonferroni post-tests. 
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3.3.4 CHANGE IN SPROUTING INDEX BETWEEN INTERVALS 
The maximum change in Sprouting index levels for both treatment groups occurred between 
the graft start and 0.5mm interval [fig. 3.5]; the difference between repair groups was 
considered significant between those intervals with a higher increase in sprouting index level 
observed in the vehicle group - the increase in sprouting index level in both repair groups 
was considered significant compared to uninjured controls.  The sprouting index level in both 
repair groups remained stable between the 0.5mm and 1.0mm interval and then fell in both 
treatment groups between the 1.0mm and 1.5mm interval. The sprouting index level then 
continued to fall at a similar rate in both treatment groups between the remaining intervals 
[fig. 3.5]. 
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Figure 3.5: Changes in Sprouting index levels at each 0.5mm interval compared to the previous interval; †† and ††† denote significant differences 
in value compared to uninjured controls, p<0.01 and p<0.001 respectively; ** denotes significant difference in value compared to vehicle treated 
graft, p<0.01. Error bars denote SEM . Statistical test: 2-way ANOVA with Bonferroni post-tests.      
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3.3.5 FUNCTIONAL AXON TRACING 
The proportion of unique axons from the from the start point [0.0mm] represented at each 
interval along the graft declined at a similar rate in both M6P and vehicle groups and no 
significant differences were found between groups at each individual interval [fig.18]. In both 
repair groups the largest loss of unique axons [25.1% in M6P; 25.2% in vehicle] occurred 
between the 0.5mm and 1.0mm intervals and from the 1.0mm interval onwards unique axon 
numbers in both repair groups were significantly lower than uninjured controls [fig. 3.6]. The 
proportion of unique axons continued to fall at a lower rate at each subsequent interval, 
resulting in a total of approximately 24% reaching the final 3.5mm interval in both repair 
groups [fig. 3.6].   
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Figure 3.6: Percentages of start axons represented at subsequent 0.5mm intervals; *** denotes significant difference compared to uninjured 
controls, p<0.001. Error bars denote SEM. Statistical test: 2-way ANOVA with Bonferroni post-tests.      
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3.3.6 AXON DISRUPTION 
When crossing the initial repair site from central nerve ending into the nerve graft [fig. 3.7] 
the average increase in axon length between the graft start and 1.5mm interval was 
significantly lower in the M6P group [13.6% ±1.2 SEM] than in the vehicle group [20.5% 
±2.4][fig. 3.8]. In both repair groups the increase in axon length was significantly higher than 
in uninjured controls [2.3% ±1.6][fig. 3.8]. 
 
Figure 3.7: Comparison of axon disruption in M6P (left) and vehicle treated repairs (right) 
across the initial 1.5mm of the repair. An individual traced axon is used to indicate differences 
in axon length/disruption. Scale bar = 0.5mm. 
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Figure 3.8: Percentage increase in axon length across the initial 1.5mm of repair; * denotes significant difference compared to vehicle group, 
p<0.05; ††† denotes significant difference compared to uninjured controls, p<0.001. Statistical test: 1-way ANOVA with Bonferroni post-tests.   
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3.4 DISCUSSION 
3.4.1 AXON SPROUTING LEVELS THROUGH REPAIRS 
It has long been recognised that injured axons sprout multiple branches which extend 
distally during the earlier stages of regeneration and it is also apparent that increases in the 
severity of an injury lead to increased axon sprouting (Bray and Aguayo, 1974, Sunderland, 
1978, Toft et al., 1988, Giannini et al., 1989, Xu et al., 2008). 
Xu et al. (2008) reported increased sprouting following 20mm long sciatic crush injuries than 
in 2mm injuries, with the level of sprouting measured at the same point distal to injury in both 
groups. This indicates that increased distal disruption can initiate an increase in sprouting in 
axons that have yet to encounter the disruption; whether the increase in sprouting is due to 
cytokine/chemokine signalling from the damaged tissues or axons encountering the 
disruption creating new sprouts proximal to the disruption is currently unclear.  
Further evidence of axon sprouting as a response to disruption/scarring was provided in a 
study by Atkins et al. (2007) that investigated the anti-scarring potential of the anti-
inflammatory cytokine interleukin-10 [IL-10]. In that study IL-10 was found to significantly 
reduce intra-neural scarring with a corresponding increase in axon regeneration across the 
repair site in electrophysiology results, however, axon count results were found to be similar 
in both IL-10 and saline controls. The reason given for this discrepancy between 
electrophysiology results and histomorphology results was that the relatively higher level of 
intra-neural scarring in saline controls caused an increase in axon sprouting resulting in 
more duplicated axons crossing the repair site (Atkins et al., 2007).    
Following imaging of repaired nerves it appeared that a great deal of disruption and potential 
sprouting occurred in both M6P and vehicle groups at the joins between the central nerve 
end and the graft, and between the graft and distal nerve ending [fig. 3.2]   
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In previous studies of nerve regeneration using YFP-H mice, one outcome measure used 
was the quantification of axons proximal and distal to the repair to generate a ratio - termed 
sprouting index - of axon sprouting into the repair (Groves et al., 2005, Sabatier et al., 2008). 
The equivalent outcome measure used in this study [and the others reported within this 
thesis] built upon the previously used sprouting index method by increasing the distal data 
points from a single reference to a total of eight separate intervals encompassing the entirety 
of the graft repair and the initial portion of the distal nerve ending. By calculating sprouting 
index ratios at multiple points along the repair the entire sprouting profile could be 
determined, giving an increased level of information compared to the previously used single 
point method. 
It was hypothesised that sprouting index profiles in the M6P groups would be closer to those 
in the uninjured group than the vehicle group, with lower initial sprouting followed by more 
stable sprouting index levels. However, sprouting index results for both repair groups were 
similar with significantly higher Sprouting index levels at the first two 0.5mm intervals of the 
repair compared to uninjured controls [fig. 3.4]. The M6P group also, interestingly, had a 
significantly lower sprouting index level at the distal nerve ending compared to the uninjured 
group - but not the vehicle group [fig. 3.4].  
Further analysis comparing the change in sprouting index level at each interval compared to 
the level at the previous interval was conducted in an attempt to discover an explanation for 
the seemingly worse performance of the M6P group. The analysis revealed that the 
sprouting index level change between the 0.0mm and 0.5mm intervals was significantly 
lower in the M6P group when compared to vehicle treated repairs [fig. 3.5]. As the sprouting 
index level changes for all subsequent intervals was similar in both repair groups, this initial 
difference would be carried through the entire repair, resulting in the M6P group - but not the 
vehicle group - having a significantly lower sprouting index at the 3.5mm interval. This lower 
increase in early sprouting index levels could indicate that axons crossing into the graft in the 
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M6P group encountered fewer obstructions and, although not clearly indicated in these 
results, lower sprouting may have also occurred in the M6P group at the graft exit. 
3.4.2 FUNCTIONAL AXON TRACING 
Although a high number of total axons regenerating through a nerve graft repair can be 
considered indicative of a better recovery, increased sprouting can lead to higher axon 
numbers without improved functionality (Atkins et al., 2007). In fact, functional recovery can 
often contrast with morphological analysis of nerve regeneration - Pagnussat et al. (2012) 
reported on the effects of different training therapies on nerve regeneration in rats, with 
significantly better functional recovery observed following skilled and unskilled training 
compared to no training. However, in a number of morphological analyses [myelinated fibre 
area, myelin thickness, myelinated fibre and axon diameters] no differences were found 
between any of the nerve repair groups. Mirroring that study, Taha et al. (2004) reported 
significantly improved morphological regeneration [increased axon density] in rat tibial 
nerves when treated with retinoic acid but no improvement in functional outcome [walking 
track analysis]. 
In the study reported in this chapter, assessing functional recovery in terms of behavioural 
assessment was not viable due to the short recovery time period [2-weeks] chosen to 
assess early stage regeneration. In order to effectively estimate potential functional recovery 
axons were traced back from each interval to determine the proportion of axons from the 
0.0mm interval that were represented at each subsequent interval - a higher proportion 
reaching the final 3.5mm interval would indicate better potential for future functional 
recovery. 
Results indicated that there was no difference between the M6P or vehicle groups in terms 
of starting interval axons represented at each subsequent interval, with less than 25% of 
0.0mm interval axons reaching the final 3.5mm interval in both groups [fig. 3.6]. That more 
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than 50% of axons from the 0.0mm interval were lost by the 1.5mm interval [fig. 3.6] further 
indicates the influence of the visible disruption observed at the graft entry point [fig. 3.2].  
 It had been anticipated that M6P treated repairs would have a higher proportion of starting 
interval axons represented at later intervals, especially the final interval.  
An increase in 0.0mm interval axons reaching the 3.5mm interval in the M6P group would 
have tied in with electrophysiology results reported by Ngeow et al. (2011a, 2011b) in 
previous studies. In both of those studies M6P treatment resulted in significantly improved 
compound action potentials and conductance velocities compared to PBS treated controls at 
6-weeks post repair - indicating a greater number of myelinated functional axons had 
crossed the repair. However, the number of axons crossing the repair is not the only factor 
needing consideration as other factors can affect functional recovery, such as misdirected 
sensory axons occupying distal motor axon endoneurial tubes and vice-versa [discussed in 
section 1.7.3]. In addition direct comparisons between this study and the Ngeow et al. 
(2011a, 2011b) studies are difficult due to the different methods of repair [graft vs. direct 
suture] and recovery periods [2-weeks vs. 6- and 12-weeks]. 
3.4.3 INITIAL AXON DISRUPTION AT GRAFT ENTRY    
As reported in section 3.3.2 [fig. 3.2] a great deal of disruption was apparent between the 
0.0mm and 1.5mm intervals in both repair groups, this disruption was further highlighted with 
the sprouting index results revealing the highest sprouting index levels to occur at the 0.5mm 
and 1.0mm [fig. 3.4] and that the majority of axons from the 0.0mm interval were lost by the 
1.5mm interval [fig. 3.6]. 
Treatment with M6P appears to have a significant impact on the amount of disruption axons 
suffer at during the early stage regeneration into the graft. This is indicated by the 
significantly shorter average axon lengths over the initial 1.5mm portion of the graft [fig. 3.8] 
in the M6P group, indicating that axons were able to take a more direct path across this 
portion of the repair.  
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These results provide an explanation for the result observed by Ngeow et al. (2011b), where 
a significant improvement in regeneration was found at 6-weeks post-repair but not at 12-
weeks post-repair. As axons in the M6P group take a shorter route across the repair they are 
likely to reach their target tissue in a shorter time on average than axons taking a longer 
route in vehicle treated repairs. This means that although axons in the M6P group would 
have a small head start over axons in the vehicle group, though this advantage would be 
negated once axons began to reach their target tissues.    
As previous M6P studies did not show a significant reduction in intra-neural scarring (Ngeow 
et al., 2011a, Ngeow et al., 2011b) it would appear that the reduction in disruption shown in 
this study is not due to an overall reduction in collagen at the injury site. However, it is 
possible that the initial rate of collagen production and deposition was reduced by the impact 
of M6P on TGF-β activation immediately following the repair.  
The impact of a reduction in collagen production in the early stages of regeneration could 
have a significant impact on the alignment of collagen fibres within the regenerating nerve 
tissue. When collagen density is low, fibroblasts responsible for collagen deposition are able 
to move through the extracellular matrix easier which results in improved collagen alignment 
(Dallon et al., 2001). Increased TGF-β1 levels - linked to increased production of collagen 
[see section 1.7.4] - have been shown to result in reduced collagen alignment, while 
increased levels of TGF-β3 - linked to decreased production of collagen - have been shown 
to promote collagen alignment (Henderson et al., 2012). 
The alignment of collagen was not investigated within the Ngeow et al. (2011a, 2011b) 
studies but it is plausible that early reductions in collagen production resulted in alignment 
more favourable for regenerating axons, prior to the effects of M6P on TGF-β activation 
wearing off and collagen levels increasing to near normal by 6-weeks post injury. 
As axon regeneration had proceeded to a point more distal than the excised segment of 
nerve examined in this study, it was not possible to determine whether the more direct path 
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taken by axons in M6P treated repairs had resulted in those axons regenerating significantly 
further than their counterparts in vehicle treated repairs. As regeneration in the leading 
axons proceeds at a rate of around 0.25mm/day through scar tissue and 1-3mm/day once 
axons cross the repair site (Gutmann et al., 1942, Al-Majed et al., 2000), any delay due to 
taking a longer path through areas of scarring can build up to a more significant difference.  
For example, the difference between average axon length across the initial 1.5mm of the 
repair in M6P and vehicle groups was 6.9% or approximately 0.1mm. The difference in time 
between axons in the M6P group and axons in the vehicle group being able to exit the scar 
tissue and increase their regeneration rate from 0.25mm/day to 1-3mm/day could lead to the 
fastest regenerating axons in the M6P group being approximately 1.25mm further ahead 
than their equivalents in vehicle group by the time the axons in vehicle group exit the scar 
tissue. 
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3.4.4 CONCLUSIONS  
The overall effect of M6P appears somewhat limited as no effects on overall sprouting or 
functional axon proportions were observed. It may be that M6P can only affect TGF-β 
activation for a short time following application before it is either cleared from the injury site 
or alternative TGF-β activation mechanisms activate sufficient TGF-β to negate the influence 
of M6P. 
The shorter path taken by axons in the M6P group has the potential to improve regeneration 
by allowing those axons to reach their target tissues in a shorter time period. As discussed 
earlier [see section 1.7.3], delays in reinnervation can result in target tissues becoming 
unreceptive to regenerating axons and also the support for regenerating axons being 
withdrawn. As such enabling axons to regenerate through scar tissue quicker [due to 
shortened path length rather than increased regeneration speed] could result in a much 
better level of recovery.  
In conclusion, this study provides further evidence of the ability of M6P to improve peripheral 
nerve regeneration within the initial period of time following nerve repair. The indication is 
that M6P helps to reduce the disruption axons encounter when crossing the repair site, with 
improved collagen alignment as a result of temporarily reducing collagen production the 
likely mechanism. Although the effects of M6P observed in this study do seem limited, M6P 
may prove useful therapeutically if used in combination with other regeneration enhancing 
agents. 
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4.0 THE EFFECTS OF EC23 ON 
NERVE REGENERATION 
4.1 INTRODUCTION  
Retinoic acid is a derivative of vitamin A that is involved in the development and 
regeneration of many different organs in many different animal species (Scadding and 
Maden, 1986a, b, c, Wion et al., 1987, Stratford et al., 1996, Maden and Hind, 2003). 
Inhibition of retinoic acid has been shown to have similar adverse effects upon heart 
development in both avian and mammalian species (Heine et al., 1985, Stratford et al., 
1996, Niederreither et al., 2001), retinoic acid is also linked to the coordination of heart and 
limb development in zebrafish (Sorrell and Waxman, 2011). 
Certain amphibians are capable of complete regeneration of severed limbs - such as axolotls 
and newts - and as such are of great interest for studying regeneration. The effects of 
vitamin A and its derivatives on regeneration in these animals have been studied in great 
detail, revealing contrasting effects of limb duplication and deletion depending upon the 
stage of development and concentrations used (Thoms and Stocum, 1984, Scadding and 
Maden, 1986a). In the axolotl, immersion in retinol palmitate has been shown to cause 
skeletal deletions in developing limbs in a dose dependent manner but conversely, in 
regenerating limbs it has been shown to cause proximodistal duplications (Thoms and 
Stocum, 1984, Scadding and Maden, 1986a). Retinol palmitate and retinoic acid have both 
been used to induce limb duplication in newt species such as Pleurodeles waltl and Triturus 
vulgaris, though complete duplicate limbs - unlike in the axolotl - were not observed 
(Lheureux et al., 1986).    
In mammals regeneration in mature animals is not as straight forward as in an amphibian 
like the axolotl, with severance of a limb resulting in little more than wound healing. 
Research into development has revealed that the level of retinoic acid in specific locations 
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within an embryo is a critical factor, with excess levels being teratogenic and insufficient 
levels being deleterious (Duester, 2008). In one study (Niederreither et al., 2002), transgenic 
mice with a deficiency in retinaldehyde dehydrogenase 2 [Raldh2] - required for retinoic acid 
synthesis (Zhao et al., 1996) - were used to demonstrate that retinoic acid synthesis is 
responsible for both forelimb growth and anteroposterior patterning of the developing mouse 
embryo. The Raldh2 knockout mice used by Niederreither et al. (2002) are not carried to 
term as they die at 10.5 days post coitum, with severe trunk defects present (Niederreither et 
al., 1999). Niederreither et al. (2002) were, by the maternal administration of retinoic acid, 
able to increase forelimb formation and extend survival times in Raldh2 embryos.      
In relation to nerve injuries, the application of exogenous retinoic acid has the potential to 
improve nerve regeneration through a number of effects, such as inhibiting inflammatory 
cytokines and increasing neurotrophin expression (Maden, 2007). For example, synthesis of 
the pro-inflammatory cytokine TNF-α has been show to be reduced in both primary and cell-
line macrophage cultures exposed to retinoic acid (Motomura et al., 1996, Wang et al., 
2007). TNF-α is known to be both helpful following nerve injury, through Schwann cell 
activation and macrophage recruitment (Gaudet et al., 2011), and detrimental due to 
inhibition of axon sprouting and the potential induction of demyelinating neuropathies (Said 
and Hontebeyriejoskowicz, 1992, Smith et al., 2009). Inhibition of TNF-α synthesis by means 
other than the application of all-trans retinoic acid has been shown to have a beneficial effect 
following nerve injury, with Lindenlaub et al. (2000) and Iwatsuki et al. (2013) both reporting 
reductions in neuropathic pain in mouse and rat models respectively - with Iwatsuki et al. 
(2013) also reporting improved nerve regeneration. 
Various retinoids, including all-trans retinoic acid, have also been shown to have a beneficial 
effect on dermal scarring by reducing fibroblast proliferation and collagen production (Daly 
and Weston, 1986, Ogawa et al., 1998). Given that inhibiting TGF-β1 and -β2 to dermal 
wounds has previously been shown to reduce scarring (Shah et al., 1992) and then later was 
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shown to reduce intraneural scarring in nerve injuries (Atkins et al., 2006a) it can be 
surmised that retinoic acid may also be effective at reducing intraneural scarring.  
There is evidence that retinoic acid can accelerate nerve regeneration, as a study by Yee 
and Rawson (2000) found that a single oral administration of retinoic acid following olfactory 
nerve transection led to the sense of smell in mice recovering significantly faster. However, 
the study by Yee and Rawson (2000) did not investigate the mechanism underlying the 
increased speed of recovery, so it is unclear whether the effect was due to an inherent 
speed increase in regenerating axons, less impedance of axons by intraneural scarring or 
improved nerve cell survival through increased neuronal support.      
Despite the evidence for retinoic acid's beneficial effects on nerve regeneration, few studies 
have investigated the effects of direct application of retinoic acid on nerve regeneration. At 
the time of writing only one study had been published in which retinoic acid was directly 
applied to the site of a peripheral nerve lesion (Taha et al., 2004). In that study the tibial 
nerve in male Wistar rats was sectioned, treated with 10-8 mol/L retinoic acid or vehicle [meal 
oil], and then repaired using end-to-end or end-to-side anastomosis techniques. Taha et al. 
(2004) found that the application of retinoic acid improved regeneration in terms of the 
morphological parameters but not in terms of functional recovery. 
A problem with the therapeutic use of all-trans retinoic acid is that it is relatively unstable and 
are easily photoisomerised into other, less effective retinoid isomers (Murayama et al., 1997, 
Suzuki et al., 1998). Given that the effects of retinoic acid have been shown to vary widely 
depending upon concentration (Thoms and Stocum, 1984, Scadding and Maden, 1986a) the 
instability of retinoic acid has the potential to cause adverse side effects when used as a 
therapeutic treatment.  
EC23 is a stable synthetic form of all-trans retinoic acid with the chemical name 4-(5,5,8,8-
tetramethyl-5,6,7,8-tetrahydronapthalen-2-ylethynyl)benzoic acid, which was synthesised 
and first reported by Christie et al. (2008). EC23 has displayed similar effects on human 
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pluripotent stem cell differentiation to those observed from all-trans retinoic acid treatment 
(Christie et al., 2008, Clemens et al., 2013) and also has improved photostability [EC23 is 
unaffected after 3-days exposure to fluorescent light, whereas all-trans retinoic acid 
degrades to just 37% of the original quantity (Christie et al., 2008)]. One other difference 
between EC23 and all-trans retinoic acid is that EC23 does appear to be more potent than 
retinoic acid (Christie et al., 2010); however, this may be a side-effect of EC23s increased 
stability, which would increase the probability of the administered dose remaining at the 
stated level rather than decreasing as all-trans retinoic acid would have the potential to do. 
EC23 is believed to have the same mechanism of action as all-trans retinoic acid, based 
upon the shared ability of both compounds to differentiate human pluripotent stem cells into 
neural cells (Christie et al., 2008). Retinoic acid can act via the retinoic acid receptors [RAR] 
and retinoid X receptors [RXR] - with both receptor types having α, β and γ subtypes 
(Zhelyaznik and Mey, 2006) - though all-trans retinoic acid only interacts with RARs. 
Following a peripheral nerve crush injury there are local increases in transcript 
concentrations of RAR-α, RAR-β, RAR-γ, and RXR-α, with protein expression of RAR-α, 
RAR-β, and RXR-α upregulated during the subsequent nerve regeneration (Zhelyaznik and 
Mey, 2006). NGF has been shown to induce neurite outgrowth through activating RAR-β via 
inducing retinoic acid synthesis (Corcoran and Maden, 1999), and RAR-α and RXR-α have 
been shown to be upregulated in Schwann cells and macrophages, respectively, following 
nerve injury - with indications that retinoic acid regulates neuroglial interactions and 
Schwann cell differentiation (Zhelyaznik and Mey, 2006).      
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4.1.1 AIM OF THIS STUDY 
The aim of the study reported in this chapter was to investigate the effects of the application 
of 10-8 mol/L EC23  to graft repairs in YFP-H mice. The following experimental groups were 
used in this study: 
 Graft repairs treated with EC23.  
 Graft repairs treated with vehicle [PBS]. 
 Uninjured nerves. 
The hypothesis for this study was that the application of EC23 would improve nerve 
regeneration through a reduction in scarring and an increase in the regeneration speed of 
axons.    
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4.2 MATERIALS AND METHODS 
General materials and methods are detailed in chapter 2, more specific details for 
this chapter are detailed below. 
4.2.1 SURGICAL PROCEDURES 
As described in chapter 2, nerve grafts of common fibular nerve tissue were obtained from a 
wild-type littermate of the experimental YFP-H mouse. These grafts were placed into a vial 
containing a solution of 10-8 mol/L EC23 dissolved in PBS and left to soak for 30 minutes 
[see 2.2.1 and 2.2.3 for general anaesthesia and surgical methods]. The concentration of 
EC23 [10-8 mol/L] was chosen as a previous study (Taha et al., 2004) had reported improved 
regeneration following the application of retinoic acid at that concentration directly to the 
recently sectioned tibial nerve in rats.   
The treated nerve tissue was used to repair a 2.5mm defect created in the CF nerve of a 
YFP-H mouse [see 2.2.1 and 2.2.3 for general anaesthesia and surgical methods]. Following 
a 2-week recovery period, nerves were harvested and mounted onto slides [see 2.2.2 and 
2.2.5 for general anaesthesia and surgical methods], imaged and analysed [see 2.3.1 and 
2.3.2 for details]. Results for vehicle [PBS] repairs and uninjured controls were taken from 
those obtained in the mannose-6-phospate study discussed in chapter 3. 
4.2.2 ANIMAL NUMBERS AND GROUPINGS 
In total 40 mice were used in the experiments described in this chapter, with 16 used 
exclusively for EC23 experiments and 24 shared with the M6P experiments [see chapter 3]. 
Equal numbers of wild type and YFP-H mice were used in the repair groups and only YFP-H 
mice used in the uninjured group. All experiments were conducted under the UK Home 
Office project license number 40/3070. 
The experimental groups for this chapter were: EC23 (n=8 YFP-H and 8 WT), vehicle (n=8 
YFP-H and 8 WT), and uninjured (n=8). To maintain equal group sizes, only the first 8 
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completed vehicle and uninjured nerve results from the M6P study [see chapter 3] were 
used in this study. 
4.2.3 SAMPLE SIZE CALCULATIONS 
The sample sizes for this study were calculated using PiFace software [v1.76: 
homepage.stat.uiowa.edu/~rlenth/Power] with standard deviation data obtained from the 
M6P study discussed in the chapter 3. 
4.2.3.1 Sample Size Choice and Justification. 
The sample size chosen for the study discussed within this chapter was n=8, which would be 
sufficient to detect differences between groups of 32.35%, 11.34% and 7.37% for sprouting 
index [fig. 4.1], functional axon tracing [fig. 4.2] and axon disruption [fig. 4.3] respectively. 
The functional axon tracing and axon disruption results were considered to be the more 
important analyses when considering sample size, as improved functional recovery and 
faster recovery speed are clinically relevant outcome measures. As such these two 
measures were used to determine the sample sizes for this study. Detectable differences of 
12% and 8% were considered reasonable, which would be achievable with sample sizes of 
n=7, however, sample sizes were increased by one to n=8 to account for any failed repairs.  
The large standard deviation levels for sprouting index results observed in the M6P study 
[see 3.3.1] meant that only a relatively large overall difference between groups [32.35% for 
n=8] could be detected without using an excessive number of animals. Despite this it was 
felt that sprouting index results could still provide a useful insight and identify potential trends 
of the differing sprouting profiles of the three repair groups [EC23, vehicle and uninjured].   
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4.2.3.2 Sample Size Calculation Results. 
 
Figure 4.1: Sprouting index analysis power and detectable difference results when using a  
sample size of n=8. Levels[row] = number of intervals; levels[col] = number of groups; 
n[Within] = sample size; SD[Within] = standard deviation value derived from M6P study results. 
Number of intervals [# means] multiplied by number of repair groups minus one gives the 
number of t-tests required for the Bonferroni post-tests [# tests].   
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Figure 4.2: Functional axon tracing analysis power and detectable difference results when 
using a sample size of n=8. 
 
Figure 4.3: Axon disruption analysis power and detectable difference results when using a 
sample size of n=8. Levels [treatment] = number of groups; see fig. 15 for remaining 
definitions. 
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4.2.4 STATISTICAL ANALYSIS 
Statistical analysis of the results was carried out as stated in section 2.3.3. All sprouting 
index and functional axon tracing results used 2-way ANOVA with Bonferroni post-tests; 
axon disruption results used a 1-way ANOVA with Bonferroni post-tests. Differences were 
considered to be significant when p<0.05.  
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4.3 RESULTS 
All animals recovered well following surgery, with no signs of infection or autotomy (self 
mutilation of the denervated region).  
4.3.1 QUALITIATIVE DIFFERENCES BETWEEN GROUPS 
There was no clear difference between EC23 and vehicle treated repair images that would 
enable the images for the two groups to be separated accurately prior to the quantitative 
analysis. Though images of EC23 repairs typically appeared to have less axon sprouting at 
the join between central nerve end and graft than vehicle repairs [fig. 4.4]. 
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Figure 4.4: Typical nerve images with intervals marked for vehicle [top] and EC23 repairs [bottom]. Scale bar = 1.0mm. 
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4.3.2 SPROUTING INDEX RESULTS 
In both repair groups sprouting index levels were at their highest at the 0.5mm and 1.0mm 
intervals, with both groups displaying significantly higher sprouting index levels than in the 
uninjured group at these intervals [table 4 and fig.4.5]. The EC23 group also had a higher 
sprouting index level at the 1.5mm interval when compared to the uninjured group.  
No significant differences were detected between repair groups at any interval along the 
repair; though in the EC23 group an increased - but non-significant - sprouting index was 
noted at the 0.0mm interval [fig. 4.5].  
In the EC23 group, sprouting index levels declined steadily from the 0.5mm interval to the 
1.5mm interval, before a larger decline between the 1.5mm and 2.0mm intervals. Following 
that decline sprouting index levels in the EC23 group remained stable at the 2.0mm to 
3.0mm intervals before declining slightly at the final 3.5mm interval [table 4 and fig. 4.5]. 
In contrast, the sprouting index levels in the vehicle group remained steady between the 
0.5mm and 1.0mm intervals before a large decline at the 1.5mm interval. Following that 
decline, a smaller, steady decline was observed between each subsequent interval from the 
1.5mm interval to 3.5mm interval [table 4 and fig. 4.5] 
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Table 4: Sprouting index levels for EC23, vehicle and uninjured groups [%]. 
 
Repair 
Position 
Average 
Sprouting 
(EC23) 
SEM 
(EC23) 
Average 
Sprouting 
(Vehicle) 
SEM 
(Vehicle) 
Average 
Sprouting 
(Uninjured) 
SEM 
(Uninjured) 
-0.5 100 0 100 0 100 0 
0 124.6 5.4 101 2.7 98.9 1.8 
0.5 175.4 12.3 182.1 9.9 96.6 1.3 
1 160.3 14 185.5 25.3 99 1.6 
1.5 137.6 8.5 130.5 15.4 95.4 1.9 
2 98.8 7.7 114.8 14.9 95.9 1 
2.5 91.3 8.1 101.8 10 96.5 2 
3 96.4 5.9 88.5 5 98 2.1 
3.5 68.1 8.3 80 12 98.8 1.7 
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Figure 4.5: Sprouting index levels at 0.5mm along the repair; ** and *** denote significant differences compared to uninjured controls, p<0.01 and 
p<0.001 respectively. Statistical test: 2-way ANOVA with Bonferroni post-tests.     
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4.3.3 CHANGE IN SPROUTING INDEX BETWEEN INTERVALS 
In both repair groups the change in sprouting index levels at the 0.5mm interval was 
considered to be significantly different than in the uninjured group; the difference between 
repair groups was also considered significant at that interval, with a higher increase in 
sprouting index level observed in the vehicle group [fig. 4.6].  
There were no other significant differences between remaining intervals with regards to the 
change in sprouting index, though interestingly the 3.0mm interval in the EC23 group had a 
small overall increase in sprouting index level after the 0.5mm interval [fig. 4.6].  
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Figure 4.6: Changes in Sprouting index levels at each 0.5mm interval compared to the previous interval; †† and ††† denote significant differences 
in value compared to uninjured controls, p<0.01 and p<0.001 respectively; * denotes significant difference in value compared to vehicle treated 
graft, p<0.05. Statistical test: 2-way ANOVA with Bonferroni post-tests.       
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4.3.4 FUNCTIONAL AXON TRACING 
The proportion of unique axons regenerating from the start interval [0.0mm] represented at 
the 0.5mm interval in the EC23 group was significantly lower than in both the vehicle and 
uninjured groups [fig.4.7]. Though the proportion of start interval axons represented at 
subsequent intervals continued to decline, the proportion was not significantly different to 
that observed in the vehicle group. In both repair groups the proportion of start axons 
represented at the 1.0mm interval onwards was considered to be significantly lower than the 
proportions observed for the uninjured group [fig. 4.7]. 
In both repair groups fewer than 50% of start axons were represented at the 1.5mm interval 
[49.7% in the EC23 group and 49.4% in the vehicle group] and at the 3.5mm interval the 
percentage had fallen to 20.3% in the EC23 group and 24.2% in the vehicle group [fig. 4.7].    
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Figure 4.7: Percentages of start axons represented at subsequent 0.5mm intervals; ††† denotes significant difference compared to uninjured 
controls, p<0.001; * denotes significant difference to vehicle group, p<0.05. Statistical test: 2-way ANOVA with Bonferroni post-tests.     
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4.3.5 AXON DISRUPTION 
When crossing the initial 1.5mm of the repair there was no significant difference in the 
increase in average axon length between either repair group, with an average axon length 
increase of 19.3% [SEM = 2.3] in the EC23 group and 21.0% [2.5] in the vehicle group [fig. 
4.8]. 
Both repair groups were observed to have a significantly greater increase in average axon 
length compared to the uninjured group, which had a average increase of 2.4% [0.6] in axon 
length [fig. 4.8].     
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Figure 4.8: Percentage increase in axon length across the initial 1.5mm of repair; *** denotes significant difference compared to uninjured 
controls, p<0.001. Statistical test: 1-way ANOVA with Bonferroni post-tests.       
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4.4 DISCUSSION 
4.4.1 AXON SPROUTING LEVELS THROUGH GRAFT REPAIRS 
There was no overall difference between EC23 and vehicle repair groups, either in overall 
sprouting index levels or at individual intervals. Differences were noted between the two 
when compared to the uninjured controls [fig. 4.5].  
One small difference in sprouting index levels was noted at the 1.5mm interval, where the 
sprouting index level for EC23 repairs was still considered to be significantly higher than 
uninjured controls, while in vehicle repairs there was no significant difference compared to 
uninjured controls [fig. 4.5]. This was reflected in the change in sprouting index results, with 
the change at 1.5mm smaller - though not significantly - in the EC23 group than in the 
vehicle group [fig. 4.6]. 
Based on the previous literature, which suggests that retinoic acid can enhance local levels 
of cytokines [or their receptors] beneficial for nerve regeneration (Ueno et al., 1993, Wang 
and Halvorsen, 1998), it had been expected that EC23 - as a synthetic form of retinoic acid - 
would have enhanced nerve regeneration. 
One possible effect of retinoic acid application that would be beneficial in increasing the rate 
of regeneration would be via its effects on the local level of insulin-like growth factor II [IGF-
II]. Treating neuroblastoma cells with concentrations of retinoic acid similar to those used in 
this study has been shown to increase IGF-II mRNA expression (Ueno et al., 1993).  
The potential of IGF-II to increase regeneration rate was shown in a study by Glazner et al. 
(1993) in which locally applied exogenous IGF-II increased the regeneration rate of sensory 
axons following sciatic nerve crush injuries in rats. Additional evidence of the ability of IGF-II 
to increase regeneration speed was provided in a study by Near et al. (1992), in which motor 
axon regeneration rate was increased following IGF-II treatment of a sciatic nerve crush 
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injury. In both the Near et al (1992) and Glazner et al. (1993) studies regeneration was 
inhibited by anti-IGF-II antiserum, further implicating IGF-II as necessary for successful 
regeneration.  
Ciliary neurotrophic factor [CNTF] is a cytokine whose effect on nerve regeneration is 
increased by retinoic acid in a different manner. Rather than increasing CNTF levels in the 
local environment, retinoic acid has been shown to increase CNTF receptor α subunit 
[CNTFRα] mRNA expression in nerve cells - resulting in an increased sensitivity to CNTF 
(Davis et al., 1993, Wang and Halvorsen, 1998, Weis et al., 1998).  
There is a significant body of evidence demonstrating that CNTF has a beneficial effect 
following nerve injury. Amongst the beneficial effects attributed to CNTF are: promotion of 
axonal regeneration (Sahenk et al., 1994, Xu et al., 2009); promotion of Schwann cell 
proliferation, activation and migration (Xu et al., 2009); improved motoneuron survival and 
enabling of sprouting (Sendtner et al., 1990, Sendtner et al., 1997, Siegel et al., 2000). 
Interestingly, while some studies have demonstrated improvements in nerve regeneration 
with the addition of exogenous CNTF (Sahenk et al., 1994, Xu et al., 2009) others have 
reported no effect. In a study by Mizisin et al (2004) the effects of CNTF in diabetic mice 
were examined, with the results of the study indicating that exogenous CNTF could 
ameliorate the effects of untreated diabetes on both uninjured and injured nerves. In diabetic 
rats treated with CNTF the outcomes measured indicated at least significant improvement 
compared to untreated diabetic rats, and in some outcomes - such as regeneration distance 
- there was no difference when compared to non-diabetic rats (Mizisin et al., 2004). 
However, non-diabetic rats treated with CNTF did not demonstrate any differences when 
compared to untreated non-diabetic rats - possibly due to sufficient CNTF being present 
naturally in those animals for the maximum effect possible to be reached (Mizisin et al., 
2004). 
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The possibility that more CNTF is present in the local environment of regenerating nerves 
than can be used is also suggested by Sendtner et al. (1997). They state that "one trophic 
unit of CNTF supports half-maximal survival of responsive neurons in 1ml of cell culture 
medium" and report that 8191 ±2250 trophic units were present in the sciatic nerve of the 
pmn [progressive motor neuronopathy] mouse strain used in their study, meaning that only a 
very small amount of the available CNTF needs to be released in order to saturate available 
receptors. 
CNTFRα expression has been shown to increase following nerve injury (Davis et al., 1993, 
Weis et al., 1998) and in a study by Lee et al. (2013) it was shown to promote both axonal 
and functional regeneration. Therefore, the reported ability of retinoic acid - and 
consequently EC23 - to further increase CNTFRα expression (Wang and Halvorsen, 1998) 
could result in an enhancement of the beneficial impact on nerve regeneration of CNTF. 
The sprouting index profile for EC23 repairs indicates that the application of EC23 has no 
real effect on the number of axons reaching later intervals when compared to vehicle repairs. 
Although EC23 repairs did maintain a significantly higher sprouting index level compared to 
uninjured controls for an additional interval than vehicle repairs, the lack of a corresponding 
increase in unique axons at that interval [see section 4.4.2] indicates that this difference is 
not functionally important.         
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4.4.2 FUNCTIONAL AXON TRACING 
The percentages of axons from the start of the repair represented at each 0.5mm interval 
were similar between both repair groups from the 1.0mm interval to the final 3.5mm interval, 
though at the 0.5mm interval the percentage was significantly lower in EC23 repairs 
[fig. 4.7]. 
It had been anticipated that EC23 would increase the rate that axons could regenerate into 
the repair, thus allowing misdirected axons in EC23 repairs to find a correct pathway into 
and along the repair quicker than their equivalents in vehicle repairs. This was expected to 
result in an increase in unique axons at later distal intervals in EC23 repairs compared to 
vehicle repairs, simply via the action of more unique axons in EC23 repairs managing to 
navigate their way to those later intervals within the experimental time period. 
One potential effect that would have an impact on the percentage of unique axons reaching 
the 0.5mm interval is the influence of CNTF - the effects of which EC23 may enhance [see 
section 4.4.1] - on the ratio of motor axons and overall axon numbers. Dubovy et al. (2011) 
reported that CNTF treatment caused an increase in the number of retrograde labelled 
motoneurons extending axons into the repair, despite lower overall numbers of axons being 
observed within the repair. They proposed that the effect was due to selective pruning of 
sensory axons and earlier pruning of duplicate motor axons (Dubovy et al., 2011), an effect 
that is beyond the scope of this study to measure. 
As the difference between unique axon percentages is negligible at the remaining intervals it 
would appear that the additional axons lost at the 0.5mm interval in EC23 repairs were also 
lost shortly afterwards in vehicle repairs [fig. 4.7]. This would appear to support the 
possibility that redundant axons were pruned sooner in EC23 repairs - perhaps as a result of 
sibling branches reaching distal endoneurial tubes and related trophic support quicker, or as 
a response to axons - that were later pruned - entering the incorrect type of endoneurial tube 
[i.e. motor to sensory/sensory to motor] and losing trophic support.          
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4.4.3 INITIAL AXON DISRUPTION AT GRAFT ENTRY 
The increase in axon length over the initial proportion of the repair [0.0mm - 1.5mm] was 
similar in both repair groups, with the increase EC23 repairs only approximately 4% less 
than vehicle repairs [fig. 4.2]. Axon length in both repair groups was significantly increased 
compared to uninjured controls over the same distance [fig. 4.8]. 
It had been anticipated that EC23 would have a beneficial effect upon this early disruption 
through a reduction in levels of scar tissue at the join between central nerve ending and 
graft. This hypothesis was based on the evidence that retinoic acid can reduce local levels of 
the inflammatory cytokine TNF-α (Motomura et al., 1996, Wang et al., 2007) - with 
reductions in local inflammation linked to reduced intraneural scarring (Atkins et al., 2007) - 
and also reduce scarring in dermal tissues via reductions in fibroblast proliferation and 
collagen production (Daly and Weston, 1986, Ogawa et al., 1998). 
However there is some contrasting evidence suggesting a role for retinoic acid in the 
increase of collagen production. Much of this evidence is related to studies on photo 
damaged skin in rodents and humans, in which retinoic acid was used to reduce surface 
wrinkles (Chen et al., 1992, Griffiths et al., 1993, Personelle et al., 1997, Bhawan, 1998). 
4.4.4 CONCLUSIONS  
In this study there were no strong indications that the application of EC23 improves the 
regeneration of peripheral nerves following graft repair. In 2004, Taha et al. reported the 
results of a study where retinoic acid was directly applied to repaired rat tibial nerves, with 
the conclusion that retinoic acid stimulated regeneration. However, their conclusion was 
drawn from results showing only a greater distal axon density in treated rat tibial nerve 
repairs without any improvement in functional recovery. It is therefore possible that the 
increased axon density that Taha et al. (2004) observed could have been a result of a larger 
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percentage of duplicated axon sprouts being present in the retinoic acid treated repairs at 
the point they used for their measurements.  
The lack of prior data for both EC23 and retinoic acid in terms of direct, local application to a 
nerve injury made it difficult to determine an appropriate concentration for the EC23 dose 
within the study presented in this chapter. As discussed earlier [see section 4.1], at the time 
of writing only one study had been published where retinoic acid was directly applied at the 
site of a nerve injury in a rodent model (Taha et al., 2004) and it was from that study that the 
concentration of EC23 used in the present study [10-8 mol/L] was derived. However, it is 
possible - given the potential doubts over the conclusion reached by Taha et al. (2004) - that 
the concentration of EC23 used was not optimal for improved nerve regeneration to take 
place. 
Alternatively, as EC23 has been shown to possess increased potency at similar 
concentrations to retinoic acid (Christie et al., 2010), - and the effects retinoic acid are dose-
dependent [see section 4.1] - it may be that the concentration used in the presented study 
was sufficient to trigger a different, adverse response in some local cell types that negated 
any remaining beneficial effects of the treatment.  
Finally, as retinoic acid acts within the cell nucleus (Maden and Hind, 2003), most of its 
effectiveness when applied locally will come from interactions with Schwann cells, fibroblasts 
and macrophages rather than the centrally located neurons. As retinoic acid applied 
systemically - via an oral dose - has been shown to accelerate functional recovery of injured 
nerves (Yee and Rawson, 2000) but local application did not demonstrate any effect on 
functional recovery (Taha et al., 2004) it is possible that a greater effect could have been 
observed administering EC23 systemically. 
In conclusion, EC23 had no overall significant effects - beneficial or adverse - on nerve 
regeneration in YFP-H mice in terms of the outcomes measured within this particular study.         
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5.0 PERFORMANCE OF MICRO-
STEREOLITHOGRAPHY CONDUITS 
IN VIVO 
5.1 INTRODUCTION 
As discussed in chapter 1 [see section 1.6.3], artificial nerve guide conduits are a potential 
alternative to nerve graft repairs. If conduits can be produced that equal the performance of 
nerve grafts over any distance in any nerve, they would likely become the "gold standard" 
repair for bridging nerve defects as they do not require the sacrifice of a donor nerve and 
thus avoid the associated potential complications. 
A large variety of different materials have been trialled in nerve guide studies with varying 
levels of success. The main difference in material choices is whether they are natural, such 
as collagen (Archibald et al., 1991, Li et al., 1992, Archibald et al., 1995, Kitahara et al., 
2000, Waitayawinyu et al., 2007, Farole and Jamal, 2008), or synthetic polymer based 
(Henry et al., 1985, Hurtado et al., 1987, Kiyotani et al., 1996, Matsumoto et al., 2000, 
Waitayawinyu et al., 2007). 
5.1.1. CURRENT NERVE GUIDE CONDUITS IN ANIMAL STUDIES 
Three of the currently approved nerve guide conduits are produced using type-1 collagen - 
Neuromatrix™, Neuroflex™ and NeuroGen®. Despite these three collagen conduits being 
approved for clinical use, only NeuroGen® conduits have featured in published animal or 
clinical studies. One early study (Archibald et al., 1991) compared NeuroGen® conduits to 
both direct suture and graft repairs in rat and Macaca fascicularis monkeys. The results of 
that study found no overall difference between conduit, graft or direct suture repairs in either 
animal model used at 12-weeks post-repair, though direct suture repairs were significantly 
better in rats at 4-weeks post-repair. A second study by Archibald et al. (1995) using a larger 
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cohort of Macaca fascicularis monkeys, over a longer period of time [42 months] also 
reported similar recoveries in the collagen conduits to graft and direct suture repairs. 
Interestingly, direct suture repairs displayed slower rates of recovery than conduit and graft 
repairs - indicating that even the small amount of tension in the repair of a 5mm gap can be 
detrimental to nerve regeneration. 
A more recent study (Waitayawinyu et al., 2007) compared NeuroGen® conduits to both 
graft and polyglycolic acid [PGA] Neurotube® conduits.  The results of the study by 
Waitayawinyu et al. (2007) indicated that there was little difference between regeneration 
when either grafts or NeuroGen® conduits were used to repair sciatic nerve injuries in rats. 
However, the results did indicate that the Neurotube® conduits performed significantly worse 
than both graft and NeuroGen® conduit repairs, with significantly lower axon counts, 
maximal muscle contraction and muscle weight recorded following Neurotube® conduit 
repairs. 
5.1.2. CURRENT NERVE GUIDE CONDUITS IN CLINICAL STUDIES   
The critical step for most conduit designs is the one from animal to human studies; if the in 
vivo results do not translate into clinical performance or conduits cannot be manufactured to 
the standards required clinically then they will fail to make the step up. 
Neurotube® conduits have been used successfully in a number of clinical studies (Weber et 
al., 2000, Rinker and Liau, 2011, Mundinger et al., 2012) and a review by Meek and Coert 
(2008) concluded that the Neurotube® conduit should be the preferred choice over the three 
alternative FDA/CE approved conduits at the time of publishing [NeuroGen®, NeuroFlex™, 
Neurolac]. Their conclusion was based on the quantity and quality of clinical data available 
for each conduit as well as the available sizes and prices of the conduits. 
A randomised prospective study comparing Neurotube® conduit repairs of the digital nerves 
against standard repairs [end-to-end suture or graft, depending upon nerve defect size] 
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found the conduits to perform better than standard repairs in certain circumstances (Weber 
et al., 2000). When nerve defects were 4mm or less, repairs that used Neurotube® conduits 
resulted in significantly better moving 2-point discrimination and sensory return grades than 
standard end-to-end suturing repairs. When used in repairing defects of 8mm or longer, 
Neurotube® conduits again fared significantly better in moving 2-point discrimination than 
the standard autograft repairs with a higher - though not quite significant - percentage of 
repairs considered to have excellent sensory return. 
Another randomised prospective study on digital nerves compared Neurotube® conduits to 
autogenous vein conduits and found no significant differences between either treatment, 
though two Neurotube® conduit repairs did require reoperation following extrusion of the 
nerve endings (Rinker and Liau, 2011). A small study by Mundinger et al. (2012) on the 
repair of the inferior alveolar nerve with Neurotube® conduits found that all patients 
experienced a reduction in pain levels, with varying levels of sensory recovery - a prior, 
single participant study also reported reduction in pain levels along with excellent sensory 
recovery (Crawley and Dellon, 1992).   
5.1.3. FUTURE NERVE GUIDE CONDUITS 
Currently, all clinically approved conduits are simple, hollow tubes that are sufficient for use 
in repairing relatively short nerve defects. Work on the next generation of nerve guide 
conduits is focussed on extending the repair length possible when using conduits, with a 
range of passive and active ideas being trialled. Passive ideas focus on the physical 
structure of the conduits, providing physically supportive environments for both regenerating 
axons and support cells, while active ideas look at incorporating cells, neurotrophic factors 
and matrix proteins within the conduits that will have a therapeutic influence on nerve 
regeneration.  
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5.1.3.1 Physical Structure and Guidance. 
One idea being investigated is the addition of intraluminal structures to provide physical 
support for regenerating axons and niches for migrating support cells to reside within.  A 
study by Kim et al. (2008) demonstrated the potential benefit of topographical cues within 
conduits by producing hollow polymer conduits from rolled up sheets of aligned or random 
fibres and using them in repairs of rat tibial nerve injuries. In their study, Kim et al. (2008) 
found that the conduits produced from aligned fibre sheets performed similarly to nerve 
grafts over a 17mm defect in a number of outcomes, whilst the random fibre conduits 
performed significantly worse. Although fewer axons and Schwann cells were identified 
across the length of the conduit repair than across the length of the graft, functional recovery 
was similar in both repairs and the difference in the percentage of axons successfully 
reaching target tissue was minimal [45% in aligned fibre conduits compared to 55% in graft 
repairs].  
A study conducted by Yao et al. (2010b) using rat sciatic nerves compared multi-lumen 
collagen conduits containing either 1-, 2-, 4- or 7-channels to both graft and  NeuroGen® 
conduit repairs. Overall the performance of all conduits trialled within the study by Yao et al. 
(2010b) was poor when compared to the graft repairs across most outcomes reported. The 
NeuroGen® conduits performed worst with regards to myelinated fibre size, density and 
thickness, while 2-channel conduits (which performed best with regards to myelinated fibre 
density) and 7-channel conduits were worst when comparing myelinated fibre number and 
compound muscle action potentials respectively. Yao et al. (2010b) concluded by suggesting 
that their 4-channel conduit was the best of those trialled; however, given the relatively poor 
results for all the conduits in that study when compared to grafts, simply adding a number of 
channels to conduits is unlikely to improve the clinical outcomes of nerve repair when using 
conduits.      
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5.1.3.2 Addition of Supportive Factors and Cells. 
More active approaches to improving conduit performance centre around the addition of 
supportive cells [Schwann cells/various stem cells], or individual trophic/tropic factors, or 
matrix proteins. Coating structural elements of conduits with proteins found in the extra-
cellular matrix has the benefit of providing regenerating axons and support cells with a more 
biological surface than the inert conduit material alone. 
Collagen and laminin are two proteins to have been used in this manner, with both having 
been shown to have beneficial effects on in vitro neurite growth and cell adhesion 
(Rangappa et al., 2000, Deister et al., 2007, Swindle-Reilly et al., 2012, Volkenstein et al., 
2012). This is supported through my own unpublished observations, obtained during my final 
year undergraduate project at the University of Aston, in which neuroblastoma cells cultured 
on collagen coated tissue culture plastic displayed a flattened morphology [indicating better 
adhesion] and increased neurite outgrowth compared to cells cultured on uncoated plastic 
[fig. 5.1]. 
 
Figure 5.1: SH-SY5Y neuroblastoma cells cultured on collagen coated coverslip [left] and 
uncoated coverslip [right] - cells cultured on collagen show increased adhesion and neurite 
outgrowth (Harding, 2010. Unpublished observations). 
Studies by two separate groups in Japan have investigated the performance of collagen 
based conduits containing laminin-coated collagen fibres, one using rats (Tong et al., 1994) 
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and the other using dogs [beagles] (Matsumoto et al., 2000). The earlier study by Tong et al 
(1994) reported good results in the conduit group compared to standard grafts over a 10mm 
sciatic nerve defect, with seemingly faster regeneration during the initial 30-days post-repair. 
The study by Matsumoto et al. (2000) reported regeneration across an 80mm peroneal 
nerve defect using similar conduits to Tong et al.(1994); however, the lack of a graft control 
to compare the conduit regeneration to in the study by Matsumoto et al (2000) limits their 
study to demonstrating that regeneration through conduits can take place over such long 
distances. 
A common method used for adding cells or individual factors is to fill conduits with a gel 
containing various support factors and/or cells. A benefit of this method is that although most 
studies using it do so with simple, single lumen conduits, it is quite easy to move into more 
complex conduit designs at a later point. Indeed, there is wisdom in making sure that a 
specific composition of gel works as well as possible using simple conduits to minimise any 
confounding factors that may arise when using complex conduits.  
A recent study by Nie et al. (2014) used a single lumen chitosan/gelatin-based conduit filled 
with a Schwann cell and TGF-β seeded collagen gel to repair 10mm rat sciatic nerve 
defects. The results of the study by Nie et al. (2014) indicated that chitosan/gelatin-based 
conduits containing the Schwann cell/TGF-β seeded gel performed equally well as autograft 
repairs for the outcome measures used (histological/electrophysiological/walking track 
analysis). The performance of the gel filled conduits was also considered to be significantly 
better than empty chitosan/gelatin-based conduits.  
The addition of Schwann cells to conduits is an established theme in nerve guide studies, 
with many different approaches to their inclusion having been investigated over the last two 
decades (Kim et al., 1994, Ansselin et al., 1997, Hadlock et al., 2000, Mosahebi et al., 2002, 
Ao et al., 2011).  
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The seeding of a gel with Schwann cells is a commonly used solution for including them 
within a conduit (Mosahebi et al., 2002, Ao et al., 2011, Nie et al., 2014), most likely due to 
its simplicity and that the Schwann cell seeded gel can be prepared immediately prior to 
implantation - limiting the amount of time the Schwann cells spend between culture 
conditions and in vivo implantation. Another advantage of gels is that - provided they are 
sufficiently viscous - they can be used with porous conduits that allow the exchange of 
signalling factors between the external environment and interior of the conduit. An alternative 
method, used in some early nerve guide studies, was to fill conduits with a suspension of 
Schwann cells and seal both ends of the conduit to prevent leakage (Ansselin et al., 1997).  
5.1.3.3 New Methods of Manufacture. 
There are almost as many different methods of manufacturing conduits as there are types of 
conduit, with new techniques being developed continually. A full discussion on the different 
techniques used in conduit manufacture can be found in section 6.1.1, while this section will 
deal with the materials and techniques utilised for producing the conduits used within this 
specific study. 
All conduits used within this study were manufactured using a micro-stereolithography [µSL] 
technique developed by the laboratories of Professor John Haycock and Dr. Frederik 
Claeyssens. To produce a conduit using their µSL technique, a bitmap image [created using 
Microsoft Paint] was used to set a digital micro-mirror device to project a laser beam in the 
desired shape - i.e. a hollow circle. Once the laser beam was projected through the digital 
micro-mirror device it was expanded and directed into a pre-polymer solution through the 
lens and mirror assembly, initially curing the pre-polymer solution at the point where the z-
axis stage was located [fig. 5.2]. The z-axis stage then proceeded to descend at a rate of 
0.01mm/s, moving the cured pre-polymer layer away from the laser beam and allowing 
subsequent layers to form. Once the desired length of conduit was achieved and the final 
layer had been given time to cure the conduit was immersed in denatured alcohol for 72 
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hours in order to ensure the removal of any remaining photo-initiator or non-cured pre-
polymer. Conduits were sterilised via UV irradiation prior to implantation. 
Initial work with this technique used a pre-polymer based on polyethylene-glycol [PEG], 
which was first tested in vitro by culturing NG108-15 [neuroblastoma/glioma hybrid] neuronal 
cells on coated glass coverslips and was found to enable similar cell morphology to 
uncoated coverslips (Pateman et al., 2014c). Prior to in vivo studies with µSL conduits, in 
vitro testing using excised rat dorsal root ganglia was conducted using µSL produced PEG 
channels to ensure that no toxic effects occurred following the µSL manufacturing process 
(Pateman et al., 2014c). These processes were later repeated using a poly-caprolactone 
pre-polymer (Pateman et al., 2014a).  
The choice of µSL as a conduit manufacturing technique was made due to a number of 
beneficial properties of the technique. Firstly, the ability of the technique to create intricate 
microstructures (Choi et al., 2006) may allow guidance channels or cell niches to be 
incorporated within future conduits. The potential wide range of fabrication materials and 
possibility for scaling up the technique for mass production through automation of processes 
were also factors in choosing µSL (Pateman et al., 2014c). 
The choice of conduit material [i.e. PEG and PCL] was based on two factors; the primary 
factor was the ability at the time to manufacture conduits using the µSL process, with a 
secondary important factor relating to the biological suitability of materials. Both PEG and 
PCL are already FDA approved for certain uses (Choi et al., 1998, Bender et al., 2004), 
which could prove beneficial if conduits of either material were later considered to have the 
potential to be used in clinical trials. Both PEG and PCL have been used previously in 
successful in vitro and in vivo conduit studies, supporting their suitability as conduit materials 
(Madison et al., 1985, DenDunnen et al., 1996, Goraltchouk et al., 2005, Chiono et al., 2008, 
Chang, 2009a, b)    
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Figure 5.2: Diagram depicting micro-stereolithography setup. A: 405nm laser source; B: digital micromirror device; C: laser beam; D: focusing 
lenses; E: focusing mirror; F: glass vial containing pre-polymer solution of polyethylene-glycol; G: conduit; H: z-axis stage.  
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5.1.4 AIM OF THIS STUDY 
The aim of the study reported in this chapter was to determine the ability of µSL conduits to 
support in vivo nerve regeneration. This study reports on the performance of three different 
designs of conduit:  
1. Hollow PEG conduits.  
2. Hollow PCL conduits.  
3. PEG conduits filled with aligned electrospun PCL fibres. 
Both designs of hollow conduit - differing only in material selection - were expected to 
display similar levels of performance to each other, while their performance compared to 
graft repairs was expected to be marginally worse. The reasoning for this expectation was 
that, while regeneration within hollow conduits would lack the innate structural and biological 
support found in graft repairs, the gap being bridged was relatively short - and previous 
studies have demonstrated the potential for hollow conduits to successfully bridge short 
gaps (Lundborg et al., 1997, Dahlin et al., 2001, Lundborg et al., 2004). 
The fibre filled PEG conduits were expected to improve upon the performance levels 
observed in hollow conduits and rival the performance of graft repairs. The expectation was 
that the physical support of the aligned fibres would better help the guidance of regenerating 
axons across the repair.   
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5.2 MATERIALS AND METHODS 
General materials and methods are detailed in chapter 2, more specific information related 
to the experiments discussed within this chapter is detailed below. 
 5.2.1 MICRO-STEREOLITHOGRAPHY PRODUCED CONDUITS 
All conduits produced using micro-stereolithography [µSL] were provided by the laboratories 
of Professor John Haycock and Dr. Frederik Claeyssens [Kroto Research Institute, 
University of Sheffield, UK]. All µSL conduits used in the study discussed here measured 
5mm long with an internal diameter of 1.0mm and a wall thickness of 0.25mm [giving a 
1.5mm outside diameter]. 
The µSL conduits were made from a pre-polymer solution of either polyethylene-glycol or 
poly-caprolactone [Sigma Aldrich, UK]. 
The µSL setup consisted of a 405nm tunable laser source set to 5mW [Vortran Laser 
Technology Inc, CA, USA], a digital micro-mirror device [Texas Instruments Inc, TX, USA], a 
lens and mirror assembly [Thorlabs Ltd, Cambridgeshire, UK], and a motorised z-axis stage 
[Thorlabs Ltd, Cambridgeshire, UK]. 
Electrospun aligned poly-caprolactone fibres measuring 5µm in diameter were used in one 
set of conduits to improve axon guidance through the conduits. These electrospun fibres 
were produced using the methods previously described by Daud et al. (2012) which also 
refer to work performed by Wang et al. (2009). Briefly, a syringe with blunt needle and filled 
with poly-caprolactone dissolved in dichloromethane was connected to a syringe pump, with 
the needle connected to a high voltage power supply. A collector, consisting of aluminium 
foil wrapped around a grounded rotating drum was rotated at 2200rpm in order to collect 
produced fibres. When the syringe plunger is depressed, the poly-caprolactone forms into 
fibres which are collected by the rotating drum [fig. 5.3]. 
126 
 
 
Figure 5.3: Depiction of electrospinning process. 
5.2.2 SURGICAL PROCEDURES 
For conduit repairs YFP-H mice were anaesthetised and the CF nerve exposed and a 3mm 
gap between central and distal nerve endings created [see 2.2.1 and 2.2.3 for full details]. 
The selected conduit was then used to repair the gap, with the nerve endings and conduit 
fixed in place using fibrin glue. Animals were allowed to recover for 3-weeks to allow 
regenerating nerve tissue in conduits to gain sufficient strength to survive harvesting [see 
section 2.2.4]. 
To obtain graft tissue, WT mice were anaesthetised and the CF nerve exposed, freed from 
surrounding tissue [see sections 2.2.2 and 2.2.3] and then covered with the muscle to 
prevent it from drying out prior to transplanting into a YFP-H mouse.  
YFP-H mice were then anaesthetised and the CF nerve exposed and a 3mm gap between 
central and distal nerve endings created [see section 2.2.1 and 2.2.3]. Graft tissue was then 
obtained from the prepared WT mouse and used to repair the YFP-H mouse CF nerve [see 
section 2.2.3]. The WT mice were culled once graft tissue was obtained and the YFP-H mice 
allowed to recover for 3-weeks. 
Following the recovery period, mice were anaesthetised [see section 2.2.2], the CF nerve re-
exposed, harvested and prepared for image analysis [see section 2.2.5].    
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5.2.3 ANIMAL NUMBERS AND GROUPINGS 
A total of 37 mice were used specifically for the in the experiments described in this chapter, 
with equal numbers of YFP-H and WT mice used in graft repairs and only YFP-H mice used 
in conduit repairs. Reused images from the M6P study [see chapter 3] provided data for the 
uninjured group [n=7] bringing the total number to 44 mice. Those images were completely 
reanalysed to take into account the increased repair length used in the studies discussed 
here and in chapter 6.    
The groups for this chapter were: uninjured [n=7], graft [n=7 YFP-H and 7 WT to provide 
graft tissue], hollow polyethylene-glycol conduits [n=7], electrospun fibre filled polyethylene-
glycol conduits [n=6, see section 5.3] and hollow poly-caprolactone conduits [n=7]. 
Two additional YFP-H mice were used in the fibre filled conduits group as early experiments 
revealed extremely poor regeneration [fig. 5.10] and it was decided that further experiments 
with the conduit in its original form were not viable.  A change in the fibre packing density 
[50% reduction] was made and a pre-soaking of the fibres in Ringer's solution prior to 
implanting was performed in order to improve the performance of the fibre conduits.       
5.2.4 SAMPLE SIZE CALCULATIONS 
The sample sizes for this study were calculated using PiFace software [v1.76: 
homepage.stat.uiowa.edu/~rlenth/Power] with standard deviation data obtained from the 
M6P study discussed in the chapter 3.  
5.2.4.1 Sample Size Choice and Justification. 
The sample size chosen for the studies discussed within this chapter was n=7, which would 
be sufficient to detect differences between groups of 27.13%, 9.54% and 8.86% for 
sprouting index [fig. 5.4], functional axon tracing [fig. 5.5] and axon disruption [fig. 5.6] 
respectively. For justification see section 4.2.3.1.  
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5.2.4.2 Sample Size Calculation Results. 
 
Figure 5.4: Sprouting index analysis power and detectable difference results for µSL conduit 
study when using a  sample size of n=7. Levels[row] = number of intervals; levels[col] = 
number of groups; n[Within] = sample size; SD[Within] = standard deviation value derived 
from M6P study results. Number of intervals [# means] multiplied by number of repair groups 
minus one gives the number of t-tests required for the Bonferroni post-tests [# tests].   
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Figure 5.5: Functional axon tracing analysis power and detectable difference results for µSL 
conduit study when using a sample size of n=7. 
 
Figure 5.6: Axon disruption analysis power and detectable difference results for µSL conduit 
study when using a sample size of n=7. Levels[treatment] = number of groups. 
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5.2.5 STATISTICAL ANALYSIS 
Statistical analysis of the results described in this chapter was carried out as stated in 
section 2.3.3. All sprouting index and functional axon tracing results used 2-way ANOVA 
with Bonferroni post-tests; axon disruption results used a 1-way ANOVA with Bonferroni 
post-tests. Differences were considered to be significant when p<0.05. 
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5.3 RESULTS 
All animals recovered well following surgery with no signs of infection or autotomy. However, 
one fibre filled polyethylene-glycol conduit was found to have become dislodged at the 
central nerve ending during the recovery period and as a result was excluded from the 
results. 
5.3.1 QUALITATIVE DIFFERENCES BETWEEN GROUPS 
Axons in uninjured nerves tended to run almost parallel through the excised section with no 
notable increases or decreases in overall numbers [fig. 5.7]. In graft repairs there were two 
areas of disruption at the joins between the transected nerve endings and graft tissue, 
though axons within the graft were similarly organised to those in the uninjured nerves 
[fig. 5.8].
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Figure 5.7: Typical uninjured nerve image with intervals marked. Scale bar = 1.0mm. 
  
133 
 
 
Figure 5.8: Typical graft repaired nerve image with intervals marked. Scale bar = 1.0mm. 
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5.3.1.1 Hollow Polyethylene-glycol Conduits. 
Images obtained for hollow polyethylene-glycol [hPEG] conduits were quite varied in 
appearance. Typically axons became disrupted and disorganised upon regenerating out 
from the transected central nerve ending in a similar manner to that observed in graft repairs 
[figs. 5.8 and 5.9]. However, unlike in graft repairs, a large level of disorganisation remained 
in hPEG conduit repairs through the repair until the axons re-entered the distal nerve ending 
[fig. 5.9].     
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Figure 5.9: Typical hollow PEG conduit repaired nerve image with intervals traced. Scale bar = 1.0mm. 
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5.3.1.2 Electrospun Fibre Filled Polyethylene-glycol Conduits. 
Initial repairs using fibre filled polyethylene-glycol [fPEG] conduits demonstrated no signs of 
successful regeneration, with few axons even appearing to enter the aligned fibres 
[fig. 5.10].  
Following alterations to the fibre density and efforts to pre-soak the aligned fibres with 
Ringer's solution immediately prior to implantation regeneration appeared to improve to 
some degree, though in typical repairs no axons managed to regenerate through to the distal 
nerve ending [fig. 5.11]. A great deal of variation between repairs was noted and can clearly 
be demonstrated by comparing a more typical repair image [fig. 5.11] to that of the best 
performing repair, in which axons successfully regenerated to the distal nerve ending in 
large numbers [fig. 5.12]. This variation was also apparent from the large SEM values for 
most quantitative results in the fPEG group [table 4, figs. 5.14 to 5.16].      
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 Figure 5.10: Failed early pilot fPEG repaired nerves - marked line indicates start of fibres. Scale bar = 0.5mm. 
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Figure 5.11: Typical fibre filled PEG conduit repaired nerve image - marked line indicates start of fibres. Scale bar = 1.0mm. 
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Figure 5.12: A fPEG repair where axons reached distal nerve ending - marked line indicates start of fibres. Axons appeared better organised than 
in hPEG [fig. 31] and hPCL repairs [fig. 35]. Scale bar = 1.0mm. 
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5.3.1.3 Hollow Poly-caprolactone Conduits. 
Images obtained for hollow poly-caprolactone [hPCL] conduit repairs - like those for hPEG 
conduits - were quite varied in appearance compared to the graft repair images. As with 
hPEG conduits [fig. 5.9], axons typically became disrupted and disorganised upon 
regenerating out from the transected central nerve ending [fig. 5.13] in a similar manner to 
that observed in graft repairs [fig. 5.8]. Axons regenerating through the hPCL conduits 
tended to be more densely arranged than axons in hPEG conduits, giving the appearance of 
greater organisation [figs. 5.9 and 5.13].   
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Figure 5.13: Typical hollow PCL conduit repaired nerve image. Scale bar = 1.0mm.
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5.3.2 SPROUTING INDEX RESULTS 
In all repair groups the highest sprouting index level observed was at the 0.5mm interval, 
with levels in fPEG, hPCL and graft groups significantly higher [p<0.001] than uninjured 
controls at this interval [fig. 5.14 and table 5]. In all repair groups the sprouting index levels 
declined at each interval between 0.5mm and 4.0mm - with the exception of the hPCL group 
where levels declined to the 2.5mm interval before increasing again at both 3.0 and 3.5mm 
intervals and finally declining again at the 4.0mm interval [fig. 5.14 and table 5]. 
In hPEG, fPEG and graft groups the lowest sprouting index levels were observed at the 
4.0mm interval, and in the hPCL group it was at the 2.5mm interval [fig. 5.14 and table 5]. At 
the 4.0mm interval the sprouting index levels for both hPEG and fPEG groups were 
significantly lower [p<0.05 and p<0.001 respectively] than uninjured controls, with the level 
for the fPEG group also significantly lower [p<0.01] than that of the hPCL group [fig. 5.14]. 
Significant differences were also found at the 1.0mm and 2.0mm to 3.5mm intervals. At the 
1.0mm interval the sprouting index level for the graft group was significantly higher [p<0.05] 
than in uninjured controls, while at the 2.0mm interval it was significantly higher [p<0.05] 
than in the fPEG group [fig. 5.14]. At the 2.5mm interval the sprouting index level for the 
fPEG group was significantly lower [p<0.01] than in both the graft and uninjured groups; the 
sprouting index level for the fPEG group remained significantly lower than in uninjured 
controls at the 3.0 and 3.5mm intervals [p<0.01 and p<0.001 respectively] and was also 
significantly lower [p<0.01] than in the hPCL group at the 3.5mm interval [fig. 5.14]. 
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Table 5: Sprouting index levels for hPEG, fPEG, hPCL, vehicle and uninjured groups [%]. 
 
Repair 
Position 
(mm) 
Average 
Sprouting 
% (hPEG) 
SEM 
Average 
Sprouting 
% (fPEG) 
SEM 
Average 
Sprouting 
% (hPCL) 
 
 
 
SEM 
Average 
Sprouting 
% (Graft) 
SEM 
Average 
Sprouting 
% 
(Uninjured) 
SEM 
-0.5 100.0 0.0 100.0 0.0 100.0  0.0 100.0 0.0 100.0 0.0 
0 115.0 3.6 117.2 3.3 115.4  6.6 111.3 4.1 98.3 1.9 
0.5 137.8 10.5 168.2 18.3 173.4  5.0 162.4 15.2 95.7 1.1 
1 113.5 17.0 127.5 18.4 106.6  9.0 148.2 12.3 98.0 1.4 
1.5 95.6 12.2 90.8 23.7 72.0  12.7 113.0 13.8 94.7 2.1 
2 76.0 13.1 53.2 25.3 67.0  11.1 105.6 9.0 95.7 1.1 
2.5 66.8 9.8 40.2 22.8 62.0  9.9 95.4 3.5 95.7 2.2 
3 77.8 9.3 38.3 25.1 67.7  9.9 93.7 7.0 97.7 2.5 
3.5 64.0 11.4 21.3 19.8 75.4  15.1 78.4 10.0 97.7 1.5 
4 52.7 10.2 11.0 9.5 67.7  15.4 64.8 7.6 97.4 1.9 
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Figure 5.14: Sprouting index levels at 0.5mm intervals along the repairs; *,** and *** denote significant differences compared to uninjured controls, 
p<0.05, p<0.01 and p<0.001 respectively; † and †† denote significant differences compared to fibre PEG conduit repairs. Statistical test: 2-way 
ANOVA with Bonferroni post-tests.       
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5.3.3 CHANGE IN SPROUTING INDEX BETWEEN INTERVALS 
The largest positive change in sprouting index level occurred at the 0.5mm interval in all 
repair groups, the level of change was significant [p<0.001] compared to uninjured controls 
in fPEG, hPCL and graft groups [fig. 5.15]. Only the level of change in sprouting in the hPEG 
group was not significantly greater than uninjured controls at the 0.5mm interval, though it 
was significantly lower [p<0.05] than the level of change observed in the hPCL group 
[fig. 5.15]. 
The largest negative change in sprouting index level for repair groups occurred at the 1.0mm 
interval - with the exception of the graft group, in which it occurred the 1.5mm interval 
[fig. 5.15]. At the 1.0mm interval the change in sprouting index level for both fPEG and hPCL 
groups was significantly greater [p<0.01 and p<0.001 respectively] than in uninjured controls 
- in addition the change in sprouting index level for hPCL was also significantly greater than 
both the hPEG [p<0.01] and graft [p<0.001] groups [fig. 5.15]. 
For the remaining intervals the change in sprouting index levels for the repair groups were 
negative - with the exceptions of hPEG and hPCL groups at the 3.0mm interval and the 
hPCL group at the 3.5mm interval, where small positive changes were observed [fig. 5.15]. 
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Figure 5.15: Changes in sprouting index levels at each 0.5mm interval compared to the previous interval; ** and *** denote significant differences 
in level compared to uninjured controls, p<0.01 and p<0.001 respectively; †, †† and ††† denote significant differences in level compared to hollow 
PCL conduits, p<0.05, p<0.01 and p<0.001 respectively. Statistical test: 2-way ANOVA with Bonferroni post-tests.       
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5.3.4 FUNCTIONAL AXON TRACING 
No significant differences were detected between repair groups at any interval in terms of 
individual start axons present. Though there were some small differences between repair 
groups at points along the repair - a lower proportion of unique axons in hPCL repairs at the 
1.5mm interval and both hPCL and hPEG lower than graft repairs at 2.0mm [fig. 5.16]. The 
percentage of unique start axons was significantly lower [p<0.001] in all repair groups 
compared to the uninjured controls at every interval from 1.0 to 4.0mm [fig. 5.16]. 
The largest loss of start axons occurred between the 0.5 and 1.0mm intervals in all repair 
groups, with 24% to 31% of unique start axons lost between those two intervals [fig. 5.16]. 
Between 49% and 61% of all unique start axons were lost between the 0.0mm and 1.5mm 
intervals with small losses continuing for the remainder of the repairs, so that at the final 
interval [4.0mm] the percentage of remaining start axons was between 4% and 20% 
[fig. 5.16]   
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Figure 5.16: Percentages of start axons represented at subsequent 0.5mm intervals; *** denotes significant difference compared to all repair 
groups, p<0.001. Statistical test: 2-way ANOVA with Bonferroni post-tests.       
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5.3.5 AXON DISRUPTION 
The average increase in axon length across the initial 1.5mm of repairs was significantly 
higher than uninjured controls in both the fPEG [p<0.05] and graft [p<0.01] groups [fig. 5.11]. 
However, in both the hPEG and hPCL groups the increases in average axon length were not 
significantly higher than uninjured controls [fig. 5.17].  
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Figure 5.17: Percentage increase in axon length across the initial 1.5mm of repair; * and ** denote significant differences compared to uninjured 
controls, p<0.01. Statistical test: 1-way ANOVA with Bonferroni post-tests.       
151 
 
5.4 DISCUSSION 
5.4.1 HOLLOW PEG AND PCL µSL CONDUITS 
5.4.1.1 Visual Differences. 
In terms of the visual appearance of the repaired nerves, hPCL repair images appeared 
similar to graft repair images [figs. 5.8 and 5.13] but hPEG repair images generally appeared 
to have a less organised appearance with axons more greatly spread out between the 
central and distal nerve endings [fig. 5.9]. Closer examination of the hPCL repair images 
does appear show that despite the similar appearance to graft images, the axons in hPCL 
repairs between central and distal nerve endings are less organised than those in graft 
repairs - which run fairly parallel through the graft [figs. 5.8 and 5.13]. 
It had been anticipated that axons within hollow conduits would, due to the lack of structural 
guidance, be somewhat less organised than those in grafts, where axons can be guided 
along existing endoneurial tubes. However, the difference between hPEG and hPCL 
conduits [axons spread out more in hPEG than hPCL] was not anticipated as both conduit 
types were similar dimensionally. One potentially key difference between the two conduit 
types is that while hPEG conduits are rigid, hPCL conduits are partially flexible, which leads 
to the possibility that the shape of hPCL conduits may have altered to a more elliptical shape 
due to pressure from surrounding tissues. This in turn may have restricted the spread of the 
regenerating nerve through hPCL conduits, providing that the path the nerve regenerated 
along was at one of the tighter radius ends of the ellipse.  
5.4.1.2 Differences in Sprouting Index. 
Quantitatively both types of hollow µSL conduits performed similarly to graft repairs overall, 
although there were some minor differences in the sprouting profiles between graft, hPEG 
conduits and hPCL conduits. In terms of sprouting there were no differences between 
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repairs [hPEG, hPCL and graft] at the start of the repair [0.0mm], with all three having a 
slightly higher sprouting index than uninjured controls [fig. 5.14].  
The most interesting differences between the conduit repair groups occurred at the 
subsequent two intervals [0.5mm and 1.0mm]. At the 0.5mm interval the sprouting index 
levels for hPCL and graft repairs had increased significantly compared to the uninjured 
controls, whilst in the hPEG repairs the sprouting index level increased by a lower amount 
which was not considered to be significantly different to the uninjured controls [fig. 5.14]. In 
addition, the difference of the increase in sprouting index level between hPEG and hPCL 
was considered significant [fig. 5.14]. In terms of the overall sprouting index levels these 
differences in sprouting index levels increases led to both hPCL and graft repairs being 
significantly higher than uninjured controls while hPEG repairs were not.    
At the next interval [1.0mm] the sprouting index levels for all repair groups decreased, 
though only in the hPCL group was this decrease considered significant when compared to 
the uninjured controls [fig 5.14]. The decrease in the hPCL group was also significantly 
different to both hPEG and graft repairs [fig. 5.14]. In terms of the overall sprouting index 
levels these changes resulted in hPEG and hPCL repairs having similar levels, not 
significantly higher than uninjured controls, at the 1.0mm interval - though graft repairs 
remained significantly higher than the uninjured controls [fig. 5.13]. 
The lower sprouting index level at the 0.5mm interval for hPEG would appear to indicate that 
axons regenerating into hPEG conduits encountered a reduced level of obstruction 
compared to those in grafts and hPCL conduits [see section 3.4.1 for discussion on 
sprouting/obstructions]. The expectation prior to starting these conduit studies was that 
axons would find regenerating into the hollow conduits easier than into the graft tissue, as 
upon exiting the central nerve ending they would not be faced with attempting to find a 
suitable endoneurial tube to regenerate along. This indeed appears to be the case in hPEG 
conduits but, despite the similarity in design between hPEG and hPCL conduits, it is not the 
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case for the hPCL conduits, which were observed to have a similar sprouting index level to 
grafts at the 0.5mm interval. 
Other than the previously mentioned flexibility differences between hPEG [rigid] and hPCL 
[flexible] there is little obvious difference between these two conduit designs. Polyethylene-
glycol has been shown to be biocompatible to a relatively high degree and, when in a 
hydrogel form, capable of supporting in vitro culturing of neural pre-cursor cells (Mahoney 
and Anseth, 2006, Mihai et al., 2011). The biocompatibility of poly-caprolactone has also 
been demonstrated to be very good (Sharma et al., 2011) and long-term it biodegrades in 
vivo without accumulation within tissues (Sun et al., 2006). Given that neither material is 
considered harmful and are often used in combination with each other (Cometa et al., 2010, 
Li et al., 2014) it appears unlikely that the differences in sprouting index levels at the initial 
repair intervals would be caused by the inherent properties of either material. So we need to 
consider, again, that the flexibility of hPCL conduits has a role to play here. 
As discussed earlier, the flexible nature of the hPCL conduits could lead to them becoming 
slightly deformed via the pressure exerted by surrounding tissues. This deformation of the 
conduit may resulting in a larger gap between conduit and nerve endings at certain points - 
this gap may allow increased ingress of granular tissues from the surrounding environment. 
When granular tissue enters a conduit it can, in sufficient quantity, interfere with axonal 
regeneration into the conduit (Williams et al., 1984). It is possible that regenerating axons 
within hPCL conduits may have had to contend with increased ingress of granular tissue 
compared with hPEG conduits, resulting in greater initial sprouting to overcome the 
obstruction.  
What may also impact upon the initial difference in sprouting index levels between hPEG 
and hPCL conduits is whether the nerve endings in hPCL conduits become damaged by any 
potential deformation of the conduit. Damage could be caused when a hPCL conduit 
deforms due to external pressures and pinches the regenerating nerve ending between its 
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walls. This is less likely than the previous hypothesis as no severe deformation was noted 
during extraction of the conduits and conduit/nerve ending positioning varied by a small 
amount in each surgical setup - which would alter the probability of the nerve ending 
becoming pinched. As the SEM for hPCL repairs at the 0.5mm and 1.0mm is relatively low 
compared to all other conduit repairs it is also unlikely that a small number of repairs with 
high sprouting index levels are skewing the results. 
Following the initial differences between hPEG, hPCL and graft sprouting index levels at the 
0.5mm and 1.0mm intervals, the sprouting index levels in both hPEG and hPCL repairs fall 
to similar levels, slightly lower than those in the graft repairs [fig. 5.14]. In both conduit repair 
groups there is a very small increase in sprouting at the 3.0mm interval, which in hPCL 
repairs continues at the 3.5mm interval [fig. 5.15]. This increase is likely to occur due to the 
regenerating axons meeting up with the distal nerve ending and then undergoing sprouting 
in order to locate suitable endoneurial tubes.  
At the final interval [4.0mm] the sprouting index level for hPEG repairs is considered 
significantly lower than uninjured controls, while in hPCL and graft repairs it is not 
significantly lower [fig. 5.14]. As discussed in the M6P study [see section 3.4.1], this is likely 
as a result of the much lower initial increase in sprouting index level at the 0.5mm interval in 
hPEG repairs compared to the hPCL and graft repairs, as this difference was then roughly 
maintained throughout the remaining intervals [fig. 5.15].  
It had been expected that axons would take longer to traverse the distance between central 
and distal nerve endings in conduit repairs as it has been reported that axon regeneration in 
hollow conduits requires an initial connective tissue bridge to form between the two nerve 
endings and migration of support cells (Lundborg et al., 1982a, Williams et al., 1984). There 
was, however, no evidence of this in the sprouting index results - the expectation being that 
significantly fewer axons would have reached the distal nerve ending in conduit repairs. This 
may be as a result of the majority of axons regenerating past the point where the nerve was 
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sectioned for removal - meaning that the difference does occur but is not revealed in the 
current model.  
Alternatively, any difference may have been negated as axons in conduit repairs do not have 
to deal with entering and exiting graft tissue which may be obstructed with scar tissue 
formed by fibroblasts causing increased scarring within the graft tissue, which could also act 
as a source of additional inflammatory factors. As axons regenerate much slower through 
scar tissue (Gutmann et al., 1942, Al-Majed et al., 2000), the potentially reduced level in 
conduit repairs may allow regenerating axons in those repairs to make up for initial delays in 
regeneration. 
5.4.1.3 Functional Axon Tracing. 
As with previous studies [see sections 3.3.5 and 4.3.4], the majority of unique axon loss 
occurred within the initial 1.5mm of the repairs, with a large amount between the 0.5mm and 
1.0mm intervals [fig. 5.16]. A post-hoc comparison does indicate a strong correlation 
between unique axon loss and the change in sprouting index level across hPEG, hPCL and 
graft repairs [fig. 5.18]. However, the large decline in sprouting index level [by approximately 
66%] between the 0.5mm and 1.0mm intervals in hPCL repairs [fig. 5.15] does not appear to 
cause a proportionately large decline in unique axons at the 1.0mm interval [fig. 5.16]. A 
smaller sprouting index level decline [approximately 14%] in graft repairs resulted in only a 
6% difference in unique axon numbers compared to hPCL repairs at the 1.0mm interval. 
Though there does appear a trend towards reduced predictability with greater unique axon 
loss or reduction in sprouting index levels based upon the comparison [fig. 5.18] 
The apparent relationship between sprouting index level change and unique axon number is 
a relatively straightforward and expected one. A decrease in the overall number of axons at 
an interval should impact both unique and duplicate axons proportionately - so if there are 
100 axons at a particular interval with 20 of them unique, then a 10% decline in total axons 
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at the next interval should result in 2 unique axons being lost compared to 8 duplicate 
sprouts.  
These proportions may vary due to certain confounding factors - the pruning of excess axon 
sprouts would increase overall axon loss without affecting unique axon loss. While potential 
for preferential regeneration of certain axon subsets may increase or decrease unique axon 
loss, depending upon whether those axon subsets show increased or decreased levels of 
sprouting. However, it was not within the remit, or capability of this particular study to 
examine these possibilities.     
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Figure 5.18: Comparison between unique axon loss and change in sprouting index at individual intervals - data pooled from hPEG, hPCL and graft 
results. A significant correlation between unique axon loss and change in sprouting was detected [p<0.0001] using Spearman's r correlation test. 
Error bars are SEM. 
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5.4.1.4 Initial Axon Disruption. 
The average path length of axons across the initial 1.5mm of the repair in both hPEG and 
hPCL conduits was not considered to be significantly longer than that taken by axons in the 
uninjured controls [fig. 5.17]. In contrast the average path length in graft repairs was 
considered significantly longer than that taken by axons in uninjured controls, indicating a 
trend towards greater disruption in the initial stages of graft repairs compared to conduit 
repairs [fig. 5.17]. 
As discussed for the mannose-6-phosphate study [see section 3.4.3] the shorter the route 
taken by axons across a repair, the sooner they will reach their target tissue. This has the 
potential to improve regeneration through enabling axons to cover the distance between 
injury and target tissue while the environment and target tissues are still permissive to 
regeneration [see section 1.7.3].  
It had been anticipated that using hollow conduits would reduce the disruption in the initial 
stages of repairs, mainly due to the axons in conduit repairs not having to regenerate directly 
into 'ready-made' tissue and find appropriate endoneurial tubes. Once axons in conduit 
repairs regenerate through any scar tissue at the exit of the central end they enter into a 
newly forming fibrin matrix, which by 5-7 days after conduit implantation forms a 
longitudinally organised link between the sectioned nerve endings (Williams et al., 1984, 
Dahlin and Lundborg, 2001). It is logical to assume that axons regenerating along with their 
supporting tissues would have less obstacles to regenerate around than axons attempting to 
regenerate into graft tissue where endoneurial tubes originally formed for a different 
arrangement of axons.  
One drawback of hollow conduits may be that, because the structural tissues need to 
regenerate along with the axons, there is a longer delay between the repair being made and 
axons regenerating into the repair. It has been known since the early-to-mid 1980's that 
following implanting a conduit fills with a fluid rich in neurotrophic factors (Lundborg et al., 
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1982b, Longo et al., 1983, Dahlin and Lundborg, 2001), typically within the first two days 
following implantation (Williams and Varon, 1985). It is then in the second week after 
implantation that Schwann cells and axons begin to enter the repair (Williams et al., 1983, 
Dahlin and Lundborg, 2001). This potential regeneration delay in conduit repairs may negate 
any gains made by axons taking a shorter route into, and across, the repair when compared 
to graft repairs.  
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5.4.2 FIBRE FILLED PEG µSL CONDUITS 
5.4.2.1 Visual Differences. 
It was immediately obvious from nerve images that the performance of the fPEG conduits - 
even following the changes discussed in section 5.2.3 - was disappointing [fig. 5.11]. Few 
axons regenerated more than 1.5mm into the conduits in most repairs and only in two 
repairs did axons reach the final [4.0mm] interval.  
In one of the two repairs where axons reached the final interval the organisation of axons 
through the repair appeared to be better organised than those axons in both types of hollow 
conduit [fig. 5.12]. This indicates that the presence of the aligned fibres may have the 
potential to improve the organisation of axons regenerating through conduits - if the axons 
can actually manage to regenerate through the conduits.   
5.5.2.2 Differences in Sprouting Index. 
Quantitatively, the sprouting index results generally corresponded with the visual images, 
with only one repair contributing a noteworthy amount of axons to the final two intervals 
[table 5 and fig. 5.14]. Initially the sprouting index levels in fPEG repairs were similar to graft 
and hPCL repairs, with a small increase in sprouting index level at the start interval [0.0mm] 
followed by a significantly higher increase compared to uninjured controls at the 0.5mm 
interval [fig. 5.15]. The sprouting index level then decreased by an amount between that of 
hPEG and hPCL at the 1.0mm interval and decreased at the 1.5mm interval similarly to the 
other repair groups [fig. 5.15]. 
The main loss of overall axon numbers appears to occur at the 2.0mm interval - where fPEG 
repairs are the only repair to decrease significantly compared to uninjured controls - with 
similar changes in sprouting index levels to the other repair groups at the remaining 
intervals. 
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As the 0.0mm interval is determined by the first signs of abnormal axon morphology, not the 
end of the central nerve ending, the point where regenerating axons first meet PCL fibres is 
between the 0.5mm and 1.0mm intervals. Seeing that axons in fPEG repairs perform 
similarly to other conduit and graft repairs across these early intervals, there is an indication 
that axon regeneration is severely impacted once axons start regenerating into the aligned 
PCL fibres. 
With the hPEG conduits demonstrating that a good level of nerve regeneration is achievable 
in conduits of the same design without any fibres, and PCL not appearing cause any 
detrimental effects when in the form of a conduit, it would appear that something about the 
electrospun PCL fibres is the cause of the failure. 
An inherent disadvantage of any synthetic material used in artificial nerve guides is the lack 
of any naturally occurring cell adhesion proteins or recognition signals (Kim and Mooney, 
1998). As the PCL fibres used in the fPEG conduits were not coated or treated with any 
matrix proteins it is likely that migrating Schwann cells would have found conditions to be 
sub-optimal at best. 
An in vitro study by Schnell et al. (2007) demonstrated that electrospun PCL fibres do 
provide a favourable substrate for cell growth and attachment, though when PCL was 
combined with collagen [at a ratio of 75% PCL to 25% collagen] the biological benefits 
increased significantly. A study by Zhang et al. (2010), which investigated the potential for 
silk fibroin to be added to poly(L-lactic acid-co-ε-caprolactone) [PLLA-CL] electrospun fibres, 
found the electrospun fibres performance enhanced when coupled with the silk fibroin 
protein [especially the fibres with a 75% PCL to 25% silk fibroin ratio]. 
A later study by the same group (Wang et al., 2011) compared the performance of silk fibroin 
PLLA-CL fibres [SF/PLLA-CL] to pure PLLA-CL fibres in conduit repairs of the sciatic nerve. 
They used the best performing ratio for the electrospun fibres from the previous study [75% 
PCL to 25% silk fibroin] which resulted in significantly better conduction velocities and 
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compound action potentials when compared to pure PLLA-CL (Wang et al., 2011). 
Histological analysis also demonstrated the benefit of SF/PLLA-CL fibres, with greater 
overall and myelinated axon numbers and also apparently greater axon organisation in 
conduits filled with SF/PLLA-CL fibres (Wang et al., 2011). 
It would appear that the use of uncoated PCL fibres, whilst not being quite as beneficial as 
matrix protein coated PCL fibres, should not be overly inhibitive to axon regeneration. One 
possible reason for the poor performance of fPEG conduits in this study could be related to 
how densely the fibres were packed into the PEG conduits. Two early pilot repairs used a 
higher density of PCL fibres [approximately double that used for subsequent experiments], 
with the result that no axons appeared to enter the fibres [fig. 5.10]. 
Following the initial two pilot repairs it was decided to reduce the density of the PCL fibres 
within the fPEG conduits. The amount that the density could be reduced by was limited, as 
reducing the density too much would lead to the fibres not fitting securely in the conduit and 
risk them falling out of the conduit once implanted.  
A second issue noticed during the implantation of the two pilot fPEG conduits was that the 
fibres were extremely dry and tended to adsorb to any moist tissue. It was felt that this was 
likely to adversely impact regeneration through drying out and damaging the sectioned nerve 
endings and also impact the secretion of neurotrophin rich fluid into the conduit [see section 
5.5.1.3]. Subsequently, for this study the fPEG conduits were soaked in Ringer's solution for 
one-hour prior to impact in an attempt to alleviate this issue. 
These alterations [reduced fibre density and pre-soaking conduits] did improve the 
performance of fPEG conduits [though only compared to the pilot fPEG conduits], with the 
majority of repairs having sprouting index levels of 50% or greater at the 1.5mm interval and 
only two repairs failing to regenerate axons to the 3.0mm interval. One repair [fig. 5.12] 
performed remarkably well, having a sprouting index of 150% at the 0.5mm interval which 
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was maintained at a similar level throughout the entire length of the conduit and only 
declining significantly upon entering the distal nerve ending.  
However, the large variation between fPEG conduit repairs [note the relatively large SEMs 
for table 5 and figs. 5.14 to 5.16] does indicate that the methods used to produce these 
alterations may require refinement in order to gain better homologated conduits. For 
example, simply placing the conduits in Ringer's solution may result in fibres in one conduit 
being completely soaked but fibres in another only being soaked at the ends, leaving the 
centre dry. Additionally, reducing variation between conduits in terms of fibre packing 
densities may also have an impact upon reducing variation between repairs.             
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5.4.2.3 Functional Axon Tracing. 
Although the proportion of unique axons regenerating through fPEG was much lower than in 
hPEG, hPCL and graft repairs [~4% compared to ~20%; fig. 5.10], only two fPEG repairs 
actually had axons regenerating through the entire repair, with one of those [fig. 5.12] 
displaying similar levels to the three other repair groups. 
Across all repair intervals the proportion of unique axons was not considered significantly 
different in fPEG repairs to the other repair groups, with little noticeable difference until after 
the 1.5mm interval [fig. 5.16]. As sprouting index results also show similar levels between 
the repair groups until after the 1.5mm interval [after which fPEG sprouting index levels 
begin to decline rapidly], this is indicates that regeneration within fPEG began in a similar 
fashion before failing midway into the repairs. 
The one successful fPEG repair [fig. 5.12] did have similar proportions of unique axons at all 
intervals as the other three repair groups. This indicates that if the PCL fibres were treated to 
prevent the regeneration failure that occurred in the majority of fPEG repairs, then functional 
recovery would be similar to the other repair groups in fPEG repairs. 
5.4.2.4 Initial Axon Disruption. 
Average axon length increases over the initial 1.5mm of the repairs in fPEG conduits were 
similar to that in hPEG and hPCL conduits, though the slightly higher increase in fPEG 
repairs did result in the disruption being considered significant compared to uninjured 
controls [fig. 5.17].  
It was anticipated that in fPEG repairs that this initial disruption would be reduced compared 
to graft repairs, the reasoning for this is mostly covered in section 5.4.1.4. The obvious 
difference between hPEG, hPCL and fPEG repairs is that axons in the hollow conduits exit 
the central nerve ending into a space containing only regenerating nerve tissue, associated 
cells and neurotrophic factors, while fPEG axons will also meet with PCL fibres. The 
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presence of the PCL fibres was not considered likely to increase disruption as, although they 
do provide a potential physical obstruction, they are flexible and do not contain their own 
population of inflammatory cells and factors as graft tissue does..  
The average axon length increase in fPEG repairs does appear to indicate that this is indeed 
the case, as despite the significant difference between fPEG repairs and uninjured controls, 
the difference between fPEG and the other conduit repairs [<2.6%] was actually smaller than 
the difference between fPEG and graft repairs [>3.1%; fig. 5.17]. In addition, only one of the 
fPEG repairs had an average axon length increase above the mean value for average axon 
length increase, with that result actually lower than the maximum in hPCL repairs and less 
than 1% higher than that in hPEG repairs. This would indicate that the reason for fPEG 
repairs having a significantly greater disruption compared to uninjured controls - while hPEG 
and hPCL repairs do not - may result from less variation in the increase in average axon 
length between the fPEG repairs, likely resulting from the guidance provided by the aligned 
PCL fibres. 
5.4.3 CONCLUSIONS 
Both hollow conduit types used in this study enabled nerves to regenerate across a short 
defect in a similar manner to nerve grafts. Although this is certainly a promising start for µSL 
produced conduits, the major test of their suitability will come when faced with repairing 
larger nerve defects. Many conduit designs have been demonstrated to have graft-equalling 
performance over short defects less than 20mm (Lundborg et al., 1982a, Archibald et al., 
1995, Francel et al., 1997, Bertleff et al., 2005, Sinis et al., 2005, Bushnell et al., 2008) but 
very few can maintain this across larger defects (Matsumoto et al., 2000).  
However, the main aim of this study was to determine a baseline level of performance for 
hollow µSL conduits in the YFP-H mouse nerve injury model and to ensure that the conduits 
would allow regeneration to occur. This aim was successfully achieved, with the majority of 
hollow µSL conduits enabling regeneration across the defect [one hPEG and one hPCL 
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failed to regenerate axons all the way to the distal nerve ending] with no notable side-effects 
other than those also observed in graft repairs [mild loss of mobility and inflammation of the 
surgical site]. 
Of the two hollow µSL conduit materials PCL appears to be the more suitable for any future 
work, as it fits more of the desired qualities of artificial nerve guides (Ciardelli and Chiono, 
2006): it is bioabsorbable, moderately flexible but still strong enough to resist collapsing and 
could be sutured in place if used on a larger nerve [though its resistance to tearing may 
require increasing]. The PEG conduits, despite their good performance in this study, are 
unlikely to ever be suitable for clinical use due to a number drawbacks of PEG: it is non-
bioabsorbable, inflexible and brittle [a number of hPEG conduits were broken during 
attempts to implant them].       
The performance of the fPEG conduits in this study was disappointing; however, the likely 
reasons for the poor performance of fPEG conduits [uncoated/dry PCL fibres] can be easily 
rectified. Although one fPEG conduit repair suffered a complete failure [central nerve ending 
dislodged from conduit], this is a potential eventuality in any conduit or graft repair where the 
repair is secured using fibrin glue rather than sutures and therefore does not reflect 
negatively upon fPEG conduits. Although the majority of fPEG repairs were disappointing, 
one [fig. 5.12] did manage to equal the performance of graft repairs and indicate that the 
aligned PCL fibres do improve the organisation and guidance of regenerating axons. 
One area of future work using µSL conduits is likely to attempt to improve the performance 
of aligned PCL fibres within conduits by coating them with beneficial matrix proteins [e.g. 
collagen, laminin]. It is probable that the PEG conduits used to house the fibres in this study 
will be replaced by PCL conduits, which will result in fully bioabsorbable conduits. 
A second area of future work could investigate the addition of Schwann cells [either from 
nerve tissue or derived from a suitable source of stem cells] or individual neurotrophic 
factors to the conduits. This may be trialled in similar length conduits to examine in the 
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addition of cells/factors can enable conduit regeneration to surpass graft repairs, or in much 
longer conduits to examine if it can enable regeneration similar to grafts over a long defect.   
In conclusion, the µSL manufacturing technique has proved useful for producing conduits, 
with precise and reproducible conduit dimensions achievable at relatively small sizes. These 
conduits have generally performed well and have great potential to be developed further. 
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6.0 PERFORMANCE OF 3D-
PRINTED CONDUITS IN VIVO 
6.1 INTRODUCTION 
Discussion of the benefits of using conduits in nerve repairs, and current and future conduit 
designs can be found in sections 1.6.3 and 5.1 respectively. The aim of this section is to 
briefly discuss prominent experimental techniques used for producing various designs of 
conduits. 
6.1.1 MANUFACTURING ARTIFICIAL NERVE GUIDE CONDUITS   
A wide variety of methods have been used in order to create conduits for peripheral nerve 
repair; a common theme is taking a cylindrical rod and coating it with a solution of the 
conduit material, once the material 'sets' the mould is removed to leave a hollow conduit (Ao 
et al., 2006, Huang et al., 2012). 
The method used by Ao et al. (2006) was to create a mould into which a 2% chitosan 
solution in 1% acetic acid was injected and a Teflon coated steel rod was then inserted into 
the centre of the mould. The chitosan solution was filtered through a nylon mesh and 
degassed by reducing pressure prior to injection into the mould, once in the mould the 
chitosan solution was frozen for 12-hours at -20ºC. Following this the mould was removed 
and the conduit [with the rod still in place] was lyophilised and then immersed in sodium 
hydroxide to neutralise the remaining acetic acid. The final steps were to rinse with 
deionised water, equilibrate using PBS and then immersed in chitosan solution - this second 
layer of chitosan was dried in a ventilation oven prior to the steel rod being removed. 
Conduits produced using this method - or methods derived from this method - have since 
been used in a number of studies (Ao et al., 2011, Mohammadi et al., 2013, Azizi et al., 
2014).  
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The conduits used by Huang et al. (2012) in their study investigating the benefits of silk 
fibroin were manufactured using a similar principle. A cylindrical rod was dipped into an 8-
10% solution of dialysed regenerated Bombyx mori [silkworm] fibroin and this coating was 
then gelled using acetic acid and frozen to create a porous conduit.  
A more complex version of this method was used by Yao et al. (2010a) in their study which 
produced multi-channelled collagen conduits. In that study a number of thin wires [relating to 
the number of channels desired] were passed through two end-caps 1cm apart in order for a 
collagen solution to self-assemble around. For the seven channel conduits they produced 
Yao et al. (2010a) inserted two wires at first, allowing the collagen solution to self-assemble 
around them and then air dry before repeating that step twice more, with a final repeated 
step for the single remaining wire. Once all wires were coated and the collagen had dried it 
was treated with a cross-linking solution overnight and then washed and freeze-dried; once 
the freeze-drying was complete the end-caps and wires were removed. 
A different take on moulding a conduit around a central rod was used by Oh et al. (2013), 
who rolled an asymmetrical porous PCL/Pluronic F127 membrane around a rod and glued 
the ends of the membrane together. The main aim of the study by Oh et al. (2013) was to 
develop conduits with different surface pores - but the same membrane properties - to 
investigate the effects of pore size on nerve regeneration. In this they found nano-pores to 
perform better than micro-pores (Oh et al., 2013) - information which the same group then 
used to investigate the effects of ultrasound and NGF treatment on nerve regeneration 
through these conduits, determining that the combination of both ultrasound and NGF 
resulted in improved regeneration compared to either treatment in isolation (Kim et al., 
2013). 
Electrospinning is a popular method used to create conduits (Panseri et al., 2008, 
Mottaghitalab et al., 2013) and a brief overview of the basics of the technique can be found 
in chapter 5 of this thesis [see section 5.2.1]. Electrospinning was used successfully to 
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create the conduits used by Panseri et al. (2008) in a study assessing their performance in a 
rat sciatic nerve injury model. The conduits were made by electrospinning PCL fibres onto 
the rotating grounded collector and then electrospinning PCL/Poly(DL-lactide-co-glycolide) 
[PCL/PLGA] fibres on top of the PCL fibres. This created a strong mechanical base through 
the PCL fibres surrounded with the tight-nit outer mesh of the PCL/PLGA fibres (Panseri et 
al., 2008). 
Mottaghitalab et al. (2013) also used electrospinning techniques in the fabrication of 
conduits, although their technique differed in that fibronectin containing silk fibroin nano-
fibres was electrospun onto a silk fibroin/single walled carbon nano-tube substrate 
[SF/SWNT], which was then rolled up to form a conduit. The SF/SWNT substrate was 
formed by freeze-drying a SF/SWNT solution; once the electrospun fibres were in place the 
substrate was soaked in PBS for 4-hours to improve flexibility prior to rolling up the substrate 
with the electrospun fibres forming the interior of the conduit (Mottaghitalab et al., 2013). 
Many of the current experimental procedures for producing conduits have certain key 
limitations that limit the potential to commercially produce conduits for clinical use. For 
example, it is clear in the methods described above that the relatively slow production rates 
and number of complex production stages would hamper any attempts to scale up 
production to a suitable level.  
Additionally, both experimental and current commercial nerve guides are generally limited in 
the variety of sizes produced. Experimental conduits are generally sized according to the 
nerve injury model they will be used in and commercially produced conduits tend to be 
available in set diameter/length combinations (Meek and Coert, 2008). This may be an issue 
for surgeons when during the initial treatment of traumatic nerve injuries, as the injured 
nerve may require a particular diameter/length combination that is not catered for.  
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In recent years additive manufacturing technologies [generally termed 3D printing] have 
garnered a great deal of interest across a broad range of industries. The main reason for this 
is that much more complex and intricate designs can be manufactured using additive 
techniques than traditional casting or subtractive techniques [where being able to remove 
casts and tooling access are limiting factors]. Potential medical uses range from educational 
and surgery planning applications (Rengier et al., 2010, Watson, 2014) to cell scaffolds and 
replacement organs (Gruene et al., 2011, Serra et al., 2013, Schubert et al., 2014).   
The µSL [micro-stereolithography] technique used to manufacture the conduits used in the 
study reported in chapter 5 is considered to be an additive manufacturing technique [through 
the curing of liquid polymer in layers] and clearly demonstrates good potential in the 
production of nerve guide conduits. With current µSL techniques conduit wall thicknesses of 
50µm and surface features of 25µm are achievable (Pateman et al., 2014b). This suggests 
that very precise structures can be created, such as niches and guiding channels, which 
could benefit regenerating axons. However, µSL still has some of the same drawbacks as 
the previously discussed techniques: the setup and manufacture of the conduits is a 
complex process - making true homogeneity between batches potentially difficult to obtain - 
and the rate of production is limited due to difficulties in producing multiple conduits 
simultaneously.  
Another additive manufacturing technique that may prove more suitable to commercial scale 
conduit production is selective laser sintering [SLS]. Complex structures can be created 
using SLS, with models of skeletal and tissue structures having been created in order to plan 
surgical procedures (Suzuki et al., 2010). However, the resolution required for creating a 
skull model - as Suzuki et al. (2010) used in one study - is much lower than would be 
required for creating topographical guidance in a conduit. The ability of SLS to produce 
many conduits of varying combinations of sizes simultaneously may prove commercially 
beneficial in the event that suitable nerve guide conduits can be produced using the 
technique. An additional benefit is that a range of conduit sizes could be produced attached 
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to a single 'Airfix kit' style frame, allowing surgeons to simply select the most appropriately 
sized conduit from the range.  
6.1.2 AIM OF THIS STUDY 
The aim of the study reported in this chapter was to investigate the potential of a 3D printing 
manufacturing technique [SLS] to produce conduits suitable for repairing peripheral nerve 
injury. The work carried out within this study was made possible following a successful grant 
application I made to the MRC Centenary Fund. 
The primary aims of the study were to: 
 Assess the ability of a SLS machine to produce suitably sized conduits to use with 
the YFP-H mouse CF [common fibular] nerve injury model. 
 Assess the performance of SLS produced conduits when used to repair a CF nerve 
injury in YFP-H mice. 
Following initial technical discussions it was expected that the available SLS machine would 
be able to produce suitably sized conduits, though the ideal sizes would be near to the limits 
of its capabilities. 
The performance of the SLS produced conduits was expected to be similar to that predicted 
for the µSL produced conduits in that they would facilitate regeneration almost to the same 
standard as graft repairs [see section 5.1.4].   
173 
 
6.2 MATERIALS AND METHODS 
General materials and methods are detailed in chapter 2, more specific information related 
to the experiments discussed within this chapter is detailed below. 
 6.2.1 SELECTIVE LASER SINTERING PRODUCED CONDUITS 
All conduits produced using SLS techniques were produced in collaboration with the 
laboratory of Professor Neil Hopkinson [Department of Mechanical Engineering, University of 
Sheffield, UK].  
The SLS machine that produced the conduits [EOS Formiga P100] used in this study uses a 
scanning system to direct a laser beam at a layer of fine nylon-12 powder [this material is 
currently the standard for this machine (Johnson et al., 2013)] and melt [sinter] it into a 
pattern determined by a CAD image file [fig. 6.1]. Once the desired pattern is sintered the 
powder stage descends by a predetermined distance, a new layer of nylon-12 powder is 
spread on top of the previous powder layer by a dispensing hopper and the next layer of the 
pattern is sintered [fig. 6.1]. Once the sintering process is complete, the conduits are 
removed from the non-sintered powder and pressurised air is used to remove loose powder, 
the non-sintered powder can then be reused - either on its own or mixed with a proportion of 
unused powder (Dotchev and Yusoff, 2009).  
Due to the small internal diameter size required for the conduits it was not possible to clear 
all non-sintered powder from inside the conduits using pressurised air. Instead, an 
appropriately sized hypodermic needle filled with denatured alcohol was used to force this 
remaining powder out of the conduits. The conduits were then soaked for 48 hours in 
denatured alcohol to remove any remaining loose powder prior to sterilisation by 
autoclaving.   
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Figure 6.1: Diagram depicting selective laser sintering process. A: laser source [30w CO2]; B: laser beam; C: scanning system; D: powder 
dispenser; E: fresh powder spreader; F: sintered powder; G: powder spreader; H: moveable powder stage. 
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Initial SLS conduit designs consisted of a range of differently sized conduits attached to a 
frame [fig. 6.2]. Examination of the conduits found that the powder occupying the centre of 
conduits with an internal diameter of 0.5mm could not be removed, in the 1.0mm internal 
diameter conduits with 0.25mm thick walls powder was also difficult to clear [fig. 6.2]. 
Although a 1.0mm internal diameter would have been comparable with that used for the µSL 
conduits [see section 5.2.1], the wall thickness requirement for the SLS conduits 
necessitated a smaller internal diameter to be used. This was in order to reduce the outside 
diameter of the SLS conduits to a suitable size to fit within the repair location. A range of 
conduits 4.0mm long with 0.5mm thick walls and internal diameters ranging from 0.5mm to 
1.0mm was then produced to determine a suitable size - with a 0.8mm internal diameter 
decided upon and produced for experimental repair. 
  
Figure 6.2: Diagrammatical representation of SLS conduit grid layout [left] and actual SLS 
produced conduits attached to frame [right]. 
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6.2.2 SURGICAL PROCEDURES 
All surgical procedures were identical to those discussed in section 5.2.2. 
6.2.3 ANIMAL NUMBERS AND GROUPINGS 
A total of 28 mice were used in the experiments described in this chapter - with 7 specific to 
this study, with the remaining 21 being controls shared with the separate but concurrently 
performed µSL study. Equal numbers of YFP-H and WT mice were used in graft repairs and 
only YFP-H mice used in conduit repairs and uninjured controls. 
The groups for this chapter were: uninjured [n=7], graft [n=7 YFP-H and 7 WT] and SLS 
conduits [n=7]. 
6.2.4 SAMPLE SIZE CALCULATIONS 
The sample sizes for this study were calculated using PiFace software [v1.76: 
homepage.stat.uiowa.edu/~rlenth/Power] with standard deviation data obtained from the 
M6P study discussed in the chapter 3.  
6.2.4.1 Sample Size Choice and Justification. 
Due to this study sharing controls with the µSL study the sample size chosen for the SLS 
conduit study was n=7 [see 5.2.4.1]. This would be sufficient to detect differences between 
groups of 35.25%, 12.62% and 7.98% for sprouting index [fig. 6.3], functional axon tracing 
[fig. 6.4] and axon disruption [fig. 6.5] respectively. For justification see section 4.2.3.1. 
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6.2.4.2 Sample Size Calculation Results. 
 
Figure 6.3: Sprouting index analysis power and detectable difference results for SLS conduit 
study when using a  sample size of n=7. Levels[row] = number of intervals; levels[col] = 
number of groups; n[Within] = sample size; SD[Within] = standard deviation value derived 
from M6P study results. Number of intervals [# means] multiplied by number of repair groups 
minus one gives the number of t-tests required for the Bonferroni post-tests [# tests].   
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Figure 6.4: Functional axon tracing analysis power and detectable difference results for SLS 
conduit study when using a sample size of n=7. See fig. 43 for definitions. 
 
Figure 6.5: Axon disruption analysis power and detectable difference results for SLS conduit 
study when using a sample size of n=7. Levels[treatment] = number of groups; see fig. 43 for 
remaining definitions. 
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6.2.5 STATISTICAL ANALYSIS 
Statistical analysis of the results described in this chapter was carried out as stated in 
section 2.3.3. All sprouting index and functional axon tracing results used 2-way ANOVA 
with Bonferroni post-tests; axon disruption results used a 1-way ANOVA with Bonferroni 
post-tests. Differences were considered to be significant when p<0.05. 
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6.3 RESULTS 
The SLS process was able to produce conduits of a suitable size for use in repairing the 
mouse common fibular nerve. A range of different conduit sizes were produced in order to 
determine what size of conduits the SLS machine could produce best, with internal diameter 
and wall thickness proving more critical than length when considering viable designs. 
When wall thicknesses below 0.5mm were trialled the powder compacted within the conduit 
lumen became too difficult to remove, this was also the case when internal diameters 
smaller than 0.8mm were trialled. 
The final design choice of conduit size was 4mm long, with an internal diameter of 0.8mm 
and a wall thickness of 0.5mm. Due to resolution issues the actual internal diameter of the 
conduits used was reduced to approximately 0.6mm, with small increases to the wall 
thickness caused by additional powder becoming attached to the intended conduit wall.  
6.3.1 QUALITATIVE DIFFERENCES BETWEEN GROUPS 
All images obtained for SLS conduits were similar in appearance, with most axons only 
extending a short distance - less than 1.5mm - out from the central nerve ending and 
displaying limited sprouting [fig. 6.6]. Additionally, loose nylon-12 powder - visible as clumps 
of a light haze - was observed within the repaired nerve tissue [fig. 6.6]. In all cases the 
appearance was markedly different to graft repairs [fig. 6.7]  
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Figure 6.6: Typical SLS conduit repair image with intervals marked. Areas of loose nylon-12 powder can be seen around the axons [examples 
marked by white arrows]. Scale bar = 1.0mm. 
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Figure 6.7 [repeat of 5.8]: Typical graft repaired nerve image with intervals marked. Scale bar = 1.0mm. 
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6.3.2 SPROUTING INDEX RESULTS 
Sprouting index levels for SLS conduits ranged from 0.0% to 140.3% [table 6]. The maximal 
sprouting index level for the SLS conduits - as in grafts - was at the 0.5mm interval, where 
the level was significantly higher than uninjured controls [p<0.001][fig. 6.8]. Unlike in the 
graft repairs, the sprouting index levels in the SLS conduits fell markedly at the subsequent 
1.0mm interval back to near uninjured levels and significantly lower than the level observed 
for graft repairs [p<0.001][fig. 6.8]. At the 1.5mm interval the sprouting index level for SLS 
conduits fell again, becoming significantly lower than uninjured levels [p<0.001] while 
remaining significantly lower than graft repairs [p<0.05][fig. 6.8]. At all remaining intervals the 
SLS conduit sprouting index levels were significantly lower than in both graft and uninjured 
groups [p<0.001], with levels falling to almost zero at the 3.0mm interval and then reaching 
zero for the final two intervals.    
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Table 6: Sprouting index levels for SLS, vehicle and uninjured groups [%]. 
 
Repair 
Position 
(mm) 
Average 
Sprouting 
% (SLS) 
SEM 
Average 
Sprouting 
% (Graft) 
SEM 
Average 
Sprouting 
% 
(Uninjured) 
SEM 
-0.5 100 0.0 100.0 0.0 100.0 0.0 
0 107.6 5.7 111.3 4.1 98.3 1.9 
0.5 140.3 14.1 162.4 15.2 95.7 1.1 
1 90.1 13.1 148.2 12.3 98.0 1.4 
1.5 61.7 15.1 113.0 13.8 94.7 2.1 
2 26.4 6.4 105.6 9.0 95.7 1.1 
2.5 7.1 2.9 95.4 3.5 95.7 2.2 
3 0.7 0.7 93.7 7.0 97.7 2.5 
3.5 0.0 0.0 78.4 10.0 97.7 1.5 
4 0.0 0.0 64.8 7.6 97.4 1.9 
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Figure 6.8: Sprouting index levels at 0.5mm intervals along the repairs; *** denotes significant difference compared to graft repairs, p<0.001; ††† 
denotes significant difference compared to uninjured controls. Statistical test: 2-way ANOVA with Bonferroni post-tests.  
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6.3.3 CHANGE IN SPROUTING INDEX BETWEEN INTERVALS 
The maximum increase in sprouting levels occurred at between the 0.0mm and 0.5mm 
intervals in both SLS conduit and graft repairs, with this increase significantly higher than the 
uninjured group [p<0.01 and p<0.001 respectively][fig. 6.9].  
The largest decrease in sprouting index level in the SLS conduit group occurred between the 
0.5mm and 1.0mm intervals, this decrease was significant compared to both graft repairs 
[p<0.01] and uninjured group [p<0.001][fig. 6.9]. This decrease in the SLS conduit group 
occurred earlier than the equivalent decrease in the graft group, which occurred between the 
1.0mm and 1.5mm intervals [fig. 6.9]. An additional significant decrease [p<0.01, compared 
to uninjured] was observed in the SLS conduit group between the 1.5mm and 2.0mm 
intervals [fig. 6.9]. 
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Figure 6.9: Changes in sprouting index levels at each 0.5mm interval compared to the previous interval; ** denotes significant differences in level 
compared graft repairs, p<0.01; †, †† and ††† denote significant differences in level compared to uninjured controls, p<0.05, p<0.01 and p<0.001 
respectively. Statistical test: 2-way ANOVA with Bonferroni post-tests. 
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6.3.4 FUNCTIONAL AXON TRACING 
Significantly fewer individual start axons were present from the 1.5mm interval onwards in 
the SLS conduit group compared to the graft group [p<0.05 at 1.5mm and p<0.001 at 2.0mm 
to 4.0mm][fig. 6.10]. As no axons had reached either the 3.5mm or 4.0mm intervals the 
proportion of start axons at these intervals was obviously zero. 
Unlike in the graft group - where the start axon percentage first became significantly lower 
than in the uninjured group at the 1.0mm interval [p<0.001] - the start axon percentages for 
the SLS conduit group were significantly lower immediately at the 0.5mm interval 
[p<0.05][fig. 6.10]. Start axon percentages for the SLS conduit group, along with the graft 
group, were then significantly lower than the uninjured group from the 1.0mm interval 
onwards [p<0.001][fig. 6.10]. 
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Figure 6.10: Percentages of start axons represented at subsequent 0.5mm intervals; * and *** denote significant difference compared to graft 
repairs, p<0.05 and p<0.001 respectively; † and ††† denote significant difference compared to uninjured controls, p<0.05 and p<0.001 respectively.  
Statistical test: 2-way ANOVA with Bonferroni post-tests.  
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6.3.5 AXON DISRUPTION 
No significant differences were detected between the SLS conduit and graft groups in terms 
of increased axon length across the initial repair disruption [p>0.05][fig. 6.11]. 
Axon length increases across the initial repair disruption in both repair groups were 
significantly higher than for the uninjured group [p<0.05][fig. 6.11].  
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Figure 6.11: Percentage increase in axon length across the initial 1.5mm of repair; * denotes significant difference compared to uninjured controls, 
p<0.05. Statistical test: 2-way ANOVA with Bonferroni post-tests. 
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6.4 DISCUSSION 
6.4.1 VISUAL DIFFERENCES 
The major differences between SLS conduits and grafts were obvious from visual images 
alone, with axons only regenerating part-way into the SLS conduits and none reaching the 
distal nerve ending in any SLS conduit repair [figs. 6.6 and 6.7].  
One interesting observation noted on the images of nerves repaired with SLS conduits was 
the inclusion of opaque specks within the regenerated tissue and around the axons [fig. 6.6]. 
These specks were considered to be unsintered nylon-12 powder from the conduits.  
The potential presence of unsintered nylon-12 powder remaining after production was known 
about prior to implantation, as SLS conduits required packed powder to be removed from the 
conduit lumen. This powder was removed by flushing conduits with 70% IMS using a 
hypodermic needle, with conduits then thoroughly rinsed with alcohol to remove remaining 
powder. Based on what can be seen in SLS conduit images, and also observations made at 
the time that nerves were extracted from the conduits, it would appear that the procedure to 
remove loose nylon-12 powder was unsuccessful. 
6.4.2 DIFFERENCES IN SPROUTING INDEX 
Sprouting index levels in SLS conduits were similar to those in graft repairs at the start 
[0.0mm] and 0.5mm intervals and significantly higher than uninjured controls at the 0.5mm 
interval [fig. 6.8]. The increase in sprouting index at the 0.5mm interval in SLS conduits, 
while not quite as large as that in grafts, was still significantly greater than uninjured controls 
[fig. 6.9]. 
The similarity to grafts did not extend beyond the 0.5mm interval indicating that - as the 
0.5mm interval is considered to be the point where axons have recently exited the central 
nerve ending - regeneration began to fail almost immediately once axons entered the 
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conduit. At the 1.0mm interval the sprouting index levels for SLS conduit repairs significantly 
decreased compared to both graft repairs and uninjured controls [fig. 6.9] and were 
significantly lower than the level in graft repairs overall [fig. 6.8]. Sprouting index levels 
continued to decline in SLS conduit repairs at subsequent intervals, being significantly lower 
than both graft repairs and uninjured controls at all remaining intervals, with only a few axons 
at the 3.0mm interval and no axons regenerating any further [fig. 6.8]. 
Taken together with the visual observations these results strongly suggest that something in 
the SLS conduit design has either an inhibitive effect on regeneration or considerably slows 
the rate of regeneration. Comparing the SLS conduits to the hollow µSL conduits that 
performed equally to graft repairs [see section 5.3.2], three clear differences are present: the 
material conduits are made from [notably the presence of unsintered powder], the internal 
diameter of the conduit and the thickness of the conduit walls. 
The difference in material is unlikely to have caused such a decline in performance, as the 
SLS material [nylon-12] is generally considered to be a biologically inert material (Williams 
and Blayney, 1987). However, the presence of unsintered micro-particles of nylon-12 within 
the conduit and the fact that these particles have been incorporated within the regenerating 
tissue is much more likely to have an adverse effect. 
The size of conduit produced by SLS was close to the limit achievable by the SLS machine, 
resulting in the specified design sizes and actual conduit sizes differing in terms of wall 
thickness and lumen diameter. Additionally, the internal diameter used was the maximum 
possible - due to the required wall thickness - that allowed the conduits to be of a suitable 
size for implantation in the repair location. The SLS conduit design used stated a 0.8mm 
lumen diameter with a 0.5mm thick wall; however, once the nylon-12 powder blocking the 
lumen was removed the actual lumen diameter was approximately 0.6mm [a 0.6mm gauge 
needle could be pushed through with force], much smaller than the internal diameter in the 
µSL [1.0mm].   
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One issue that has been noted in both experimental and clinical conduit repairs [along with 
general studies on nerve regeneration] is that when the regenerating nerve is compressed or 
constricted by the conduit, regeneration is adversely impacted and/or localised pain 
necessitates the removal of the conduit (Krarup and Gilliatt, 1985, Krarup et al., 1988, Itoh et 
al., 2002). This is a particular problem in non-degradable conduits such as silicone tubes 
(Lundborg et al., 1997, Dahlin et al., 2001, Lundborg et al., 2004), as due to increases in the 
myelination of axons occurring over time the axons become constrained by the size of the 
conduit (Schlosshauer et al., 2006). Additionally, as noted in section 3.3.1, tying a suture 
tightly around the end of the sectioned central nerve ending completely prevents 
regeneration from occurring.  
The ideal internal diameter of conduits is debateable, with early studies indicating a diameter 
2.5 to 3 times the size of the nerve (Ducker and Hayes, 1968) and more recent studies 
claiming 1.3 times the size of the nerve to be suitable (Lundborg et al., 2004). Considering 
that the diameter of the mouse common fibular nerve is typically around 0.35mm [based on 
surgical and microscope observations] and in many of the graft repairs the width of the nerve 
was observed to increase to ~0.8-1.0mm, then it does seem likely that regenerating nerves 
within SLS conduits were constrained to some degree by the conduits. Although as some 
axons have managed to regenerate partially across the repair, the level of compression from 
the conduit is probably sufficient to restrict the regeneration of many, but not all, axons 
[fig. 6.12].   
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Figure 6.12: Effects of conduit compression on nerve regeneration. Left: Narrow internal 
diameter of conduit [blue] constricts regenerating nerve, impeding regeneration of outer axons 
[red] while inner axons [green] are cushioned by connective tissue. Right: Wider internal 
diameter allows nerve to regenerate unimpeded. 
The reduced internal diameter for SLS conduits indicates that the wall thickness is at least 
0.65mm, with a strong possibility that additional material was also added to the outer portion 
of the wall further increasing the wall thickness. The detrimental effects of thicker conduit 
walls have been established for many decades, with Ducker and Hayes (1968) noting that 
thicker-walled conduits [1.65mm] resulted in neuroma build up at both central and distal 
nerve endings, an effect absent in thinner-walled conduits [0.13mm]. Den Dunnen et al. 
(1995, 1998) have also reported on the detrimental effects of thicker walled conduits; 
however, in those cases the detrimental effects were caused by the swelling of the conduit 
material constricting the regenerating nerves.  
In most other cases thick conduit walls have a negative effect on regeneration by limiting the 
exchange of nutrients and neurotrophic factors between the conduit interior and surrounding 
tissues (Kokai et al., 2009). As all conduits used in the studies discussed in this chapter and 
chapter 5 were considered non-porous the poor level of regeneration in SLS conduits is 
unlikely to be due to this effect. A possible physical effect of the thicker conduit walls in SLS 
conduits is that the sectioned nerve endings are positioned at a steeper angle when entering 
the conduits [fig. 6.13], this may increase the pressure on the nerve at the edge of the 
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conduit, causing a similar effect to compression on the nerve at that site [see above for 
discussion on effects of excess compression on regeneration].  
 
Figure 6.13: Representation of the impact of conduit wall size on sectioned nerve ending 
positioning.  
6.4.3 FUNCTIONAL AXON TRACING. 
Due to the lack of axons regenerating through to the latter portions of the SLS conduits only 
the proportions of unique axons at the first few intervals are of any real interest for 
comparing to grafts.  
It is difficult to directly compare the significant differences displayed in these results with 
those in the previous chapter due to the effects on statistical analysis of different numbers of 
groups in each study. Additionally, the differences in conduit sizes between the µSL and 
SLS studies is likely to impact on the ability to compare differences between the studies. 
However, it is interesting to note that while both hPEG and SLS conduit repairs have a lower 
[though not significant] sprouting index level than graft repairs at the 0.5mm interval, the 
proportion of unique axons at that interval in SLS repairs was lower than in grafts and 
significantly lower than uninjured controls but in hPEG repairs the proportion remained at a 
similar level to grafts [figs 5.16 and 6.10]. 
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The immediate loss of unique axons in SLS conduit repairs suggests that axons are failing to 
regenerate immediately after exiting the central nerve ending, rather than simply 
regenerating slower than grafts. As discussed in section 6.4.1.2, compression of the 
regenerating nerve can adversely affect regeneration, this compression may also impact 
upon the proportion of unique axons regenerating into the SLS conduits. Regenerating 
axons at the outer edges of the nerve are more likely to be impacted by compression due to 
having a lower quantity of connective tissue surrounding and protecting them [fig. 6.12]. 
Conversely, the regenerating axons closer to the centre of the nerve will be less impacted by 
any compression due to a greater quantity of surrounding connective tissues and other 
axons protecting them [fig. 6.12].  
This selective inhibition of axons would be more likely to result in greater loss of unique 
axons early in the repairs than an effect causing indiscriminate inhibition of axons. This 
would be due to individual axons and their sprouts being closer together at earlier points in 
the repairs, increasing the chance of all sprouts of one axon being inhibited.   
6.4.4 INITIAL AXON DISRUPTION. 
That disruption across the initial 1.5mm of repairs in SLS conduits is the same as in grafts 
shows that, despite having no clear structural obstacles in their path [such as graft scar 
tissue and endoneurial tube location], axons were still diverted to a similar degree as grafts. 
With SLS conduits being of a similar design - although with different dimensions - to the 
hollow µSL conduits used in the chapter 5 study [i.e. single lumen hollow tubes], the 
disruption levels should, hypothetically, be similar to those conduits. However, in the µSL 
study both hollow conduit designs were not considered to have significantly increase axon 
lengths compared to uninjured controls across the initial portion of repairs and had lower 
[though not significantly] increases compared to grafts [see section 5.3.5]. 
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The presence of loose nylon-12 powder within the regenerating nerve tissue [fig. 6.6] may 
have had an influence on the paths taken by regenerating axons. The images obtained from 
SLS conduit repairs indicate that clusters of the powder were situated throughout the repairs, 
which would have created numerous obstacles for regenerating axons to navigate around. 
6.4.5 CONCLUSIONS 
It is clear from the results presented here that at the current time the SLS process is not 
suitable for producing nerve guide conduits. This is due to issues with size tolerance, conduit 
quality and available materials.  
One important issue was that the actual internal diameters of the SLS conduits were smaller 
than the designs had called for, potentially compressing the regenerating nerves and 
retarding axon regeneration. The internal diameter size had been specified as being 0.8mm 
with 0.5mm wall thickness to give an outer diameter of 1.8mm - which was the largest that 
could be suitably positioned in the repair area. When wall thicknesses below 0.5mm were 
trialled the internal diameters were severely reduced and in some cases entirely blocked.  
As the minimum wall thickness was limited by the production method, any increase in 
internal diameter would result in a larger outer diameter conduit. The size of the conduits 
used in both SLS and µSL studies [see chapter 5] was close to the limit of what could be 
implanted using the common fibular nerve injury model and required the minimum age of 
mice at setup time to be increased from 8-weeks [used in M6P and EC23 studies] to 12-
weeks to allow mice to grow to a sufficient size. As such any increases in conduit size would 
risk causing the mice undue discomfort and increase the risk of the conduit becoming 
dislodged by the movement of the joint. 
Another issue is that nylon-12 powder came loose from the conduit and became absorbed 
into the regenerating nerve tissue. This would appear similar to an issue in SLS commonly 
termed the 'orange peel' phenomenon, where surfaces of manufactured objects have an 
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undesirable rough texture. This effect is generally considered to be caused by the use of 
powder that had previously been used but not sintered - though supplementing the used 
powder with new can bring it back up to acceptable levels [48-50% new powder](Dotchev 
and Yusoff, 2009).  
However, in the study discussed here a 50/50 blend of new and used powder was used, 
which should have prevented the 'orange peel' effect. This suggests that the loose powder 
could have been an effect caused by the SLS machine used to produce the conduits being 
near the limit of its resolution when producing such small sized objects. 
 Finally, although nylon-12 is considered biologically inert (Williams and Blayney, 1987), it 
does not fit with the desired properties of an artificial nerve guide - it is rigid, non-
bioabsorbable and non-porous, where the opposite is considered desirable (Ciardelli and 
Chiono, 2006). Nylon-12 [also referred to as polyamide-12] is currently the standard material 
in SLS when using commercially available SLS machines such as the EOS Formiga P100 
used in this study (Johnson et al., 2013). Although other materials can be used in SLS 
[e.g. PCL, nano-hydroxyapatite, calcium phosphate (Bose et al., 2013)] there is a tendency 
for 'in house' purpose built SLS machines to be used rather than commercially available 
ones (Chen et al., 2014). 
Despite the poor results of this study, SLS manufacturing of conduits may still be of use in 
the future. Though in order to be able to provide suitable conduits it is critical that more 
biologically favourable materials can be found to work within the SLS process and that 
manufacturing tolerances can be improved significantly.   
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7.0 GENERAL DISCUSSION 
The aim of this chapter is to:  
 Summarise the previous studies YFP-H mice [sections 7.1.1]. 
 Discuss observations on the use of YFP-H mice within the studies contained within 
this thesis [section 7.1.2] 
 Discuss possible future work that could lead on from the studies contained within this 
thesis [section 7.2] 
 Give a general conclusion on the use of the YFP-H mouse common fibular nerve 
injury model [section 7.3]. 
7.1. USE OF THE THY-1-YFP-H MOUSE STRAIN 
The previous uses of the YFP-H mouse strain and its performance in the studies discussed 
in this thesis will be discussed in this section, the generation of this strain and others is 
discussed in section 1.8.4. 
7.1.1 PREVIOUS STUDIES USING THY-1-YFP-H MICE 
Amongst all of the transgenic mouse strains generated by Feng et al. (2000), the thy-1-YFP-
H strain is by far the most utilised - with the laboratory of Arthur W. English responsible for a 
significant number of studies using the strain (English et al., 2005, Groves et al., 2005, 
Sabatier et al., 2008, English et al., 2011). 
The study by Groves et al. (2005), which investigated the effects of proteoglycan 
degradation on peripheral nerve regeneration, was used as the basis for the development of 
the model used in the studies described within this thesis. Groves et al. (2005) harvested 
graft tissue from both CF nerves of WT mice and soaked tissue from the left CF nerve in 
10µl of PBS and tissue from the right CF nerve in 10µl of chondroitinase ABC, keratinase, 
heparinase I or heparinase III. The graft tissue was allowed to soak for one-hour prior to 
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being used to repair both CF nerves in YFP-H mice, the graft tissue was secured using 
equal ratios of fibrinogen, fibronectin and thrombin and once the surgical site was closed the 
mice were allowed to recover for one-week. Following recovery the repaired nerves were 
exposed and fixed in situ prior to being removed and placed on slides for imaging. 
The analysis methods used by Groves et al. (2005) were based around the number of axons 
regenerating and their length. The first method compared the number of axons prior to the 
injury with the number of axons that had entered the graft, creating a single point sprouting 
index (Groves et al., 2005). The axon length analysis was presented in a more complex 
manner, but essentially measured the entire profile length of the axons entering the graft and 
presented these as cumulative percentage of axons against axon lengths, and percentage of 
all axons reaching four different lengths [100, 200, 500 and 1000µm]. In terms of the 
outcomes of these analyses, Groves et al. (2005) considered increased single point 
Sprouting index levels and a greater proportion of longer axons to represent improved 
regeneration. They concluded that treatment with chondroitinase or heparinase I improved 
regeneration due to significantly higher proportions of axons longer that 1000µm being 
present in those repairs and the significantly higher sprouting index result in heparinase I 
treated repairs [both compared to PBS treated repairs](Groves et al., 2005).    
In addition to the results reported as the main objective for their study [effects of 
proteoglycan degradation on nerve regeneration], Groves et al. (2005) also reported on 
some aspects of the YFP labelling in the YFP-H mouse strain. By investigating the makeup 
of the appropriate dorsal and ventral roots [those at L4 and L5] Groves et al. (2005) were 
able to determine that significantly more sensory axons [58%] were labelled with YFP than 
motor axons [42%], and that the profile of neurone sizes was skewed towards medium and 
large sized neurones in the YFP labelled population. 
However, a separate study by Witzel et al. (2005) - which investigated the pathway sampling 
of axons regenerating through a sciatic nerve graft - reported that 72% of YFP labelled 
202 
 
axons in the sciatic nerve were sensory, with motor axons making-up 28%. Both Witzel et al. 
(2005) and Groves et al. (2005) used relatively low numbers of YFP-H mice [4 and 3 
respectively] which may have introduced some discrepancy between the two studies, though 
the pattern of YFP labelling is reportedly unchanged between mice of the same transgenic 
strain (Feng et al., 2000).  
A more likely cause for the discrepancy in sensory/motor neurone labelling ratios between 
the studies by Witzel et al. (2005) and Groves et al. (2005) is how each study investigated 
this. Witzel et al. (2005) used Fluoro-Gold retrograde labelling in order to dual-label any YFP 
labelled neurons with axons in the sciatic nerve, they then fixed and sectioned [40µm] the 
appropriate dorsal and ventral root sections and counted any double labelled neurons. 
Groves et al. (2005) instead whole mounted the dorsal and ventral roots and used confocal 
microscopy to acquire images of 10µm sections through the entire thickness of the mounted 
tissue. Of the two methods, that of Witzel et al. (2005) appears to have the greater potential 
for error - with the thicker sections perhaps obscuring the fluorescence of some neurones or 
the fact that sections were physically sectioned contributing to possible error. Indeed, issues 
with differing tissue shrinkage between nerve sections were reported to have prevented the 
counting of axons across the sciatic nerve injuries within the study by Witzel et al. (2005). 
Though how these sort of errors would lead to selective bias against detection of YFP 
labelled motor neurones is unclear, as any obscuring of neurones would be expected to be 
random in both dorsal and ventral roots. 
Discrepancies when investigating the patterns of YFP labelling do appear unexpectedly 
common between studies using YFP-H mice. The earliest published study that utilised YFP-
H mice, which investigated the potential for the strain to be used as a tool for investigating 
Wallerian degeneration (Beirowski et al., 2004), differed again to both Groves et al. (2005) 
and Witzel et al. (2005) when reporting on YFP labelling.  
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The study by Beirowski et al. (2004) reported no significant difference between the ratio of 
YFP labelled sensory and motor axons from the L4 dorsal and ventral roots [55% sensory to 
45% motor] - closer to the ratio reported by Groves et al. (2005) [58% to 42%] than that 
reported by Witzel et al. (2005) [72% sensory to 28% motor]. However, unlike the study by 
Groves et al. (2005), Beirowski et al. (2004) reported much lower YFP labelled axon 
numbers overall - an average of 30.5 in the L4 dorsal root and 24.5 in the L4 ventral root, 
compared to the 122.6 and 87.2 respectively reported by Groves et al. (2005). This four-fold 
difference between the studies is difficult to understand but is unlikely to be due to variations 
between mice within the strain - as this would show up in both studies as extremely large 
error values - so must be due to either a difference in techniques or investigator error. The 
main difference reported in the techniques used by Beirowski et al. (2004) and Groves et al. 
(2005) to fix, harvest and image the dorsal and ventral roots was that following transcardial 
perfusion of the mice and tissue harvesting, Beirowski et al. (2004) proceeded to further 
process the tissue prior to whole mounting, whereas Groves et al. (2005) proceeded directly 
to whole mounting the tissue.  
In addition to the large differences in YFP labelled axons reported in the L4 dorsal and 
ventral roots by Beirowski et al. (2004) and Groves et al. (2005), there is a notable difference 
between the studies in terms of the number of YFP axons reported in the sciatic nerve. 
Although only Beirowski et al. (2004) actually reported the quantity of YFP labelled axons in 
the sciatic [28.5 ±8.3 SEM], the number of YFP axons that Groves et al. (2005) reported in 
the CF nerve [36.02 ±2.35] - a branch of the sciatic - makes it clear that, again, there is a 
large discrepancy between the findings of the two studies. Again it is unclear why Beirowski 
et al. (2004) appear to be observing consistently lower YFP labelled axon numbers than 
Groves et al. (2005), despite using similar techniques. Considering that for the studies 
discussed within this thesis, the average number of YFP axons observed in the CF nerve 
prior to the injury site [~30] was similar to that reported by Groves et al. (2005), it would 
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appear that something in the experimental setup used by Beirowski et al. (2004) prevented 
them from observing all YFP axons that were present.   
As mentioned at the start of this section, the laboratory of Arthur W. English has been 
responsible for a large proportion of the studies utilising the thy-1-YFP-H mouse strain. The 
study by Groves et al. (2005) was the second using this particular strain that they had 
published, following shortly after a study demonstrating that neurotrophin-4/5 is required 
during peripheral nerve regeneration (English et al., 2005). In that study, English et al. 
(2005) used graft tissue from wild-type, neurotrophin-4/5-/-, neurotrophin-4/5+/- and BDNF+/- 
mice to repair CF nerve injuries in YFP-H mice. English et al. (2005) concluded that 
regeneration through both neurotrophin-4/5-/- and neurotrophin-4/5+/- grafts was significantly 
worse than through wild-type grafts. 
As with the study by Groves et al. (2005), English et al. (2005) used a single point sprouting 
index and cumulative profile lengths of the axons entering the graft to assess the differences 
between repairs. Also used was the percentage of axons of different profile lengths, 
presented as a histogram with 100µm bin sizing. 
Studies by the same group include a number investigating the effects of treadmill training, 
starting with Sabatier et al. (2008) reporting its beneficial effects on nerve regeneration and 
later following up with studies looking at the effects of neurotrophin-4/5 (English et al., 2011), 
BDNF (Wilhelm et al., 2012) and sex differences (Wood et al., 2012) in combination with 
treadmill training.  
Other laboratories have also successfully used YFP-H mice in a wide range of study types. 
In investigations of peripheral nerve regeneration using YFP-H mice the saphenous nerve 
has proved useful when imaging the same regenerating nerve over a time-course. Pan et al. 
(2003) used transcutaneous imaging in a YFP-H saphenous nerve injury model [using 
transection, crush and crush following a conditioning lesion injuries] to reveal the potential of 
the immunosuppressive drug FK506 to ameliorate the regeneration blocking effects of the 
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chemotherapeutic drug vincristine. A study by Yan et al.(2011) used YFP-H mice to 
investigate the effect of different FK506 dosing regimens on saphenous nerve regeneration 
following crush injury. They reported that in groups where FK506 was administered prior to 
the nerve crush, axon regeneration rate and overall length was improved compared to 
control groups and groups where FK506 administration was delayed, regardless of the 
FK506 concentration (Yan et al., 2011).     
Cheng et al. (2010) reported an interesting effect of hair clipping on the local pattern of 
cutaneous axons. Following hair clipping in YFP-H mice where no skin damage occurred the 
local levels of YFP expression increased, particularly around the hair follicles - this was used 
to demonstrate the plasticity of cutaneous axons (Cheng et al., 2010). 
As with other strains of thy-1-XFP mice [see sections 1.8.5.1 and 1.8.5.4], there has been 
interest in using the YFP-H strain to investigate effects of various insults on retinal ganglion 
cells (Dursun et al., 2011, Kalesnykas et al., 2012, Oglesby et al., 2012, Feng et al., 2013). A 
study by Dursun et al. (2011) investigated the effects of early post-natal ethanol intoxication 
on retinal ganglion cells in YFP-H mice, reporting an overall decrease in cell numbers along 
with altered morphology [reduced soma size and increased dendritic tortuosity].  
A study by Oglesby et al. (2012) used YFP-H mice to develop a semi-automated quantitative 
analysis method of assessing retinal ganglion cell morphology, mapping out the distribution 
of YFP labelled retinal ganglion cells in the retina in the process. This was followed up with a 
study using the developed analysis method to assess retinal ganglion cell morphology 
following optic nerve crush or experimentally induce glaucoma (Kalesnykas et al., 2012). 
The study by Kalesnykas et al. (2012) reported large reductions in YFP labelled retinal 
ganglion cells, axons and dendrite structure following optic nerve crush injuries, and 
reductions in axons but not retinal ganglion cells along with increases in soma size and 
dendritic structure following experimental glaucoma.     
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7.1.2 OBSERVATIONS ON USING THE THY-1-YFP-H MOUSE NERVE INJURY 
MODEL 
In using the YFP-H mouse CF nerve injury model of mice exclusively for the studies 
contained within this thesis both the benefits and limitations of the model can be revealed. 
A key benefit - and one used to great effect in many of the studies discussed in the previous 
section (English et al., 2005, Groves et al., 2005, Sabatier et al., 2008) - is the ability to trace 
the path taken by regenerating axons across the entire repair. Prior to the studies presented 
within this thesis, this tracing generally took the form of tracing axons from the point where 
they exited the central nerve ending to where their regeneration had ended (Groves et al., 
2005). This tracing method was investigated as a potential analysis method when looking at 
how to obtain the best data from the YFP-H model; however, concerns over its accuracy and 
the quantity of analysis-hours required were raised. 
Tracing axons in images from early pilot repairs revealed that many axons took a convoluted 
path through the early stages and many sprouted numerous times across the repair. This 
results in analysers having to decide which sprout to follow and could end up skewing results 
based on the analyser's preference for choosing long/short sprouts. In addition, many axons 
managed to regenerate further into the distal nerve ending than was feasible to excise [the 
CF nerve ultimately passes around the knee joint and becomes difficult to access] so the 
entire length of those axons could not be measured. This, coupled with the convoluted 
routes taken by many axons, results in actual axon length data becoming almost 
meaningless.  
Although marking set intervals onto the images allows a more accurate measure of 
regeneration length to be taken [e.g. every interval crossed by an axon adds 0.5mm to its 
length regardless of if it took a much longer route between intervals], tracing from the central 
nerve ending towards the distal still has an issue with the analyser's choice of which axon 
branches to follow. Thus, the decision was made to trace axons in the opposite direction 
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[distal to central] to take advantage of the convergence of axon branches to improve the 
repeatability of the analysis. 
The addition of the initial axon disruption analysis was made in an attempt to quantify the 
average amount of disruption that traced axons underwent while in the initial stages of the 
repair. Throughout all the studies reported in this thesis the greatest visual disruption in 
repairs occurred between the 0.0mm and 1.5mm intervals, and as such the average path 
length of axons that successfully regenerated between these two intervals was used to 
assess early disruption. A minor issue experienced when using this analysis method was 
that a small number of axons in some repairs doubled back on themselves to re-cross the 
1.5mm interval. In these cases it was decided to measure axon length from the first crossing 
of the interval only to maintain consistency. This also prevented instances where a small 
number of very long doubled back axons could result in a repair with very little other 
disruption being considered to be worse than one with no doubled back axons but much 
greater disruption overall.    
One problem encountered with axon tracing during these studies is that on some occasions 
the fluorescent axons were obscured by excess tissue - such as blood vessels - that had not 
been removed from the nerve prior to mounting [fig 7.1]. Although the removal of as much 
excess tissue as possible was performed upon extracting the nerve, it was not always 
possible to remove all of this tissue due to difficulties in discriminating excess tissue from 
nerve tissue. As some early attempts to remove all excess tissue resulted in damage to the 
nerve tissue it was decided that risking small areas of obscured fluorescence would be 
preferable.   
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Figure 7.1: Close-up view of YFP nerve with suspected blood vessels obscuring fluorescent 
axons. 
Another common issue noted with axon fluorescence were variations in brightness between 
different areas of the nerve [high vs. low axon density] and also between different axons 
[large vs. small axons]. This causes difficulties when obtaining images of the nerves as too 
much brightness results in overexposure and too little results underexposure [both making 
axons difficult to view]. As such the brightness balance used when acquiring images needs 
to be carefully chosen in order to ensure the best possible image is obtained.  
The fact that the YFP fluorescence persists through repeated imaging with no noticeable 
fading is of great benefit for two main reasons. Firstly, acquiring a stack of images through 
the nerve usually takes 30-60 seconds and if the fluorescence faded quickly then the images 
making up the stack would have vastly differing brightness levels - adversely effecting the 
resultant composite image. Secondly, on some occasions the composite images from some 
microscope fields were found to not line up correctly with adjacent fields, necessitating the 
reacquisition of images. 
It was observed during these studies that, although the YFP fluorescence persists through 
repeated imaging, there is a tendency for it begin to leach from the axons into the 
surrounding tissues after approximately 3 to 6 months [fig. 7.2]. Although axons can still be 
made out at this point, the high levels of background fluorescence does make the images 
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difficult to use in analysis. However, the time between nerve harvesting and this leaching 
should be sufficient to obtain any required images. 
 
Figure 7.2: Example of fluorescence leaching into non-axonal tissues in 6-month post-harvest 
nerve. 
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7.2 FUTURE WORK SUGGESTIONS 
7.2.1: INVESTIGATION OF DIFFERENT EC23 CONCENTRATIONS 
Although EC23 did not demonstrate any beneficial effects in the study discussed here there 
are valid doubts as to whether the concentration used was optimal [see chapter 4]. To 
determine whether EC23 is biologically active at the chosen dose [10-8 mol/L], a reporter 
assay - such as a luciferase reporter assay - could be performed on appropriate cells [such 
as nerve, fibroblast and Schwann cell lines]. These assays work by transfecting cells with a 
gene vector containing a promoter response element that produces a bioluminescent 
enzyme when bound to the desired transcription factor [in this case, retinoic acid receptors] 
(Ho et al., 2013).  
A series of in vitro experiments to investigate whether different concentrations have a 
greater influence on regeneration may also be of use. These could take the form of culturing 
intact or dissociated DRGs to determine the effects of various EC23 concentrations on 
neurite outgrowth and Schwann cell migration. If the application of a particular EC23 
concentration proves to be beneficial in terms of increased neurite growth/length or faster 
migration of Schwann cells, then further in vivo experiments may be warranted. 
7.2.2: IMPROVEMENT OF ALIGNED PCL FIBRES 
The use of PCL fibres within conduits in the study discussed in chapter 5 gave disappointing 
results overall, though the one apparently successful repair in those conduits [fig. 5.12] does 
suggest that fibre filled conduits have promise. The poor performance may have been a 
result of the uncoated fibres affecting the dispersal of neurotrophic factors through the 
conduit, poor migration of Schwann cells into the conduit, or simply that axons were unable 
to satisfactorily interact with the fibres [see section 5.4.2]. Coating the fibres with matrix 
proteins, such as collagen or laminin, may help with Schwann cell migration into the conduits 
and axons may be able to interact better with the coated surface.  
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7.2.3: INCORPORATION OF REGENERATION ENHANCING AGENTS AND/OR 
CELLS INTO NERVE GUIDES 
 Adding various neurotrophic factors or support cells to conduits is currently considered to be 
necessary to enable successful regeneration over longer distances than current conduits 
can support [see section 5.1.3.2]. The µSL conduits used in chapter 5 may benefit from the 
addition neurotrophic factors/Schwann cells if they are to be trialled over significantly longer 
nerve defects, with the possibility of incorporating regeneration enhancing agents - such as 
M6P - also worth considering. The question of how to incorporate such things into the 
conduits is one requiring much thought: the simplest way is to combine the desired 
factors/cells/agents with a hydrogel insert; another - requiring a more technical approach - 
would be to incorporate factors/agents into a bioabsorbable conduit material, which would 
then release the factors in a controlled manner to boost regeneration. 
7.2.4: FURTHER CHARACTERISATION OF FLUORESCENCE IN THE YFP-H 
MOUSE STRAIN 
As discussed in section 7.1.2, previous studies have attempted to characterise numbers of 
YFP-H labelled axons in different nerves; however, those studies have tended to vary greatly 
in their conclusions and have generally only dealt with either the sciatic or common fibular 
nerves. In addition, the study by Feng et al. (2000) which reported the generation of this 
strain gave only extremely approximate information regarding fluorescent labelling within the 
different neuronal tissues. Therefore it would be of great interest to use any spare tissue 
from experimental mice to build up a greater level of detail about the levels of YFP-H 
labelling in various neuronal tissues. This information could then be used by investigators to 
design future studies investigating different aspects of the nervous system. 
 
 
212 
 
7.2.5: INVESTIGATE THE POTENTIAL OF A SCIATIC NERVE INJURY MODEL 
IN YFP-H MICE 
Although the CF nerve injury model in YFP-H mice has proven successful in the studies 
within this thesis and elsewhere [see section 7.1.2], sciatic nerve injury models are much 
more common due to the increased size of the sciatic nerve. The advantage of the sciatic 
over the CF nerve is that regeneration across much longer nerve defects can be assessed 
and the nerve is easier to handle during repair. In addition, using the sciatic in a YFP-H 
mouse model would allow better comparisons between this model and others [such as 
electrophysiological ones]. The obvious drawback with a YFP-H sciatic nerve injury model is 
the greatly increased number of YFP axons that would need to be analysed. Whether the 
large number of YFP axons in sciatic nerves can be analysed accurately or not would be the 
main topic an investigation into a YFP-H sciatic nerve injury model.       
7.3 CONCLUSIONS 
Although this model does have some minor drawbacks, the benefits it offers easily outweigh 
them - especially if this model is used in collaboration with other models to gain a broader 
view of the effects of different interventions. This is often the case with other models and 
methods, such as the pairing of electrophysiology with walking gait analysis and histological 
techniques (Ngeow et al., 2011a, Ngeow et al., 2011b).  
In the studies presented within this thesis a number of effects were observed [i.e. decreased 
axon disruption in M6P treated repairs and reduced axons organisation in hollow conduits] 
that would have been either very difficult or impossible to have observed using other 
methods.  
This model also appears to lend itself well to the screening a number of promising 
interventions prior to moving forward with the better performing interventions into longer-term 
studies - mainly as results can be obtained within 2-weeks.  
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So in conclusion, the YFP-H mouse CF nerve injury model provides a valuable tool for 
investigating peripheral nerve regeneration and further use and development of the model 
should be encouraged.  
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